<ead xmlns="urn:isbn:1-931666-22-9" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:isbn:1-931666-22-9 http://www.loc.gov/ead/ead.xsd">
  <eadheader countryencoding="iso3166-1" dateencoding="iso8601" langencoding="iso639-2b" repositoryencoding="iso15511">
    <eadid>FA1103A.xml</eadid>
    <filedesc>
      <titlestmt>
        <titleproper type="filing">Rockefeller University collection of the Medical Letter publication, 1996-2004</titleproper>
        <titleproper>A Guide to the Rockefeller University collection of the Medical Letter publication, 1996-2004 <num>FA1103A</num></titleproper>
      </titlestmt>
      <publicationstmt>
        <publisher>Rockefeller Archive Center</publisher>
        <address>
          <addressline>15 Dayton Avenue</addressline>
          <addressline>Sleepy Hollow 10591</addressline>
          <addressline>archive@rockarch.org</addressline>
          <addressline>URL: <extptr xlink:href="http://www.rockarch.org" xlink:show="new" xlink:title="http://www.rockarch.org" xlink:type="simple"/></addressline>
        </address>
      </publicationstmt>
    </filedesc>
    <profiledesc>
      <creation>This finding aid was produced using ArchivesSpace on <date>2016-11-01 13:41:51 -0400</date>.</creation>
      <descrules>Describing Archives: A Content Standard</descrules>
    </profiledesc>
  </eadheader>
  <archdesc level="collection">
    <did>
      <langmaterial>
        <language langcode="eng">English</language>
      </langmaterial>
      <repository>
        <corpname>Rockefeller Archive Center</corpname>
      </repository>
      <unittitle>Rockefeller University collection of the Medical Letter publication</unittitle>
      <origination label="creator">
        <corpname role="aut" source="lcnaf">Rockefeller University</corpname>
      </origination>
      <origination label="creator">
        <corpname role="aut" source="lcnaf">Medical Letter, Inc</corpname>
      </origination>
      <unitid>FA1103A</unitid>
      <physdesc altrender="whole">
        <extent altrender="materialtype spaceoccupied">122.5 Cubic Feet</extent>
      </physdesc>
      <unitdate normal="1996/2004" type="inclusive">1996-2004</unitdate>
    </did>
    <processinfo id="4f6518ea8bae3b64eb48a7b6e5a4ac82">
      <head>Processing Information</head>
      <p>Minimal processing</p>
    </processinfo>
    <prefercite id="08d6bd5a3343d88ae174562240e1c48c">
      <head>Preferred Citation</head>
      <p>Information regarding the Rockefeller Archive Center's preferred elements and forms of citation can be found at <extref href="http://www.rockarch.org/research/citations.php">http://www.rockarch.org/research/citations.php</extref></p>
    </prefercite>
    <accessrestrict id="8e22992d16c1acad66ec2350a423e469">
      <head>Conditions Governing Access</head>
      <p>Records more than 25 years old are open for research with select materials restricted as noted. Brittle or damaged items are available at the discretion of RAC.</p>
    </accessrestrict>
    <fileplan id="b18026630ad0911a346cf5ce064ebdd5">
      <head>File Plan</head>
      <p>Former Classification: I 891-U</p>
    </fileplan>
    <otherfindaid id="80d67a066600f6ef1d33e75468f27af6">
      <head>Other Finding Aids</head>
      <p>For additional Medical Letter materials open for research see:</p>
      <p>FA241 Rockefeller University collection of the Medical Lettter publication</p>
    </otherfindaid>
    <scopecontent id="96fc3f4b0ecc38c530137eb411f39ada">
      <head>Scope and Contents</head>
      <p>Contents includes: original manuscripts, reprints, advertising and package inserts, sources check, consultatnts drafts, manufacturers replies, and bibliography.</p>
    </scopecontent>
    <bioghist id="6c159867ba2a2151b8b7399752c3890b">
      <head>Biographical / Historical</head>
      <p>The Medical Letter on Drugs and Therapeutics is an independent, non-profit publication providing unbiased critical evaluation of drugs in terms of their effectiveness, adverse effects and possible alternative medications.</p>
    </bioghist>
    <userestrict id="37e428481bbdbecee9f5c722527c7cfc">
      <head>Conditions Governing Use</head>
      <p>Use agreement is required prior to providing access. See RAC Head of Reference for assistance.</p>
    </userestrict>
    <dsc>
      <c id="722d135ab2e6b9a0415068e6118db069" level="file">
        <did>
          <unittitle>TML, 38-9 - Acarbose for diabetes mellitus</unittitle>
          <unitdate type="inclusive">1996 February 2</unitdate>
          <container id="617a6ce86ab68f3f1d052924a3c9b84f" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="2903db2fab578536a216f6dde4b3888e" parent="617a6ce86ab68f3f1d052924a3c9b84f" type="folder">1-4</container>
        </did>
        <accessrestrict id="6413d819e0f61297a55139d343bc6b2f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="8e0dd5900ff39bfca71872aabc11f428" level="file">
        <did>
          <unittitle>TML, 38-55 - Acetaminophen, NSAIDs and Alcohol</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="c5aa82db1a42bac88bd5ab9e32eeb89c" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="11b6835b46fe13636a8e1c0451b6ec13" parent="c5aa82db1a42bac88bd5ab9e32eeb89c" type="folder">5-7</container>
        </did>
        <accessrestrict id="656f8049cade326890b44a882a172390">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="92bb9fbbd017dace4f8bbbdfdcec0a7a" level="file">
        <did>
          <unittitle>TML, 38-43 - Acute reactions to Drugs of Abuse</unittitle>
          <unitdate type="inclusive">1996 May 10</unitdate>
          <container id="b41be28fa5ce088356a2212a7ccb04d4" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="3ae70ee9db82ba19e6c2e53c76bd8525" parent="b41be28fa5ce088356a2212a7ccb04d4" type="folder">8-12</container>
        </did>
        <accessrestrict id="ca3616172a78ef218806617937be4ae3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="299c68349552c9c16b93a8a4762f739e" level="file">
        <did>
          <unittitle>TML, 38-35 - New drugs for HIV</unittitle>
          <unitdate type="inclusive">1996 April 12</unitdate>
          <container id="d0e6da3a7a7bc59a175fc9e1eb78d706" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="8c2dc01a41330d3f48bca42dd3c9a59f" parent="d0e6da3a7a7bc59a175fc9e1eb78d706" type="folder">13-17</container>
        </did>
        <accessrestrict id="86a00cb09aea1b9f00fe35947afa8c0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c5fa85f3bd2884f1a9dfd36830a4fb4d" level="file">
        <did>
          <unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="8375665e814521027fbba003660d708c" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="efa58dca31524487b93d386e433dbb3f" parent="8375665e814521027fbba003660d708c" type="folder">18</container>
        </did>
        <accessrestrict id="6490910db6cb9773d516babe0e3ba2c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="25c672276d8de231f00bfa483bb42cb2" level="file">
        <did>
          <unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="8e53d184cd579877cee6030d20d74572" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="33251203fe2775437919e194fb5967cc" parent="8e53d184cd579877cee6030d20d74572" type="folder">1-3</container>
        </did>
        <accessrestrict id="2d841e9b213eca4386b5020a0f960ab2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="520cba0819f4d1a661ffbae9d84a72d2" level="file">
        <did>
          <unittitle>TML, 38-61 - Anatrozle for metastatic breast cancer</unittitle>
          <unitdate type="inclusive">1996 July 5</unitdate>
          <container id="3ea33d590d54cd1e8c7b20d279b76d50" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="11db76a00acf84d105c230a689b7854b" parent="3ea33d590d54cd1e8c7b20d279b76d50" type="folder">4-6</container>
        </did>
        <accessrestrict id="391e7265783eb309c372f58724caf420">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="b466c2ae20545eb902a029aabfadd4a2" level="file">
        <did>
          <unittitle>TML, 38-25 - Choice of Antimicrobial Drugs</unittitle>
          <unitdate type="inclusive">1996 March 29</unitdate>
          <container id="3a8f04c40036dfae3343ad614b78551b" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="790ab02a81171bfed7b406caf8655b2e" parent="3a8f04c40036dfae3343ad614b78551b" type="folder">7-9</container>
        </did>
        <accessrestrict id="abc8cefbfb0e5ceded73db45b93e2776">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="ef71891079fc8afb056a13746e052f75" level="file">
        <did>
          <unittitle>TML, 38-52 - Drugs for Cardiac Arrythmias</unittitle>
          <unitdate type="inclusive">1996 August 30</unitdate>
          <container id="d19a75082baf7e569982f07bc47ee2b8" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="0d174a223e4261492a6714cd9d892490" parent="d19a75082baf7e569982f07bc47ee2b8" type="folder">10-16</container>
        </did>
        <accessrestrict id="e9ba90f8f6e01a82041a2cb46e749402">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="630284f8fa9310d4604f35f82942ec99" level="file">
        <did>
          <unittitle>TML, 38-52 - Azelaic acid a new topical drug for acne</unittitle>
          <unitdate type="inclusive">1996 June 7</unitdate>
          <container id="26bb8833c57a050024548eff6b582e70" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="7762549e26c108d3d7231f22d7302f4c" parent="26bb8833c57a050024548eff6b582e70" type="folder">17-18</container>
        </did>
        <accessrestrict id="7d350d2c114c77a5007cc5bd6bef48d0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="4b06c4e94eeae1bbd7e893099db3bb23" level="file">
        <did>
          <unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="2425eb4ef754d963686e35209cd84723" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="971c3bf6e9174ab7d66f06ba2a8100bd" parent="2425eb4ef754d963686e35209cd84723" type="folder">19-20</container>
        </did>
        <accessrestrict id="c9d5e1a415d2921805aa74b729504b02">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="cdf8cc07b4cfdaccc7c2d14cfe460d41" level="file">
        <did>
          <unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="42830d910cc97bb36c62d05aece23f74" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="b85a768a37d940874bb0253dbaf0c161" parent="42830d910cc97bb36c62d05aece23f74" type="folder">1</container>
        </did>
        <accessrestrict id="bc8ec69f68ddfbb05692b444a9d33f73">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="8e8440ccfa5de303b70df4a8556b7da1" level="file">
        <did>
          <unittitle>TML, 38-103 - Bone Density Testing</unittitle>
          <unitdate type="inclusive">1996 November 26</unitdate>
          <container id="6ae7aeef13015838afcfa9221aad4756" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="15c20d2cdc59751905e6f85c07989385" parent="6ae7aeef13015838afcfa9221aad4756" type="folder">2-3</container>
        </did>
        <accessrestrict id="9371d9820f979006c113e8341494696d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="2bc3e056d1f8fa2492e7303d95310131" level="file">
        <did>
          <unittitle>TML, 37-109 - Dirithromycin</unittitle>
          <unitdate type="inclusive">1995 November 24</unitdate>
          <container id="ae6b7b172f0283af9efc4e66a6ca0b9f" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="e2ef5246bc41785d24df267fb8080ab6" parent="ae6b7b172f0283af9efc4e66a6ca0b9f" type="folder">4-7</container>
        </did>
        <accessrestrict id="70e63df474c05d465a52ed6834a63c2e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="404e68490aeea4bc03276bd2e1972297" level="file">
        <did>
          <unittitle>TML, 38-108 - Calcium Supplements</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="401593632d6596ad0458986c14f8688b" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="7bf17a79b3af457be2292f8cef063fb3" parent="401593632d6596ad0458986c14f8688b" type="folder">8-12</container>
        </did>
        <accessrestrict id="6397bcfd119b8dee01530ad0c01d2fe0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="787f855d64193a39aa5fa640c29b09f9" level="file">
        <did>
          <unittitle>TML, 38-40 - Radiofrequency cather abilation for treatment of cardiac arrhythmias</unittitle>
          <unitdate type="inclusive">1996 April 26</unitdate>
          <container id="5f3db90f93354fa7fa21ede5f0bd726a" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="42bac0d1d65cdad85eff235e7d0e6fc2" parent="5f3db90f93354fa7fa21ede5f0bd726a" type="folder">13-16</container>
        </did>
        <accessrestrict id="9407b24c4bbb8b9a8280fd95b434f402">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="6ee9fed32bd765fba31910157fc457da" level="file">
        <did>
          <unittitle>TML, 38-23 - Cetibuten - a new oral cephalosporin</unittitle>
          <unitdate type="inclusive">1996 March 15</unitdate>
          <container id="d2ac29e8eb0ba2b1598cfb2a0db8ff84" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="7bf2b78a403f9d474b97d47d7a06e233" parent="d2ac29e8eb0ba2b1598cfb2a0db8ff84" type="folder">17-19</container>
        </did>
        <accessrestrict id="fe428baa314a27bf86569a7a685bf75c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="cf9669d33a59dba3ffbe8f50f22fca78" level="file">
        <did>
          <unittitle>TML, 38-84 - Cefepime (Maxime) - a new parenteral cephalosporin</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="43ae71cdffb5ec584a886d458241ca3b" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="7df2c8ca710e2b912e7a963b16306886" parent="43ae71cdffb5ec584a886d458241ca3b" type="folder">1-4</container>
        </did>
        <accessrestrict id="cd47248ae2cfc55d2fb4424654263054">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="7dd0747a03e955ecdd43cb4fc77cc296" level="file">
        <did>
          <unittitle>TML, 38-46 - Chlorzoxazone hepatotoxsicity</unittitle>
          <unitdate type="inclusive">1996 May 10</unitdate>
          <container id="ccb17a09b1991862cb6cfd28c2a574ed" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="8d0586bf9e50b8662834b60364a00ffb" parent="ccb17a09b1991862cb6cfd28c2a574ed" type="folder">5</container>
        </did>
        <accessrestrict id="2fb3ed462271aeec0fb14801053de435">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="9050bc8c28970ad791e377582e9c079c" level="file">
        <did>
          <unittitle>TML, 38-67 - Choice of Lipid-Lowering drugs</unittitle>
          <unitdate type="inclusive">1996 August 2</unitdate>
          <container id="c2a1ff5d12ac04b1e00e5b823113c746" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="df4912665e5bbd241a5b1bde78a9e7a4" parent="c2a1ff5d12ac04b1e00e5b823113c746" type="folder">6-13</container>
        </did>
        <accessrestrict id="88da501863cd117b47bcae321e4b3b00">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="5c5e7299af1de05e46453f0fea0e1720" level="file">
        <did>
          <unittitle>TML, 38-21 - Cetirizine - a new antihistamine</unittitle>
          <unitdate type="inclusive">1996 March 15</unitdate>
          <container id="e78b42d97a1f1ad587d985f1f73223a1" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="901104b07a4062ccceba698708f680b4" parent="e78b42d97a1f1ad587d985f1f73223a1" type="folder">14-18</container>
        </did>
        <accessrestrict id="0f7c6d142759503d2196573bb0b89f9a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="0f91362447d7a3cdff68d7ebac520b38" level="file">
        <did>
          <unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="b20ab728b6025abaf6cfebac638667d6" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="358af3c7000b76b7764d5fd8cdd00ab4" parent="b20ab728b6025abaf6cfebac638667d6" type="folder">19-20</container>
        </did>
        <accessrestrict id="4e5c9545497b1cea799d01d6d8e16965">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c714362a04b8f852b521155e586e0af2" level="file">
        <did>
          <unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="82b474f4e6942abc55c4f4739bc8a4a7" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="458e0de41f52ce1397b0008e4ddbe53c" parent="82b474f4e6942abc55c4f4739bc8a4a7" type="folder">1</container>
        </did>
        <accessrestrict id="a545b57ddc41b86449988949e310c707">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="484f5bda82347b92c1fd763adae1bf8a" level="file">
        <did>
          <unittitle>TML, 38-64 - Dexfenfluramine for obesity</unittitle>
          <unitdate type="inclusive">1996 July 19</unitdate>
          <container id="0575004b1ee69e3d3c213774dfe02df7" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="bece30c31742223e737838cbaec6a2cc" parent="0575004b1ee69e3d3c213774dfe02df7" type="folder">2-5</container>
        </did>
        <accessrestrict id="0ae4223f8a683f538d4cd77c366f1250">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="8d0423127d33593f9f53a6262dc9f97c" level="file">
        <did>
          <unittitle>TML, 38-87 - Docetaxel (Taxotere) for advanced breast cancer</unittitle>
          <unitdate type="inclusive">1996 September 27</unitdate>
          <container id="be4890a6269d743272b56d7587b31b18" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="a9b920c8d7eb43c7743f08e21191dd4f" parent="be4890a6269d743272b56d7587b31b18" type="folder">6-8</container>
        </did>
        <accessrestrict id="ed7cc80f5cac6080418667469e63fcc5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="a348057f4e83121c70f8e63e18862273" level="file">
        <did>
          <unittitle>TML, 38-14 - Epoprostenol for primary pulmonary hypertension</unittitle>
          <unitdate type="inclusive">1996 February 16</unitdate>
          <container id="88bc2070d2dda9ea0a5e7653fbffd50a" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="8955b9c0930280fde38d9fbb5bb9af04" parent="88bc2070d2dda9ea0a5e7653fbffd50a" type="folder">9-10</container>
        </did>
        <accessrestrict id="9060f4c1941e62cde507283711c42123">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="4fb37dc500fa2658eede9f802e9df8f8" level="file">
        <did>
          <unittitle>TML, 38-95 - Fexofenadine</unittitle>
          <unitdate type="inclusive">1996 October 25</unitdate>
          <container id="f8a9f936bb801a701076f7b0829428df" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="56cbb77b00cefde6cc74be04342f7f3c" parent="f8a9f936bb801a701076f7b0829428df" type="folder">11-12</container>
        </did>
        <accessrestrict id="a8ff5bd8f8c9a8beb936876d0ab13404">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="64be8e3eb6b9a7f019087998bc44abd8" level="file">
        <did>
          <unittitle>TML, 37-13 - Fluvoxamine for obsessive compulsive disorder</unittitle>
          <unitdate type="inclusive">1995 February 17</unitdate>
          <container id="0edc174f30e7ffbdf974f76b8b850c8a" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="cc9a6c2060cbebd4f8f5369aad44e5ab" parent="0edc174f30e7ffbdf974f76b8b850c8a" type="folder">13-16</container>
        </did>
        <accessrestrict id="695bcbd1bf632b907b932d7960966f9f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="892b6eca462f2e15ad9ec8aa8eca30aa" level="file">
        <did>
          <unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="453c46dade710af65a06508b077830ca" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="98362fe7578ec8bd27220bdb2251f123" parent="453c46dade710af65a06508b077830ca" type="folder">17-21</container>
        </did>
        <accessrestrict id="beb3673044e9a99bc1e5e6f80a600a9c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="35c106caf84841f600db741ede502382" level="file">
        <did>
          <unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="8442c96084e34793052eb9b889b2d4ea" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="042add8982dc0769991b19a5628da7dc" parent="8442c96084e34793052eb9b889b2d4ea" type="folder">1</container>
        </did>
        <accessrestrict id="f54d8351e9c7683733c760ddc9c6386f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="9c02c90545e46d220940cf2a507e0a28" level="file">
        <did>
          <unittitle>TML, 38-10 - Systematic antifungal drugs</unittitle>
          <unitdate type="inclusive">1996 February 2</unitdate>
          <container id="ef12546f4cbfe98610de06026fb9a2e8" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="563cde6243c208e93bf32880b0f60c67" parent="ef12546f4cbfe98610de06026fb9a2e8" type="folder">2-3</container>
        </did>
        <accessrestrict id="24650d75f7a4fe5ddaf748532b77d1c8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="af3d9dfc1b1412c493e47fcf1216a75b" level="file">
        <did>
          <unittitle>TML, 38-102 - Gemcitabine for treatment of pancreatic cancer</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="53be6c13aff17f0e2df27c9d45871d25" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="ec39af571b0c11b5f3496f03841a727b" parent="53be6c13aff17f0e2df27c9d45871d25" type="folder">4-6</container>
        </did>
        <accessrestrict id="7105d2dd194378e7c1b806e1786142c0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="237f462175824d3b36e04281c83344ac" level="file">
        <did>
          <unittitle>TML, 38-47 - Glimepiride for NIDDM</unittitle>
          <unitdate type="inclusive">1996 May 24</unitdate>
          <container id="e886a5e829ac5a0ebe279fb5e76e630c" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="1cc9c774f8357ce359b0a427ed90c1aa" parent="e886a5e829ac5a0ebe279fb5e76e630c" type="folder">7-8</container>
        </did>
        <accessrestrict id="d0c68415f609b87b8e322217b54f482b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="f5f43d18d02fa3b8ac7f25b5d2f4bf4e" level="file">
        <did>
          <unittitle>TML, 38-92 - Drugs for chronic heart failure</unittitle>
          <unitdate type="inclusive">1996 October 11</unitdate>
          <container id="e1483c69e6b64c82d7d79344fd787b04" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="8bfc1b77f5aa8472e464b1f76e49a9df" parent="e1483c69e6b64c82d7d79344fd787b04" type="folder">9-13</container>
        </did>
        <accessrestrict id="a3631f3ddc4c9deaa183f2128f324ec8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="df185de80953b9ba72734fc53563026f" level="file">
        <did>
          <unittitle>TML, 37-73 - Grapefruit juice interactions with drugs</unittitle>
          <unitdate type="inclusive">1995 August 18</unitdate>
          <container id="5d34510d9ac2a99198eee871851227cb" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="5b95ba5b5dab56cf3a456df1662574bb" parent="5d34510d9ac2a99198eee871851227cb" type="folder">14-16</container>
        </did>
        <accessrestrict id="ee2185b1e98265927be53db9e0fa2dda">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="9ea393808d7941a34a9237ff7d3e21d0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">1995</unitdate>
          <container id="9cf20697fd26b7279c894dcc8efbb277" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="61e690bc1df143401aa4efc6ff058a09" parent="9cf20697fd26b7279c894dcc8efbb277" type="folder">17-20</container>
        </did>
        <accessrestrict id="052ebcc34a91845237e97c0df53775e3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="b5728f730c61991eb3d049832355c05c" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">1995</unitdate>
          <container id="5df321a5ac1be9be1d4c624ad00d59c5" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="504b34cf8f5ca0a632b016ba454b4bd0" parent="5df321a5ac1be9be1d4c624ad00d59c5" type="folder">1-2</container>
        </did>
        <accessrestrict id="8725ceb0317248c73c37ce2386f5e01b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="34fded3e81407289cef7298c43db888c" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Pain</unittitle>
          <unitdate type="inclusive">1995</unitdate>
          <container id="39b35162129180e8771b2be726546b63" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="c7814a2b0755746684edeccca36aed8e" parent="39b35162129180e8771b2be726546b63" type="folder">3-7</container>
        </did>
        <accessrestrict id="fd6c1b22c3706f5ee95e16758bf6f9f6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="73f114dc6e630afb990634a443031d95" level="file">
        <did>
          <unittitle>TML, 37-95 - OTC H2 Blockers for heartburn</unittitle>
          <unitdate type="inclusive">1995 October 27</unitdate>
          <container id="dab33ac714b83c9f33eb52aa9c0d0a40" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="892de799614dda491047ed878d181f73" parent="dab33ac714b83c9f33eb52aa9c0d0a40" type="folder">8-10</container>
        </did>
        <accessrestrict id="6f9d54ac52d448a971ae1e70ff68a5a9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="e3ff759a8063b390ff0175205e40649d" level="file">
        <did>
          <unittitle>TML, 38-6 - Rho (D) IV Immune Globulin</unittitle>
          <unitdate type="inclusive">1996 January 19</unitdate>
          <container id="7433ff117acaf3617fae52dbe3443c71" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="cd6bd71ff5d002547bb912945e4f9835" parent="7433ff117acaf3617fae52dbe3443c71" type="folder">11-13</container>
        </did>
        <accessrestrict id="ce939d07fa2fe96e5b623cff81c37a02">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="343b5e9d7ba1058f32a08341d9be9f4a" level="file">
        <did>
          <unittitle>TML, 38-17 - Advice for Travelers</unittitle>
          <unitdate type="inclusive">1996 March 15</unitdate>
          <container id="80e119ca7936a66ec1172a67f0314954" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="b2efb484095c00a3d1d10224b6373829" parent="80e119ca7936a66ec1172a67f0314954" type="folder">14-16</container>
        </did>
        <accessrestrict id="c3bea7a676bd5b9981068ccf42242297">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="314ebfe0a12d0bad31002df2bbabf782" level="file">
        <did>
          <unittitle>TML, 37-98 - Influenza Vaccine, 1995-1996</unittitle>
          <unitdate type="inclusive">1995 September 1</unitdate>
          <container id="1e869725a448a72cd3aac82834770b0e" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="a894e9ddad6eaa7af87299ef52ca2890" parent="1e869725a448a72cd3aac82834770b0e" type="folder">17</container>
        </did>
        <accessrestrict id="aaa5f55ecc1b4da36b3c2d152b9841b0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="fa30b8e25d30bd60ee7b9207731748dd" level="file">
        <did>
          <unittitle>TML, 38-86 - Influenza Vaccine, 1996-1997</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="c255783f2930c329f10eda8ce5e3ff76" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="7222ee648869caf718d5d0a87964e750" parent="c255783f2930c329f10eda8ce5e3ff76" type="folder">18</container>
        </did>
        <accessrestrict id="5726a4d76a933c3152d68d2618f96f58">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="76dcb6a56a7b5f83636afb906304e3de" level="file">
        <did>
          <unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle>
          <unitdate type="inclusive">1996 July 5</unitdate>
          <container id="918bfde64bef6ed0bfbc02f7e0bb4d1c" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="789b43e713c82d548391f53bb05a9b8d" parent="918bfde64bef6ed0bfbc02f7e0bb4d1c" type="folder">19</container>
        </did>
        <accessrestrict id="c85f0b8357c82829d2a4eb5e651846cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="bcfc06fa9fa8a02872f2c29e1146f46b" level="file">
        <did>
          <unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle>
          <unitdate type="inclusive">1996 July 5</unitdate>
          <container id="fbf6b754fd6acf298f5ddb574447c80d" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="474ecb88bb0e0e40b672cb7f27e02816" parent="fbf6b754fd6acf298f5ddb574447c80d" type="folder">1-4</container>
        </did>
        <accessrestrict id="5afb2bc4dd74607653137719b41bcbd1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="ca2a00af5d69b29922032ebf4abb0fa9" level="file">
        <did>
          <unittitle>TML, 38-63 - Interferon beta IA for relapsing multiple sclerosis</unittitle>
          <unitdate type="inclusive">1996 July 19</unitdate>
          <container id="862c7ab7a804567d5ba092655404a1f2" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="8868b8f6c820c2ad2b67a374a1f5ece4" parent="862c7ab7a804567d5ba092655404a1f2" type="folder">5-6</container>
        </did>
        <accessrestrict id="03343319e99b7f0ef24a7fc83ce57bad">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c90350a57c09afa4b1edf8990faf82c4" level="file">
        <did>
          <unittitle>TML, 38-5 - Intraconazole for onychomycosis</unittitle>
          <unitdate type="inclusive">1996 January 19</unitdate>
          <container id="13e6d6f831cf9044c18f0fcf94cd5a18" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="42acecbf6354b793dfbdf4a6820a752f" parent="13e6d6f831cf9044c18f0fcf94cd5a18" type="folder">7-10</container>
        </did>
        <accessrestrict id="a3ae42f0dfac2f6884835c0dd4cbe74b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="838bd206e5b57f1350c9a04ae42f2583" level="file">
        <did>
          <unittitle>TML, 38-100 - Latanoprost - A topical prostaglandin for glaucoma</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="f4e0973f7a6556b20b7160b63e580c63" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="f85554c2fb3c37db11a660c542be11d3" parent="f4e0973f7a6556b20b7160b63e580c63" type="folder">11-14</container>
        </did>
        <accessrestrict id="2e48e9ac6a735700c373ee378f599caa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="45a205e5a189cb71c6708535b75c4937" level="file">
        <did>
          <unittitle>TML, 38-97 - Lispro - A rapid onset insulin</unittitle>
          <unitdate type="inclusive">1996 October 25</unitdate>
          <container id="40a9e5663f1aa4b00d58ebcb078f7266" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="7011a60cd38978fa3aaac359e7ad013a" parent="40a9e5663f1aa4b00d58ebcb078f7266" type="folder">15-16</container>
        </did>
        <accessrestrict id="0c7d5401af543b0c0983defbe212a6e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="2cbe2967f283fa20d7d713e0125238d8" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="c9bcf515a238e058f2953bf691c127d3" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="201014bed2562633fd19fb54378947ce" parent="c9bcf515a238e058f2953bf691c127d3" type="folder">17-18</container>
        </did>
        <accessrestrict id="25976cdf1f32d7fc8a1e78cb2f48d34d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="f7093bc2141bbd10998f3dc5ff41875b" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="6acca9088e00612133edc84314a378bd" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="e95d1f763d81cf1bde3161b9793d05ee" parent="6acca9088e00612133edc84314a378bd" type="folder">1-3</container>
        </did>
        <accessrestrict id="5de98fca91cbe16591ff580840223c8c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="e7f67d0b2048a576bdc2a8c6ef1f5674" level="file">
        <did>
          <unittitle>TML, 38-13 - Nisoldipine - a new calcium-channel blocker for hypertension</unittitle>
          <unitdate type="inclusive">1996 February 16</unitdate>
          <container id="ea321913cc2ddcec32a7d61363427865" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="2627bdb6a8d6699f01dec615a5c8627e" parent="ea321913cc2ddcec32a7d61363427865" type="folder">4-7</container>
        </did>
        <accessrestrict id="310f0f0a8b17bda4d5be0d11e8e3909a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="0ab086d0742f0a6f31a054d358cbefcf" level="file">
        <did>
          <unittitle>TML, 35-62 - Nedocromil for asthma</unittitle>
          <unitdate type="inclusive">1993 July 9</unitdate>
          <container id="34c92e11970e0792f71aa02db04092d9" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="444a31cfe6d437ba4e1860f2a9d90ccd" parent="34c92e11970e0792f71aa02db04092d9" type="folder">8-12</container>
        </did>
        <accessrestrict id="d876b6e0e035d2d97ee9711f878a831c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="9f3042b173404cf6a3ccd9df900d20c0" level="file">
        <did>
          <unittitle>TML, 38-1 - New drugs for osteoporosis</unittitle>
          <unitdate type="inclusive">1996 January 5</unitdate>
          <container id="fdcbe00e7d8c4e8090599e385d9c9a6c" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="1d2b1b9fbcfa54efc0e496060a4a51c4" parent="fdcbe00e7d8c4e8090599e385d9c9a6c" type="folder">13-18</container>
        </did>
        <accessrestrict id="059f4c0e348f3f79f9eac8942a1b7673">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="e20404fc9c2c5857d90b819cb9c70cc0" level="file">
        <did>
          <unittitle>TML, 38-53 - Prostatron</unittitle>
          <unitdate type="inclusive">1996 June 7</unitdate>
          <container id="d948dc7b563200ea4e5c78e14ed0c4ff" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="4af4df9366bce6f178007542d687e0ff" parent="d948dc7b563200ea4e5c78e14ed0c4ff" type="folder">19-20</container>
        </did>
        <accessrestrict id="fa8555c81ed0ff184e52c7e939db327c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="cbfa8d04b93b4e3d89a843bbf9e3d7f8" level="file">
        <did>
          <unittitle>TML, 38-107 - Pallidotomy for Parkinson's Disease</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="6764ab9e6a7b97bf4c50a3cc61c1a0b9" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="68b6a940c73ad91e07c2ee915dbfd345" parent="6764ab9e6a7b97bf4c50a3cc61c1a0b9" type="folder">1-3</container>
        </did>
        <accessrestrict id="6ec525e7fd9b38dcd1bce23ad46d101c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c1416d4fc58c7899cbc27ca73d15c172" level="file">
        <did>
          <unittitle>TML, 38-57 - Simethicone for gastrointestinal gas</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="e8b73e10b5d50a9081184e46caa87c69" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="aedffbba08d716c125a435ae6c4fca26" parent="e8b73e10b5d50a9081184e46caa87c69" type="folder">4-5</container>
        </did>
        <accessrestrict id="76d78aedee8d1ddf219a07affe27bb10">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="26af25957e59124a08f91eba499fc700" level="file">
        <did>
          <unittitle>TML, 38-106 - Sodium Phenylbutyrate for urea cycle enzyme deficiencies</unittitle>
          <unitdate type="inclusive">1996 November 22</unitdate>
          <container id="6e2b5d0b7a7511be947a5ce65dd396e0" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="a8841eb631ea4991e2ab4c81238f3b10" parent="6e2b5d0b7a7511be947a5ce65dd396e0" type="folder">6-7</container>
        </did>
        <accessrestrict id="8f55e867e223cf7fc8c205180e5bb1b9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="4273a72d699f99aeabfcab12d5bde513" level="file">
        <did>
          <unittitle>TML, 38-72 - Terabinafine for onychomycosis</unittitle>
          <unitdate type="inclusive">1996 August 16</unitdate>
          <container id="1bab2b5862d58573218741e1644c1f89" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="918626b412d8fe43682803e38a5acf5e" parent="1bab2b5862d58573218741e1644c1f89" type="folder">8-11</container>
        </did>
        <accessrestrict id="f99d89a3af0b743be45c7d543c9a47b3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="afa8fcead3849c57e46148fac07fdf16" level="file">
        <did>
          <unittitle>TML, 38-49 - Androderm (Testosterone patches)</unittitle>
          <unitdate type="inclusive">1996 May 24</unitdate>
          <container id="6c09b80fcb6fa246b2cafa08e1d71726" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="e783d1d321c6d7c88a5b8d9e23be8ac6" parent="6c09b80fcb6fa246b2cafa08e1d71726" type="folder">12-15</container>
        </did>
        <accessrestrict id="6c9daad633f6ca6f23f9cb9675ec5725">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="e83fc33c009862fb85873ce44225451e" level="file">
        <did>
          <unittitle>TML, 38-96 - Toptecan hydrochloride for metastic ovarian cancer</unittitle>
          <unitdate type="inclusive">1996 October 25</unitdate>
          <container id="b2f40c79ac213597c9c0c0da3050fe48" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="baab6b4b1363cd7eae5450949362c3f4" parent="b2f40c79ac213597c9c0c0da3050fe48" type="folder">16-18</container>
        </did>
        <accessrestrict id="f4f4ca0b76dee28258679841660c3e53">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="1d1e2499f47a2c5a2498c508251c060e" level="file">
        <did>
          <unittitle>TML, 38-3 - Valacyclovir</unittitle>
          <unitdate type="inclusive">1996 January 5</unitdate>
          <container id="f8e06d6b1f2631d363326639af3a2129" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="970cafc3fd18240d3c247527c5bc2db2" parent="f8e06d6b1f2631d363326639af3a2129" type="folder">19</container>
        </did>
        <accessrestrict id="5e026f0f926c42121383574e48a743ca">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="e3cd99c272218799e02c72a5e28f33c9" level="file">
        <did>
          <unittitle>TML, 38-3 - Valacyclovir</unittitle>
          <unitdate type="inclusive">1996 January 5</unitdate>
          <container id="31faea6fccf1eb751ad9dfce0bab0c95" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="31e0bcb735143124c4307db11b7d79ce" parent="31faea6fccf1eb751ad9dfce0bab0c95" type="folder">1-2</container>
        </did>
        <accessrestrict id="ed67782a99870c0e712a42cf95c5cfc7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="2146f075bfb01adf0c99fddbe6268b26" level="file">
        <did>
          <unittitle>TML, 38-104 - Trandolapril - An ACE inhibitor for treatment of hypertension</unittitle>
          <unitdate type="inclusive">1996 November 22</unitdate>
          <container id="0ae0bba094cca231f54e311da7016b98" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="ed6c739322d4adc008292b5d2e641564" parent="0ae0bba094cca231f54e311da7016b98" type="folder">3-5</container>
        </did>
        <accessrestrict id="a1dd4aa7256167e609397b035b7478d7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="7a2f268994b16b4876604d64167ade0b" level="file">
        <did>
          <unittitle>TML, 38-71 - Umbilical cord blood for bone marrow transplantation</unittitle>
          <unitdate type="inclusive">1996 August 16</unitdate>
          <container id="98e9715eff3369264f8ae5c4b12060ed" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="4dcdeb0ad558ba1ef5a25c3160a3582c" parent="98e9715eff3369264f8ae5c4b12060ed" type="folder">6-8</container>
        </did>
        <accessrestrict id="c284795ebfbae6dd142f49e2c3d64449">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c7fa6ad1765f84becedf7fbe8dae1981" level="file">
        <did>
          <unittitle>TML, 38-51 - Clarithromycine and omeprazole of helliobacter pylori</unittitle>
          <unitdate type="inclusive">1996 June 7</unitdate>
          <container id="7a75d5853530e3c3ebdafd5e10360914" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="3cb6d75a5b39389951c09c4312d8c862" parent="7a75d5853530e3c3ebdafd5e10360914" type="folder">9-11</container>
        </did>
        <accessrestrict id="d93e4e485f03621de43519409ecd0ebb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="d2847f832cf8b7dfa8bae10d4079561b" level="file">
        <did>
          <unittitle>TML, 38-15 - New Uses of Thalidomide</unittitle>
          <unitdate type="inclusive">1996 February 16</unitdate>
          <container id="17e3512405b6c8c1cc008ff64be856b7" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="605afdf3fff8d65e9fee733746917367" parent="17e3512405b6c8c1cc008ff64be856b7" type="folder">12-14</container>
        </did>
        <accessrestrict id="5a934c0b2b5e5cf25f836a73de95c999">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="07f911d357717fedb196ba2a95b08c6f" level="file">
        <did>
          <unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="76dd68aec9a18bd4b3599572857a93f3" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="2ffaa23f6efb24a5284d21c0b96f0acc" parent="76dd68aec9a18bd4b3599572857a93f3" type="folder">15-19</container>
        </did>
        <accessrestrict id="7ad69902cf7b5b84adb8b1470b88ef97">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c0d2ae8c9a59eb2afc81bad688a8e0d9" level="file">
        <did>
          <unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="a73d1901b812a3169841031fa224c5cf" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="acf0f9acd86a8d44f0a92e34ede24913" parent="a73d1901b812a3169841031fa224c5cf" type="folder">1-2</container>
        </did>
        <accessrestrict id="42570c5418d18c7d11e5ecb6d56fc38d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="0d91fc0adca0e054072c6a3fff1ac1f6" level="file">
        <did>
          <unittitle>TML, 38-65 - Drugs past their expiration date</unittitle>
          <unitdate type="inclusive">1996 July 19</unitdate>
          <container id="0332e8cedf1282706afb4e7e10be7bff" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="1607866887e15496a2ad6e6ecdf3eec8" parent="0332e8cedf1282706afb4e7e10be7bff" type="folder">3-4</container>
        </did>
        <accessrestrict id="861175c1c60e1d08ff94909fca12e380">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="b6e8488842fc6d3ed56539b8c5e7c344" level="file">
        <did>
          <unittitle>TML, 38-38 - Ibutilide</unittitle>
          <unitdate type="inclusive">1996 April 12</unitdate>
          <container id="61ed2bf1aa76c9298ff6914f6b108b74" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="3c76c3fd42f8a41818e21541846e0151" parent="61ed2bf1aa76c9298ff6914f6b108b74" type="folder">5-6</container>
        </did>
        <accessrestrict id="d854aa1bc446941f011a8970567a2b37">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="93c5ceb8486269a6440d4a1164bd8a19" level="file">
        <did>
          <unittitle>TML, 38-91 - DHEA</unittitle>
          <unitdate type="inclusive">1996 October 11</unitdate>
          <container id="40cb566d6ea54a36fff2fcf011b9382c" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="0fbf108704fd9d0f26f44059ee46349c" parent="40cb566d6ea54a36fff2fcf011b9382c" type="folder">7-9</container>
        </did>
        <accessrestrict id="0b753cb331038a0a1193ae254361f43e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="489aaa51c24f7c3822366d6381860b83" level="file">
        <did>
          <unittitle>TML, 38-88 - Meropenem - A new parenteral broad-spectrum antibiotic</unittitle>
          <unitdate type="inclusive">1996 September 27</unitdate>
          <container id="812573781a51d459e221d03abf59fe4c" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="f4003f08f419f07b07993c26e7897822" parent="812573781a51d459e221d03abf59fe4c" type="folder">10-14</container>
        </did>
        <accessrestrict id="06a4c2f05bc64d8b4ee6a3b07e593fe9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="3a54f51aec4a83bee985f1670be2aff6" level="file">
        <did>
          <unittitle>TML, 38-39 - Methotrexate and Misoprostol for abortion</unittitle>
          <unitdate type="inclusive">1996 April 26</unitdate>
          <container id="d126cd7444a169576c1d13e07e3a6e7b" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="77749acf67855581977d2acb83d90126" parent="d126cd7444a169576c1d13e07e3a6e7b" type="folder">15</container>
        </did>
        <accessrestrict id="6b3edef9531f4a2fde2d3628c5d7cdd0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="43193a32312eb0204d12fd64fa6b6993" level="file">
        <did>
          <unittitle>TML, 38-111 - Zafirlukast for asthma</unittitle>
          <unitdate type="inclusive">1996 December 20</unitdate>
          <container id="61d5b90dd15655d593302654020fcd0b" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="6d3b06a9d500b55a6253a30912997c8e" parent="61d5b90dd15655d593302654020fcd0b" type="folder">16-18</container>
        </did>
        <accessrestrict id="13e892949bbc4a48ce8c4285b3b1007e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="49b7007dcadc3c636c88f299dc526e0d" level="file">
        <did>
          <unittitle>TML, 31-83 - Samarium 153 lexidronam for painful bone metastases</unittitle>
          <unitdate type="inclusive">1997 August 29</unitdate>
          <container id="1d1dc29a180eaf2e592255a89ef909f8" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="c32808e9817cbf0bbde6439cf829c91e" parent="1d1dc29a180eaf2e592255a89ef909f8" type="folder">1-3</container>
        </did>
        <accessrestrict id="592e1bece31e2f3f6b5ae1b6e1a8011e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="61b0c640e3f013a34c64133724020fa2" level="file">
        <did>
          <unittitle>TML, 38-69 - Drugs for non-HIV viral infections</unittitle>
          <unitdate type="inclusive">1997 August 1</unitdate>
          <container id="a860cbaf331461e1f7906af0f072e4b6" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="4f809eaf4637cf22f49e60c23b983b2c" parent="a860cbaf331461e1f7906af0f072e4b6" type="folder">4-12</container>
        </did>
        <accessrestrict id="84c4988675afd57f7b095139aa7bfdfe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="133977107f40fa3272c401b7abcc89de" level="file">
        <did>
          <unittitle>TML, 39-18 - Zileuton for asthma</unittitle>
          <unitdate type="inclusive">1997 February 28</unitdate>
          <container id="c8652ec10dbf6d59cb86115a30a20908" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="8bd5c19ec93c4a4f510ef748711d60b4" parent="c8652ec10dbf6d59cb86115a30a20908" type="folder">13-14</container>
        </did>
        <accessrestrict id="4717fa288dd120e806e05499350ddf6f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="be46a606b805462c6cc03b6ec8b2c39e" level="file">
        <did>
          <unittitle>TML, 39-9 - Zinc for the common cold</unittitle>
          <unitdate type="inclusive">1997 January 31</unitdate>
          <container id="eb6d51c62dddeb0709024713d21daaf8" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="4b56f5dd0f0cbb9ef9b9fc59aee43b87" parent="eb6d51c62dddeb0709024713d21daaf8" type="folder">15-17</container>
        </did>
        <accessrestrict id="ad1088be46d6652eb0405e32258a0bf9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="1a7499e6fbd604c0b75b6d778dc5c0f9" level="file">
        <did>
          <unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="0e6224d857193d231b19198a6434a548" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="d2686a3d85a25134570e633c2de5ca63" parent="0e6224d857193d231b19198a6434a548" type="folder">18-20</container>
        </did>
        <accessrestrict id="ebe0ac100a42ac94570bd02c0e0ccdbb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="c3fee2e8cf6e2d58695098807e086dab" level="file">
        <did>
          <unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="b01dc9153227fe7d4ae7fad7732ca5f7" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="220a84cd2e78232b1c000c7e20ea306c" parent="b01dc9153227fe7d4ae7fad7732ca5f7" type="folder">1</container>
        </did>
        <accessrestrict id="898d939f278bc6e6c335eb092f07c5a8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="393de6e6b75d4f4817695af30349dd68" level="file">
        <did>
          <unittitle>TML, 39-80 - Ropivocaine - a new local anesthetic</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="b23c61a62a32024572926be97cf3b612" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="53097719f08b93eb6d5e62c9eec28afb" parent="b23c61a62a32024572926be97cf3b612" type="folder">2-4</container>
        </did>
        <accessrestrict id="7af0a96e2cfe06eaffa6999f5bfd2c77">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="4be741eb1bacb7f18527f5b2df647302" level="file">
        <did>
          <unittitle>TML, 39-41 - Levofloxacin and sparfloxacin</unittitle>
          <unitdate type="inclusive">1997 April 25</unitdate>
          <container id="0087d266f555d96b209721e46fb5d7b5" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="c959f26e2ade18ecf4debaef197b7246" parent="0087d266f555d96b209721e46fb5d7b5" type="folder">5-10</container>
        </did>
        <accessrestrict id="7550d2d00d3b056285daa384c568544b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b81fc7aadd5fecc407e846095655da0e" level="file">
        <did>
          <unittitle>TML, 39-10 - Lasers in dermatologic surgery</unittitle>
          <unitdate type="inclusive">1997 January 31</unitdate>
          <container id="e0ec28ae38c5d59f7bcfe1e6f24d3080" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="8963880f33636a8036ca17d823c86dac" parent="e0ec28ae38c5d59f7bcfe1e6f24d3080" type="folder">11-15</container>
        </did>
        <accessrestrict id="0f1f31dc544a7820b6b3740572840e2c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="d6a872b6263ad2beca76d2809d741c78" level="file">
        <did>
          <unittitle>TML, 39-84 - Skin surgery with lasers - an additional note</unittitle>
          <unitdate type="inclusive">1997 August 29</unitdate>
          <container id="4fafadcf5a110688c06177526aaa05d6" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="ead5eed6cd96f71aaa15a24fb47e5b02" parent="4fafadcf5a110688c06177526aaa05d6" type="folder">16</container>
        </did>
        <accessrestrict id="37b13c54d0d04ba5299304f96256cfc0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="62572ae54e7b47c32783a5b7f9f92261" level="file">
        <did>
          <unittitle>TML, 39-51 - Topiramate for epilepsy</unittitle>
          <unitdate type="inclusive">1997 May 23</unitdate>
          <container id="f93e524c9b8108b288557dd4b2c2e465" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="c7d1a871a52d9d3eb3181eba53d452d5" parent="f93e524c9b8108b288557dd4b2c2e465" type="folder">17-19</container>
        </did>
        <accessrestrict id="1f453b72cb65c772c8bbcb8b965fc251">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="bbfc9de7adb6df0701f6173947f38bd2" level="file">
        <did>
          <unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="f74664b08c6cd902f2d4e7a3ba73fee1" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="d3fb5c47ad0269178a88f679aa42db6f" parent="f74664b08c6cd902f2d4e7a3ba73fee1" type="folder">20</container>
        </did>
        <accessrestrict id="63c006cdd8a94fd253916b0a5c2fcbfc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="6b378b12b2f16c81d85d36343d81a41b" level="file">
        <did>
          <unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="e126175729fcc71cf22c160eef249b47" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="daaeadf96ae0199513c67f598062d9c5" parent="e126175729fcc71cf22c160eef249b47" type="folder">1-2</container>
        </did>
        <accessrestrict id="62290c3388efd25a1b03329c60a4c2c5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="bf256a51de793456a4c7d083f141288c" level="file">
        <did>
          <unittitle>TML, 39-65 - Tiludronate for Paget's disease of bone</unittitle>
          <unitdate type="inclusive">1997 July 18</unitdate>
          <container id="c4bd3f443a1bd9001f13a0f209bc7bb1" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="d077c9894b51e2d4deecd3496fbc79a8" parent="c4bd3f443a1bd9001f13a0f209bc7bb1" type="folder">3-5</container>
        </did>
        <accessrestrict id="a0af36cf2f0f39c3b6bf43a2f3d1a8f3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="e50c791d98c44790d8141d27cd4cfcab" level="file">
        <did>
          <unittitle>TML, 39-62 - Tizanidine for spasticity</unittitle>
          <unitdate type="inclusive">1997 July 4</unitdate>
          <container id="e473641e04244d6646f67e291d1a5691" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="54c0678ee359fea719d4ffe4057eeb56" parent="e473641e04244d6646f67e291d1a5691" type="folder">6-8</container>
        </did>
        <accessrestrict id="264d6479c0b4544b7007e8c452a7cee5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="12444cf584e83734f66bfc290040544a" level="file">
        <did>
          <unittitle>TML, 39-49 - Troglitazone for non-insulin-dependent diabetes mellitus</unittitle>
          <unitdate type="inclusive">1997 May 23</unitdate>
          <container id="14aadcb7e93fc48b48658c63da350101" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="403f194e4bee1c59da068347286bc72b" parent="14aadcb7e93fc48b48658c63da350101" type="folder">9-11</container>
        </did>
        <accessrestrict id="c2dbaf70c1400524b9601ade32d9aa09">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="64f0edfa5bd3b5159911a74e751d912b" level="file">
        <did>
          <unittitle>TML, 39-43 - Valsartan for hypertension</unittitle>
          <unitdate type="inclusive">1997 April 25</unitdate>
          <container id="1579ed26d42f179a2ccaf41956150a76" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="9b5781bc55783555e011b55ccd98890a" parent="1579ed26d42f179a2ccaf41956150a76" type="folder">12-14</container>
        </did>
        <accessrestrict id="d5a76faf4ca30d9de5137cfcad807f6e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="eb014687998353d0fb60326357526127" level="file">
        <did>
          <unittitle>TML, 39-1 - Drugs for treatment of peptic ulcers</unittitle>
          <unitdate type="inclusive">1997 January 3</unitdate>
          <container id="d4e4ae272493583515eb4148156cdc36" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="567e9491b30779e55e7eeefdf7d93b27" parent="d4e4ae272493583515eb4148156cdc36" type="folder">15-20</container>
        </did>
        <accessrestrict id="1fcec8ea591c0f4b6123d11e89e69ddb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="3436a17eac9c6f31692eb5d354b51a44" level="file">
        <did>
          <unittitle>TML, 39-109 - Pramipexole and Ropinirole for Parkinson's disease</unittitle>
          <unitdate type="inclusive">1997 November 21</unitdate>
          <container id="5b3335ce38207a7b1bdf7bcf7a4d64f7" label="Mixed Materials (A0000000075858)" type="box">16</container>
          <container id="fb519c43146d31a52c850960d1d5963f" parent="5b3335ce38207a7b1bdf7bcf7a4d64f7" type="folder">1-4</container>
        </did>
        <accessrestrict id="9f23fe9c137d23133c2b5049c5b64530">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="ea94f0229ffb76d4e8a48dbf172eec36" level="file">
        <did>
          <unittitle>TML, 39-105 - New drugs for psoriasis</unittitle>
          <unitdate type="inclusive">1997 November 7</unitdate>
          <container id="f9dee2886affecc25a2729acd3d980f7" label="Mixed Materials (A0000000075858)" type="box">16</container>
          <container id="fb523da8e551eb8b149ce836b0387948" parent="f9dee2886affecc25a2729acd3d980f7" type="folder">5-8</container>
        </did>
        <accessrestrict id="d1471d567708b0ca9a5c6d93f5f254f0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="12f50952f7ba8eb3afd7e492d332b4a1" level="file">
        <did>
          <unittitle>TML, 39-33 - New drugs for psychiatric disorders</unittitle>
          <unitdate type="inclusive">1997 April 11</unitdate>
          <container id="44c84e2621a4dc31b4d9e07ea8acdd03" label="Mixed Materials (A0000000075858)" type="box">16</container>
          <container id="dd88124ab761afb7cd69b1514cb29bd3" parent="44c84e2621a4dc31b4d9e07ea8acdd03" type="folder">9-15</container>
        </did>
        <accessrestrict id="dbaf4673299ed575f189876448054a58">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="123a71748e8ade20af228276bab2d8b6" level="file">
        <did>
          <unittitle>TML, 39-117 - Quetiapine for schizophrenia</unittitle>
          <unitdate type="inclusive">1997 December 19</unitdate>
          <container id="645db67571282b39f61acd078f9ecb4c" label="Mixed Materials (A0000000075858)" type="box">16</container>
          <container id="52320f79ea7b0e2528590c30cefd93ca" parent="645db67571282b39f61acd078f9ecb4c" type="folder">16-18</container>
        </did>
        <accessrestrict id="8bbc739b2ed931419befe4ab8eb4eb63">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="498df0f2d9dce92679b2aa347629be3f" level="file">
        <did>
          <unittitle>TML, 39-17 - Reteplase (Retavase)</unittitle>
          <unitdate type="inclusive">1997 February 28</unitdate>
          <container id="0c1bc0e9eef643d9d186ee82807b569c" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="7cc974b23a4f59dfc50a77d1bc0f5f18" parent="0c1bc0e9eef643d9d186ee82807b569c" type="folder">1-2</container>
        </did>
        <accessrestrict id="b2dca34162d6868414a816046edfdff2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="6ba7d8b0dcb752d130b074f42b440dd7" level="file">
        <did>
          <unittitle>TML, 39-53 - Donepezil (Aricept) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">1997 June 6</unitdate>
          <container id="c0178345458544284acadc5cb0845a8a" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="e5d12c1bbf2d364774a1a5ed9660775f" parent="c0178345458544284acadc5cb0845a8a" type="folder">3-5</container>
        </did>
        <accessrestrict id="6532d645696e8a65297e0563e103f695">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="7c2e04e9e7b332289a442e6977a1f7d9" level="file">
        <did>
          <unittitle>TML, 39-81 - Diagnostic tests for HIV</unittitle>
          <unitdate type="inclusive">1997 August 29</unitdate>
          <container id="f3e21edbf8cc045bd3039f9dce5c1113" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="51c3fe2a891fd92e2b545e57ed0c9c1d" parent="f3e21edbf8cc045bd3039f9dce5c1113" type="folder">6-10</container>
        </did>
        <accessrestrict id="9570ef3f38bf3a851322c3c3fb7d17cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="fdd2b028e08760f46ba2467c4b638924" level="file">
        <did>
          <unittitle>TML, 39-21 - Drugs of Choice - Cancer Chemotherapy</unittitle>
          <unitdate type="inclusive">1997 March 14</unitdate>
          <container id="e40c0dc24eb102fae81730119ecb2319" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="a4e78b537385a98d94ee202e59917d20" parent="e40c0dc24eb102fae81730119ecb2319" type="folder">11-16</container>
        </did>
        <accessrestrict id="28f03f207bd6c378f505103883232f68">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="42935bf2b5b11b084838a1252d3b3db8" level="file">
        <did>
          <unittitle>TML, 39-77 - Bupropion for smoking cessation</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="694058d024d667c8f3d1b71b004bf9b7" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="5a9abb62c597a8403a704c2177fce523" parent="694058d024d667c8f3d1b71b004bf9b7" type="folder">17</container>
        </did>
        <accessrestrict id="6c0f62c3539d7b57d8122eb2501ba830">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="be3b6c8f67d8d9c4ef7e3226b17983fb" level="file">
        <did>
          <unittitle>TML, 39-63 - Topical butenafine for tinea pedis</unittitle>
          <unitdate type="inclusive">1997 July 4</unitdate>
          <container id="f2c0a7a8bd6236645399b46b5deaf172" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="2d15784588ddc791c906fc203661fdf0" parent="f2c0a7a8bd6236645399b46b5deaf172" type="folder">1-2</container>
        </did>
        <accessrestrict id="5cc6b055d5b6e621ab0c71131fdd66e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="856acb144bbba7a94b1cb63f73185f43" level="file">
        <did>
          <unittitle>TML, 39-56 - Pentosan</unittitle>
          <unitdate type="inclusive">1997 June 6</unitdate>
          <container id="4fd2fe90343cc17ba1409229a0a808c1" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="711422b883e20d64b9bcef871bf1e391" parent="4fd2fe90343cc17ba1409229a0a808c1" type="folder">3-4</container>
        </did>
        <accessrestrict id="9279dfdd8fa0fb9cdb6e31006d0ff6a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="afd34d20934d1be77bfc49f4d1241183" level="file">
        <did>
          <unittitle>TML, 39-103 - Mibefradil - a new calcium-channel blocker</unittitle>
          <unitdate type="inclusive">1997 November 7</unitdate>
          <container id="aa6a2e86c89b7e7ec7bfd1497acb2020" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="fd682cbb74b49a56a8b23d5729107aa0" parent="aa6a2e86c89b7e7ec7bfd1497acb2020" type="folder">5-8</container>
        </did>
        <accessrestrict id="bc77a13d4a14fc45f23bfb7a5bb57c5d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="de42e2f43ebae331da9c0b8180abb87c" level="file">
        <did>
          <unittitle>TML, 39-59 - Midodrine for orthostatic hypotension</unittitle>
          <unitdate type="inclusive">1997 June 20</unitdate>
          <container id="df21acec429af2168e7d72d2cb7ef45b" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="11ceea9357d849336a1e9c522bba7684" parent="df21acec429af2168e7d72d2cb7ef45b" type="folder">9-11</container>
        </did>
        <accessrestrict id="01d73c68e8dd39b1c0b73b6d7700c7a0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="96ceef3812b648bc28698beed66c5d75" level="file">
        <did>
          <unittitle>TML, 39-47 - Treatment of Lyme disease</unittitle>
          <unitdate type="inclusive">1997 May 9</unitdate>
          <container id="f521862857a007e87d14efcba4572957" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="39bdd7a14fc12895bb532efc319d59a8" parent="f521862857a007e87d14efcba4572957" type="folder">12-14</container>
        </did>
        <accessrestrict id="1456685e80bfcccf0ad9c93511c65c4d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="eaedccce6a322747a43e566f8dfc2b7d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="04f7a38ba51e2c93c84a09c5fce213df" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="bbd7b9c799778a778bccde9a8ec45dc9" parent="04f7a38ba51e2c93c84a09c5fce213df" type="folder">15-17</container>
        </did>
        <accessrestrict id="640807ffbd5e5ea720da4f60f781a4b9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="95b6682482a9d062317fcf262cc7f718" level="file">
        <did>
          <unittitle>TML, 39-85 - Influenza vaccine</unittitle>
          <unitdate type="inclusive">1997 September 12</unitdate>
          <container id="2fd7057a0cbb395043a83ada228250eb" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="74a22cd0841aee844d76ef12650dfc4a" parent="2fd7057a0cbb395043a83ada228250eb" type="folder">18</container>
        </did>
        <accessrestrict id="bae55e07ca01b84992a5b395e88b6ccc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="9c5534af6d0a227ae1ad47876c813383" level="file">
        <did>
          <unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="4e0837636fdd50cf09b984677b10fa07" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="0275aa0a02e07d192fa47e4b55dd2eed" parent="4e0837636fdd50cf09b984677b10fa07" type="folder">19</container>
        </did>
        <accessrestrict id="071f86249d57b3a639f1f0ac1e82c1db">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="8d02c5507ec798ca4d7bb6188acc62a5" level="file">
        <did>
          <unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="e8e9b3fa830c32d3fd27831c36308c71" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="b307abd361ca47f40fe8fe88c261a400" parent="e8e9b3fa830c32d3fd27831c36308c71" type="folder">1</container>
        </did>
        <accessrestrict id="36454ffdeab70b1b39646403fa3b2960">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="0cdb2a091afd3228142c89eb37d2380a" level="file">
        <did>
          <unittitle>TML, 39-118 - Imiquimod for genital warts</unittitle>
          <unitdate type="inclusive">1997 December 19</unitdate>
          <container id="d50fb73f36235bfb25b9e236c226c537" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="031ee5a7b36e611eba27947d2d679351" parent="d50fb73f36235bfb25b9e236c226c537" type="folder">2-3</container>
        </did>
        <accessrestrict id="d975c63ad23263fd275260f9460dcf1e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="f4d2ffb826a588ff6c493adbd06a92be" level="file">
        <did>
          <unittitle>TML, 39-64 - Drugs for epilepsy</unittitle>
          <unitdate type="inclusive">1997 February 6</unitdate>
          <container id="c950c9d3efd654070d7a66a4f5dec6bb" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="42f790cf23e69894eaffd9b5423c7064" parent="c950c9d3efd654070d7a66a4f5dec6bb" type="folder">4-6</container>
        </did>
        <accessrestrict id="c20b70cbd97aa855e62537fb259a09f6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="028b89ba84e332c879eab9899c191875" level="file">
        <did>
          <unittitle>TML, 39-66 - Fosfomycin for urinary tract infections</unittitle>
          <unitdate type="inclusive">1997 July 18</unitdate>
          <container id="2eb1f4c97ae8bc8d8c4426a8023f9bf0" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="c3f513d967b1f8302958a24dcfec645f" parent="2eb1f4c97ae8bc8d8c4426a8023f9bf0" type="folder">7-9</container>
        </did>
        <accessrestrict id="e0aa9d9341298313dcd22b6a4157d3bc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="73ee7f93d0af26d64d0c1fc7ba0c7201" level="file">
        <did>
          <unittitle>TML, 39-86 - Systemic antifungal drugs</unittitle>
          <unitdate type="inclusive">1997 September 12</unitdate>
          <container id="59d2f6d98d51c76536eab6ccb4c91807" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="fdbcd073658da56698e2ca72deacff17" parent="59d2f6d98d51c76536eab6ccb4c91807" type="folder">10-13</container>
        </did>
        <accessrestrict id="226ecab6ab43654c9c5dd63a5e3e2b52">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="6bf77dfe11efd36cf8146b826560cb4c" level="file">
        <did>
          <unittitle>TML, 39-61 - Glatiramer acetate for relapsing mutiple sclerosis</unittitle>
          <unitdate type="inclusive">1997 July 4</unitdate>
          <container id="efbd0b587ff053c48d9db18d8bae29fa" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="ecfd84d4e532e5ad7b98947ab87cc51b" parent="efbd0b587ff053c48d9db18d8bae29fa" type="folder">14-16</container>
        </did>
        <accessrestrict id="58267fbb42c582dd03ac8830411c1803">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="f36ff800dacbd73013d42dab42cf5f5b" level="file">
        <did>
          <unittitle>TML, 38-6 - Drugs for head lice</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="8d4e2b6d50a752845f68705090ac8c15" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="e60432156d52693ed2eeafd864a50708" parent="8d4e2b6d50a752845f68705090ac8c15" type="folder">17-18</container>
        </did>
        <accessrestrict id="92296119b0cbe67e59973a003090f421">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="e13f3fa0ec576057f7033815a81111e1" level="file">
        <did>
          <unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle>
          <unitdate type="inclusive">1997 September 26</unitdate>
          <container id="ac681380658643a42453dc08364c70d2" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="bcebdce6a1850e03e1a7b1b167a8ad38" parent="ac681380658643a42453dc08364c70d2" type="folder">19-20</container>
        </did>
        <accessrestrict id="e7cb03a6203eb58d2833529692c66d60">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="dfc2de9cdb5bf3a8437e564fa717ffbd" level="file">
        <did>
          <unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle>
          <unitdate type="inclusive">1997 September 26</unitdate>
          <container id="34fd28b7e3e2517f2cf6ca4d3d5bd449" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="16e7e3a9841ade17ace6db45b14ed79f" parent="34fd28b7e3e2517f2cf6ca4d3d5bd449" type="folder">1-2</container>
        </did>
        <accessrestrict id="d913972842d3a79acf9b906df7f951e7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="95d8be151e4ef26242db019df375f791" level="file">
        <did>
          <unittitle>TML, 39-94 - Drugs for hypertension</unittitle>
          <unitdate type="inclusive">1997 November 1</unitdate>
          <container id="3b0b97371cd7362b608e24a3f1ff483d" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="5716a95826ed4edb57b480c1175fad33" parent="3b0b97371cd7362b608e24a3f1ff483d" type="folder">3-5</container>
        </did>
        <accessrestrict id="2db96bdb2ad3f2367bdf1559b5ea1133">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="f8696aa81da52173ff18b97bd7eb4067" level="file">
        <did>
          <unittitle>TML, 39-19 - Adapalene for acne</unittitle>
          <unitdate type="inclusive">1997 February 28</unitdate>
          <container id="1090a6ba2ad4ac5c4fd703aba5a9b3c1" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="1bc5c7292aaba8f9bccfbdd0033f7d34" parent="1090a6ba2ad4ac5c4fd703aba5a9b3c1" type="folder">6-7</container>
        </did>
        <accessrestrict id="cefd2ab82f2cd38f2cef5b4253fea1fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="d3c8f38c2b75ab98def9cb12e7933ba3" level="file">
        <did>
          <unittitle>TML, 39-29 - Atorvastatin - a new lipid-lowering drug</unittitle>
          <unitdate type="inclusive">1997 March 28</unitdate>
          <container id="0d88d7de39f6f235ff6ba0366c5d4883" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="3b77e6afdc10af40e6fac9c52703a051" parent="0d88d7de39f6f235ff6ba0366c5d4883" type="folder">8-9</container>
        </did>
        <accessrestrict id="f50e6cdc96d78aa80586f8c46bb4b44f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b2a72d06fe2be2cec8bad5a6a0fda27b" level="file">
        <did>
          <unittitle>TML, 39-45 - Azelastine nasal spray for allergic rhinitis</unittitle>
          <unitdate type="inclusive">1997 May 9</unitdate>
          <container id="15a66661e3e0504b4991fcbb2d387798" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="cf713781573279a19ea0f9ff4327de4b" parent="15a66661e3e0504b4991fcbb2d387798" type="folder">10-13</container>
        </did>
        <accessrestrict id="2c8bdc164c637c083bf92b35d52554fc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="36e76c3b20aacff333ba5d98cfca27de" level="file">
        <did>
          <unittitle>TML, 39-12 - Betaine for homocystinuria</unittitle>
          <unitdate type="inclusive">1997 January 31</unitdate>
          <container id="189778b552eb758237ad3a136bc0125c" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="98cfa6f3f5e274a369f98af7843aec0a" parent="189778b552eb758237ad3a136bc0125c" type="folder">14-15</container>
        </did>
        <accessrestrict id="55bd4c86ccf4811f99aac2673693e945">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="e4ca902373c4579a78db0d3b8d513633" level="file">
        <did>
          <unittitle>TML, 39-93 - Bromfenac for analgesia</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="f05da5fb523acb8be16aa12cbdeb4f4a" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="a2d0039e833c18d18e488086504de7e0" parent="f05da5fb523acb8be16aa12cbdeb4f4a" type="folder">16-17</container>
        </did>
        <accessrestrict id="18bd5ce580d159e1acce03ad34266cc9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="1a9cef87a6b1f62bf27f90e19d47c4e1" level="file">
        <did>
          <unittitle>TML, 39-54 - Brimonidine - an alpha2-agonist for glaucoma</unittitle>
          <unitdate type="inclusive">1997 June 6</unitdate>
          <container id="73a97ce38f9b0db6c68433c572c75f6f" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="5a8ad5d4048a0548f725f69dc5c1c148" parent="73a97ce38f9b0db6c68433c572c75f6f" type="folder">18-19</container>
        </did>
        <accessrestrict id="c12a956b010223394c6ca9d2025942d6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="56fc5093674d1372e80ed218ae8bd368" level="file">
        <did>
          <unittitle>TML, 39-13 - Safety of channel blockers</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="98c8d8441d19c8934e921646e29f688d" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="267ba8b87a5c12098a0bf4bd8431581c" parent="98c8d8441d19c8934e921646e29f688d" type="folder">20</container>
        </did>
        <accessrestrict id="12b089183fda270bbeecc135b190b589">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="1f85013ec13e639596b728f22f1aafc4" level="file">
        <did>
          <unittitle>TML, 39-13 - Safety of channel blockers</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="6fe1ac1fec21da44247a52bca03523ac" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="04233a9596e208d4661a670fe89fa81d" parent="6fe1ac1fec21da44247a52bca03523ac" type="folder">1-2</container>
        </did>
        <accessrestrict id="8a33d90a046f00da2d8b9b030020c09e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b4a11be555144c67db801913b3a95361" level="file">
        <did>
          <unittitle>TML, 39-58 - Cabergoline for hyperprolactinemia</unittitle>
          <unitdate type="inclusive">1997 June 20</unitdate>
          <container id="2fdd3abad4ec58ff46744f6e41611dad" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="7c845eb59c3fb5f13cc5570fbeb3136a" parent="2fdd3abad4ec58ff46744f6e41611dad" type="folder">3-6</container>
        </did>
        <accessrestrict id="300ca74e312c726f3bc6c5c2409ffa88">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="8fa954deb6dc2ce7385244a3d8abc5a9" level="file">
        <did>
          <unittitle>TML - Dovonex</unittitle>
          <unitdate type="inclusive">1993</unitdate>
          <container id="cfef558835f86d36d152cff7027dde87" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="1928debec02c2ba26274e69de472b397" parent="cfef558835f86d36d152cff7027dde87" type="folder">7</container>
        </did>
        <accessrestrict id="7ed0890a439df753466be5a70bc31770">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="c70f3345ad4c90f6af9d560ffb1f3777" level="file">
        <did>
          <unittitle>TML, 39-108 - Olopatadine for allergic conjunctivitis</unittitle>
          <unitdate type="inclusive">1997 November 21</unitdate>
          <container id="fc46f9b34dba10d9d033c403516b4477" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="a6880bcb7d91aee44fdf5afaaa40247e" parent="fc46f9b34dba10d9d033c403516b4477" type="folder">8-9</container>
        </did>
        <accessrestrict id="7e05d25159387c3bcb0a7a1a1a57fbe9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="0f25168045c3874b852fc2566864c22b" level="file">
        <did>
          <unittitle>TML, 37-1 - Drugs for asthma</unittitle>
          <unitdate type="inclusive">1996 January 6</unitdate>
          <container id="234d2ac307c6ab37d994615aeb97cc55" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="b66a08538d009fd6daee37a8c51e8f5f" parent="234d2ac307c6ab37d994615aeb97cc55" type="folder">10-14</container>
        </did>
        <accessrestrict id="5124cbd46d2a439f4f59c00468b6016b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="dbe0049fdc51d967d42b54af228c58ae" level="file">
        <did>
          <unittitle>TML, 39-32 - Intra-transurethral Alprostadil for impotence</unittitle>
          <unitdate type="inclusive">1997 March 28</unitdate>
          <container id="361321890cabf6529981b5f88b4453b9" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="ab7b656222a3d3daa380dbc744a6f937" parent="361321890cabf6529981b5f88b4453b9" type="folder">15-16</container>
        </did>
        <accessrestrict id="108454fd852ec91b5893f1a78b4694b9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="3fff697896297fb5b3e546b99c7bb615" level="file">
        <did>
          <unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="1d7a36448d689c6b75e1d09b6b77b813" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="e05effc99547f9245280e15bc11a51f3" parent="1d7a36448d689c6b75e1d09b6b77b813" type="folder">17-21</container>
        </did>
        <accessrestrict id="6e01c10d6e482faec33ca1e6f744b4e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="ac009d8a6eba90db98f499f6852dd496" level="file">
        <did>
          <unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="1ae1aff24453b4c7d47ac05ad1186621" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="ef6ee4591da7d89a0926edbc079c2571" parent="1ae1aff24453b4c7d47ac05ad1186621" type="folder">1-3</container>
        </did>
        <accessrestrict id="1cdb7a1ff11f6e216e339e64f20c58a7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="364c7d8d424593144cdef790c4e94d75" level="file">
        <did>
          <unittitle>TML, 39-111 - AIDS - Drugs for HIV infection</unittitle>
          <unitdate type="inclusive">1997 December 12</unitdate>
          <container id="103e719010eb60f2b22921be1d7271d2" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="c4d96cf498e6d57883a4537b123af1f4" parent="103e719010eb60f2b22921be1d7271d2" type="folder">4-9</container>
        </did>
        <accessrestrict id="a96e0ada70322de7df279993ca3ff3a5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="fe5bfd483d4da9cb09abcd8d8e9114e4" level="file">
        <did>
          <unittitle>TML, 39-97 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">1997 October 24</unitdate>
          <container id="ae33fc6bc381444260becb7149ee24b9" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="612e88e4c2a969866a8420cf693ac8d1" parent="ae33fc6bc381444260becb7149ee24b9" type="folder">10-15</container>
        </did>
        <accessrestrict id="ce3e85fc72e05bedc7f21da6973965b7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="6568c1026445dec6f8e364671c21bd39" level="file">
        <did>
          <unittitle>TML, 39-120 - Anagrelide for essential thrombocythemia</unittitle>
          <unitdate type="inclusive">1997 December 19</unitdate>
          <container id="9136d81d4dcd38942f3c52f791ef6299" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="443f9780a63bea74a65de19d2ddd39be" parent="9136d81d4dcd38942f3c52f791ef6299" type="folder">16-18</container>
        </did>
        <accessrestrict id="8df589a9af326009da84ebecd5cf8932">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b0b4f71d2ecf84b337ced4a504f89306" level="file">
        <did>
          <unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="549daf5aa0e2dd23ec2b60c308adb7c1" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="3623cd4772d21da3172cd3345c0df410" parent="549daf5aa0e2dd23ec2b60c308adb7c1" type="folder">19</container>
        </did>
        <accessrestrict id="8df622f363be5b50961c92589e209dc4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b1ac2f651904161cd98b8d42f99e3aa1" level="file">
        <did>
          <unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="a31c8809c9d43b4e51bb8096b48fb1c1" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="02fad2f0328e645b3467da5fc19f0eff" parent="a31c8809c9d43b4e51bb8096b48fb1c1" type="folder">1-4</container>
        </did>
        <accessrestrict id="181d3a4b218653d1790e4861871f62dd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="edca2ebba2d38b14ec07a5b9c16a0276" level="file">
        <did>
          <unittitle>TML, 39-89 - Carvedilol for heart failure</unittitle>
          <unitdate type="inclusive">1997 September 26</unitdate>
          <container id="28edd228c8d6d467ff57f7f278df40b6" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="44b10c53981243a2fed8e5d69643e7c6" parent="28edd228c8d6d467ff57f7f278df40b6" type="folder">5-9</container>
        </did>
        <accessrestrict id="f5705dc19e306f206ec780b8d160e15c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="3f1ba5c10401cadfc440c87da71224cb" level="file">
        <did>
          <unittitle>TML, 39-57 - Topical penciclovir for herpes labialis</unittitle>
          <unitdate type="inclusive">1997 June 20</unitdate>
          <container id="0adf3d86e1548db81d7b37534631a9ef" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="d5a3ad7fe2b101b5ff496cd58c3ce94a" parent="0adf3d86e1548db81d7b37534631a9ef" type="folder">10-11</container>
        </did>
        <accessrestrict id="053d8eeeb8327c9a50460b4a07f88f4f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="6311bd1ab3c17838b525980881eb7804" level="file">
        <did>
          <unittitle>TML, 38-17 - Drugs for migraine</unittitle>
          <unitdate type="inclusive">1995 March 3</unitdate>
          <container id="e0a1944cc3d51b01445196cfc4cb1c98" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="f60e45bc7bc4f6d9dac6ac5066c698bf" parent="e0a1944cc3d51b01445196cfc4cb1c98" type="folder">12-16</container>
        </did>
        <accessrestrict id="3d255045a576ae1c355c7f2fcc48b4a7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="d46efc5621917384073357b190321659" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="442b513d287b0028f6067e6f2d5cd10a" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="adca6cd0acc6d9788975f14c1b82fca1" parent="442b513d287b0028f6067e6f2d5cd10a" type="folder">17-21</container>
        </did>
        <accessrestrict id="663777121320adda427992b307d1db2f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="fa4a7928ccfffaadb72cf4771e4d8edc" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="4cf9b42d02716afff8729c8ccb8af144" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="aba1501fcfcc0f9629025a64f6dd79e0" parent="4cf9b42d02716afff8729c8ccb8af144" type="folder">1</container>
        </did>
        <accessrestrict id="702b01fd73a7deda0a72869d6f566a47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="318ae2efe1275c93a47e9ae522f706ea" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="1d7e6d74a05f440eaf8ef07b7de7adc2" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="baf95fee560bf95d6b1965388b49086b" parent="1d7e6d74a05f440eaf8ef07b7de7adc2" type="folder">2-3</container>
        </did>
        <accessrestrict id="f2ea2b6f0f794d84b25ea1befb0a8255">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b4b3b22e307f4ce6c5d2eb8f6d664d9c" level="file">
        <did>
          <unittitle>TML, 38-5 - Olanzapine for schizophrenia</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="6a956d635903bdae977475e1c75718ba" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="e442f5559467aa86de294bc5c5983107" parent="6a956d635903bdae977475e1c75718ba" type="folder">4-6</container>
        </did>
        <accessrestrict id="54d3d516459a5d0fc04e78b00339b8f9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b5cf0dfe90fdcc6067f140e30b6809d1" level="file">
        <did>
          <unittitle>TML, 38-113 - Mirtazapine - a new anti-depressant</unittitle>
          <unitdate type="inclusive">1996 December 20</unitdate>
          <container id="6ab450b0fa111a1787dbe3933455b8e6" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="a65523666054494a02e8c0a3e13a8a6b" parent="6ab450b0fa111a1787dbe3933455b8e6" type="folder">7-9</container>
        </did>
        <accessrestrict id="6a61863bdf42f359838de02eb3140260">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="c2e1fc197d7490d826da206b516a38a5" level="file">
        <did>
          <unittitle>TML, 40-5 - Drugs of Choice - Rheumatoid Arthritis</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="e05da95b4ffb041fd366dc344f7fbf59" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="96906b64c4af22eadf768ad7f33ac812" parent="e05da95b4ffb041fd366dc344f7fbf59" type="folder">10-16</container>
        </did>
        <accessrestrict id="5d151812a70ad7aab1e31b15864a8198">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="fc12244326436c163ce3062f2ee5441e" level="file">
        <did>
          <unittitle>TML, 40-59 - Clopidogrel for reduction of artherosclerotic events</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="bdfbd10046c40e5ff03a0740c51ae5b5" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="c321534ba0d4f06e461c088484f16292" parent="bdfbd10046c40e5ff03a0740c51ae5b5" type="folder">1-3</container>
        </did>
        <accessrestrict id="010c90cf26351f4881154a4f6ad41ad3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="b00d90227ff22e5ebe7df4b968c6ec73" level="file">
        <did>
          <unittitle>TML, 40-113 - Citalopram for depression</unittitle>
          <unitdate type="inclusive">1998 December 4</unitdate>
          <container id="cbd7771eae7d61847899d4f659595156" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="706f124d6b750561c51467efdae845c8" parent="cbd7771eae7d61847899d4f659595156" type="folder">4-8</container>
        </did>
        <accessrestrict id="e132e378e63282bf8014cd21bd84bf26">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="85788caeb20c27238d916bb497645405" level="file">
        <did>
          <unittitle>TML, 40-52 - Anthrax vaccine</unittitle>
          <unitdate type="inclusive">1998 May 8</unitdate>
          <container id="ce8939f88562526528359e9aed9c7a74" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="5c0cf66e1ac027c5596f3ed1f905ef16" parent="ce8939f88562526528359e9aed9c7a74" type="folder">9-10</container>
        </did>
        <accessrestrict id="0a33ad6cdce119b325c656b5c6f11151">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="7481cf56a926bcaa665f596bebcba058" level="file">
        <did>
          <unittitle>TML, 40-63 - Ginkgo Biloba for dementia</unittitle>
          <unitdate type="inclusive">1998 June 19</unitdate>
          <container id="8e6489dd64e2e4091a93a234fc26a4b5" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="6da76e9e0e3e7b5c5358d67ee9e0c1a1" parent="8e6489dd64e2e4091a93a234fc26a4b5" type="folder">11-13</container>
        </did>
        <accessrestrict id="16e326bcc4bc4a1b019667382b3e42a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="276f7a6dda26470f835e467b2e300373" level="file">
        <did>
          <unittitle>TML, Sildenafil - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="0b464d9176c72abcab1b81b0f9752b50" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="d02baeafda4336ffee02185cc88e3138" parent="0b464d9176c72abcab1b81b0f9752b50" type="folder">14-16</container>
        </did>
        <accessrestrict id="c072f69e2c5f4579df7b9a32a2d6638a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="8d9d5a14ea3c38a9bcf53eea15278788" level="file">
        <did>
          <unittitle>TML, 40-69 - Hyaluronan injections for osteoarthritis of the knee</unittitle>
          <unitdate type="inclusive">1998 July 3</unitdate>
          <container id="d81da9068c2552d0213d38d4b543edf1" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="5c20dcef9e46c2138fd82e7c6abeef21" parent="d81da9068c2552d0213d38d4b543edf1" type="folder">17-19</container>
        </did>
        <accessrestrict id="548bd13d1ee4dd091a7071fb17973086">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="e605d151c50d15b7436fa8b95fabcc04" level="file">
        <did>
          <unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle>
          <unitdate type="inclusive">1998 May 22</unitdate>
          <container id="91d976a2e92ae79acf0acbaeb0297498" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="be4d33bd7a730955a528f90a95c91ded" parent="91d976a2e92ae79acf0acbaeb0297498" type="folder">20-21</container>
        </did>
        <accessrestrict id="72272d08b8d2095400f484d84b5c8623">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="a2c45fce823914fd5f240eb8ce64a6d3" level="file">
        <did>
          <unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle>
          <unitdate type="inclusive">1998 May 22</unitdate>
          <container id="173ba72768bcbe5f59eb66cd32a13261" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="3e9883655f854ec9c854c83138754ae8" parent="173ba72768bcbe5f59eb66cd32a13261" type="folder">1</container>
        </did>
        <accessrestrict id="e61fbc122231a69d11de05471824b4f7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="58fc0933c16d75f16f20c226741f40fc" level="file">
        <did>
          <unittitle>TML, 40-21 - Drugs that cause psychiatric symptoms</unittitle>
          <unitdate type="inclusive">1998 February 13</unitdate>
          <container id="9ef64733c8bebeba58cf67eceec5dc8a" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="1da92ab5ce439460a6680df33d80b818" parent="9ef64733c8bebeba58cf67eceec5dc8a" type="folder">2-5</container>
        </did>
        <accessrestrict id="cd18c294101a7fb036bca53986751b48">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="f466040faafb3cd515b6f7e5924186a3" level="file">
        <did>
          <unittitle>TML, 40-47 - Advice for Travelers</unittitle>
          <unitdate type="inclusive">1998 April 24</unitdate>
          <container id="f534f5d39786963208663c72bd0a90b2" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="f8f6744bd45f30ba45649f5372604634" parent="f534f5d39786963208663c72bd0a90b2" type="folder">6-9</container>
        </did>
        <accessrestrict id="d3ea0598c816f490bd7b26c48572450a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="d9d7051c247d055cb3a4caa57119bc34" level="file">
        <did>
          <unittitle>TML, 40-68 - Fenofibrate</unittitle>
          <unitdate type="inclusive">1998 July 3</unitdate>
          <container id="b1c42d8b53974b79668845217ab7689d" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="17a5bf97b527eea560ddee04926add84" parent="b1c42d8b53974b79668845217ab7689d" type="folder">10-13</container>
        </did>
        <accessrestrict id="a905e6ecf288f2137eb025ea245ec0aa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="0902f98f4048374d057a60de2d1b7855" level="file">
        <did>
          <unittitle>TML, 40-30 - Trovafloxacin</unittitle>
          <unitdate type="inclusive">1998 March 13</unitdate>
          <container id="cbd2336cfb56228ea4ea8e06ca17911c" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="3a81dc5f4a6fd4408e0efa5b83c993a7" parent="cbd2336cfb56228ea4ea8e06ca17911c" type="folder">14-16</container>
        </did>
        <accessrestrict id="d64cfc2f0c18fe44c79492b16479dde8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="40a127b41aba4ab1210aebb60355f7eb" level="file">
        <did>
          <unittitle>TML - Tuberculosis - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="bd501a87ee3441c48bcc6cb842d3ab7c" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="064813e506a75b2a0390c175b5643e7c" parent="bd501a87ee3441c48bcc6cb842d3ab7c" type="folder">17-18</container>
        </did>
        <accessrestrict id="aa2e94224c5f71c8078141e7e709d476">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="2821241f88ab33b4108c2fb8ef546a03" level="file">
        <did>
          <unittitle>TML - Tuberculosis - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="6c7d738c9de6de389f4646a1ecd433e0" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="b27891fbf9b4d82bd15e3d2cb4954447" parent="6c7d738c9de6de389f4646a1ecd433e0" type="folder">1-2</container>
        </did>
        <accessrestrict id="0fedc35030a79ffd7934a9d9c5acbe14">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="a5e3fba9d86330d4c75e3f31b4844108" level="file">
        <did>
          <unittitle>TML, 40-51 - Sildenafil - An oral drug for impotence</unittitle>
          <unitdate type="inclusive">1998 May 8</unitdate>
          <container id="28f954fdd7d8299e6ee9e0685ac036ce" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="9985fc0f4c8b057c549576e28bcec8cc" parent="28f954fdd7d8299e6ee9e0685ac036ce" type="folder">3-4</container>
        </did>
        <accessrestrict id="c2a74a29c84ba08cf5bbb6cb60889b41">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="41484f1614916c304d00c6a0e2776c25" level="file">
        <did>
          <unittitle>TML, 40-67 - Sucralose - a new artificial sweetner</unittitle>
          <unitdate type="inclusive">1998 July 3</unitdate>
          <container id="bd57281212a58846b0c3d223cc2065dc" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="776209c905cc2a467492c412da80f3bb" parent="bd57281212a58846b0c3d223cc2065dc" type="folder">5-7</container>
        </did>
        <accessrestrict id="9e54423aecee12c7635588555d8c357f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="18a33071dfc9246e7c9a4f9970fc624f" level="file">
        <did>
          <unittitle>TML, 40-17 - Grepafloxacin - a new fluoroquinolone</unittitle>
          <unitdate type="inclusive">1998 January 30</unitdate>
          <container id="e49fd92a542ef420672a2e4bea7509f6" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="7edff53008ca46f9db8749456714f16d" parent="e49fd92a542ef420672a2e4bea7509f6" type="folder">8-9</container>
        </did>
        <accessrestrict id="bc7dcf48bb1a978d5d8891678f65f0b7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="95bd003fd739d4b3a6ffdfb96fae1bc6" level="file">
        <did>
          <unittitle>TML, 40-55 - Repaglinide for type 2 diabetes mellitus</unittitle>
          <unitdate type="inclusive">1998 May 22</unitdate>
          <container id="3e1ad4174de9a070643f796327e89990" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="c526887ea39976667f985805024c6b32" parent="3e1ad4174de9a070643f796327e89990" type="folder">10-12</container>
        </did>
        <accessrestrict id="ea7f89c9aaeab7997ab0ab65a3fbabdf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="c689105113c5b23ebb896f340bf02ea0" level="file">
        <did>
          <unittitle>TML, 40-62 - Crystal Ear hearing aid</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="f5b3519f884c8c086fc14e607e7fe028" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="24660808e3f3ba10c8d99f0fe160bed1" parent="f5b3519f884c8c086fc14e607e7fe028" type="folder">13</container>
        </did>
        <accessrestrict id="dc4b7b184944400de9cfe92635a05ead">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="705d7bf07e8ff402ef32c0df389a3828" level="file">
        <did>
          <unittitle>TML, 40-89 - Antiplatelet</unittitle>
          <unitdate type="inclusive">1998 September 11</unitdate>
          <container id="f2dca80d9772519000bf84a37431bc4c" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="df21686e58dcdddeec2771c9b91adc7a" parent="f2dca80d9772519000bf84a37431bc4c" type="folder">14-16</container>
        </did>
        <accessrestrict id="ae0c798c535816e3564f3b350306c0eb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="cc4045365330c91030e2afc2941ff362" level="file">
        <did>
          <unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">1998 November 20</unitdate>
          <container id="006c8c8f7b8541de04d63756188263ec" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="1e448f20f94ea3cf81e264ce184284cc" parent="006c8c8f7b8541de04d63756188263ec" type="folder">17-19</container>
        </did>
        <accessrestrict id="d3830363a0deac040fb1a2187fcc43a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="74cd9f3df4304220a489f3cd523e97f4" level="file">
        <did>
          <unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">1998 November 20</unitdate>
          <container id="c9478edd11da36a71be47c05b7cb0912" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="21b0fdf8d277a1b4ee46cd101d78c4fb" parent="c9478edd11da36a71be47c05b7cb0912" type="folder">1</container>
        </did>
        <accessrestrict id="78f65a64160f8c684e6ad4a73eb82afd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="8f7886d013678b0f444c0e7ce3af676b" level="file">
        <did>
          <unittitle>TML, 40-65 - Rituximab for non-hodgkins lymphoma</unittitle>
          <unitdate type="inclusive">1998 June 19</unitdate>
          <container id="177cefe16ca9b44e870f3b4e6e92714a" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="0367d3dc5f0253534c2b92ae18835443" parent="177cefe16ca9b44e870f3b4e6e92714a" type="folder">2</container>
        </did>
        <accessrestrict id="8e2b80b72a52938a5c321da498c8b722">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="236c02b396ea229adb1f079d93029f01" level="file">
        <did>
          <unittitle>TML, 40-32 - Sibutramine for obesity</unittitle>
          <unitdate type="inclusive">1998 March 13</unitdate>
          <container id="8a239072644572ec1fe80f562e8d3e39" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="ca566bba9bbd4926a6bd619bf07aeabe" parent="8a239072644572ec1fe80f562e8d3e39" type="folder">3-5</container>
        </did>
        <accessrestrict id="83216716b614ac8cc38fcaa01b43355e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="34d5d1374a9121f748a24968ebe6c128" level="file">
        <did>
          <unittitle>TML, 40-27 - Zolmitriptan for migraine</unittitle>
          <unitdate type="inclusive">1998 February 27</unitdate>
          <container id="5412660bd53113736fd91ab4acc46429" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="6dc3a9b7f9e172f7ba80dfa1a3a5cdd8" parent="5412660bd53113736fd91ab4acc46429" type="folder">6-8</container>
        </did>
        <accessrestrict id="9f78fcde35549e85ae6f6ddddad23091">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="f1f292c6e674c3d7e6f2610c2dbf9aec" level="file">
        <did>
          <unittitle>TML, 40-73 - Becaplermin - Platelet-derived growth factor for diabetic ulcers</unittitle>
          <unitdate type="inclusive">1998 July 17</unitdate>
          <container id="302a2c13cd599ba43c62866190f536b0" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="7e9351b2a4bd212851cff141208d4d23" parent="302a2c13cd599ba43c62866190f536b0" type="folder">9</container>
        </did>
        <accessrestrict id="a90cd7de6fbf79e2a9a41d8e6d5f1884">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="fae1826f224dc5554dd9d77d43d63320" level="file">
        <did>
          <unittitle>TML, 40-19 - Arbutamine for stress testing</unittitle>
          <unitdate type="inclusive">1998 January 2</unitdate>
          <container id="19fd817a7772c76685df056487be0d55" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="ae725d11d26808e447ac551bedb3516e" parent="19fd817a7772c76685df056487be0d55" type="folder">10-11</container>
        </did>
        <accessrestrict id="3cf800c016782dc93e3a36b622f7b36c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="b4e4ab750a7b095f09a475bb6f5bb4c1" level="file">
        <did>
          <unittitle>TML, 40-75 - Vitamin supplements</unittitle>
          <unitdate type="inclusive">1998 July 31</unitdate>
          <container id="38e9aa37a44cbfe29f36932bbb5b2ac0" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="6c7b0bae93729c801628aaa56d09f8ec" parent="38e9aa37a44cbfe29f36932bbb5b2ac0" type="folder">12-16</container>
        </did>
        <accessrestrict id="59259d5d91da3a2acb6cb86529f69bd9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="06914f95afdacb00ca224c63b35cc3e5" level="file">
        <did>
          <unittitle>TML, 40-92 - Gliadel wafers for treatment of brain tumors</unittitle>
          <unitdate type="inclusive">1998 September 11</unitdate>
          <container id="701fd953d06dda6a3a00e85221885949" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="37259aa01bd1b59c772d66e3909b4649" parent="701fd953d06dda6a3a00e85221885949" type="folder">17-18</container>
        </did>
        <accessrestrict id="e29a7c4b92a2feed9fd0b7e0a0bb8f72">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="f35a3fcbf2b099a50baf329b7d2a8f36" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="cc70f7c6c88fdb2b1af2ef86ce5947ea" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="f6dee72918a9b3bba27357e172f42572" parent="cc70f7c6c88fdb2b1af2ef86ce5947ea" type="folder">19</container>
        </did>
        <accessrestrict id="0093f9f9cae39c07366f1e9c0c119fa4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="bc19dc00f1b6834157cb02e6fcfef4a4" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="af7cea183e5ecb8f598b460ba25fb3b3" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="99718e3620fda63ef7a6fb86541ad272" parent="af7cea183e5ecb8f598b460ba25fb3b3" type="folder">1-5</container>
        </did>
        <accessrestrict id="530223b01deda9e053da32d105382b18">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="559cb584a41d6690a7e856498ab89795" level="file">
        <did>
          <unittitle>TML, 40-106 - Trastuzumab for metastatic breast cancer</unittitle>
          <unitdate type="inclusive">1998 November 6</unitdate>
          <container id="3d8617e89199b0141628935cf6b5f0d7" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="fab420843d227ba667e9c5ea0c9ee881" parent="3d8617e89199b0141628935cf6b5f0d7" type="folder">6-7</container>
        </did>
        <accessrestrict id="cf7ce77fd85e6bc2a2e126d922cb2364">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="ece2250f2916521ae284b1830da4848e" level="file">
        <did>
          <unittitle>TML, 40-114 - Three new drugs for HIV infection</unittitle>
          <unitdate type="inclusive">1998 December 4</unitdate>
          <container id="64d28b6928fe1706f8eef7f83931759e" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="d4e8b7387221ce54d4b59286878fcfc9" parent="64d28b6928fe1706f8eef7f83931759e" type="folder">8-11</container>
        </did>
        <accessrestrict id="4e7f5d2236f53f8ccc2b28a5bf8873c1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="7dd5458e0da29270a7d0b887632c23ac" level="file">
        <did>
          <unittitle>TML, Sexually Trasmitted Diseases - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="9ee1b0734ee12daf071b9e95414f5062" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="aae8852ac17e5102e425ab380ce97232" parent="9ee1b0734ee12daf071b9e95414f5062" type="folder">12-14</container>
        </did>
        <accessrestrict id="0b261ea329af56d20325ac31bcf03cbe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="6e5b03bb37f1b1e46c63603fddb7f5a0" level="file">
        <did>
          <unittitle>TML, 40-53 - Dolasetron</unittitle>
          <unitdate type="inclusive">1998 May 8</unitdate>
          <container id="61006f9ac11e43b7d4d583d5a0b64650" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="54f0942d15bf3ff5b46075d8b186b7d4" parent="61006f9ac11e43b7d4d583d5a0b64650" type="folder">15-18</container>
        </did>
        <accessrestrict id="2f191b313a6f595b28c9d77fec25b021">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="b33fb65d9a2e71bddfa4f269d47aeef6" level="file">
        <did>
          <unittitle>TML, 40-18 - Irbesartan for hypertension</unittitle>
          <unitdate type="inclusive">1998 January 30</unitdate>
          <container id="3810b042d36f01079f091d4f81e89985" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="f25b817aa497be08730250d553c4ca06" parent="3810b042d36f01079f091d4f81e89985" type="folder">1-4</container>
        </did>
        <accessrestrict id="5fe32f0354336c745f49eaad8ec99c60">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="6332598d843148b2b6fcca7483c23ff2" level="file">
        <did>
          <unittitle>TML, 40-33 - The Choice of Antibacterial Drugs</unittitle>
          <unitdate type="inclusive">1998 March 27</unitdate>
          <container id="373c131b476b1b0faefd670d3fa33c2b" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="6f2487473a6ab7b8d810ae00dc316b6c" parent="373c131b476b1b0faefd670d3fa33c2b" type="folder">5-8</container>
        </did>
        <accessrestrict id="4de55d18dd59d1c77f9f4fdd38e7a4d2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="6062e376e8011b03bf27092730e8219d" level="file">
        <did>
          <unittitle>TML, 40-93 - New monoclonal antibodies to prevent transplant rejection</unittitle>
          <unitdate type="inclusive">1998 September 25</unitdate>
          <container id="54cb8ac37bf781b3a060dfe5879db625" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="e837af43bb36ff2a0579629147ddcbb1" parent="54cb8ac37bf781b3a060dfe5879db625" type="folder">9-12</container>
        </did>
        <accessrestrict id="a10e4c82bc99d39cee6a7ddd1ca31b10">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="de828b3fc932777396bebd27f5fab7dd" level="file">
        <did>
          <unittitle>TML, 40-117 - Choice of lipid-lowering drugs</unittitle>
          <unitdate type="inclusive">1998 December 18</unitdate>
          <container id="97fe254e318fb58e377d5a6b6ffd6882" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="735005cd7a7e9e1ae061e1c2bfb4cecf" parent="97fe254e318fb58e377d5a6b6ffd6882" type="folder">13-16</container>
        </did>
        <accessrestrict id="ec87238d62e4af8195602bcb6756e8f3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="0bba41a40cc25a8da0e7a635fb7e3df8" level="file">
        <did>
          <unittitle>TML - Drugs for Parasitic Infections</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="eda020d7cf92c8bb0fa71a3606948980" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="2932ac418a3f53ec9bfa8623b5d3603f" parent="eda020d7cf92c8bb0fa71a3606948980" type="folder">17-19</container>
        </did>
        <accessrestrict id="e69b8784cca126a51aa694fe76fa93ef">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="13029629c9a2c8c4645ba910bddc0ec5" level="file">
        <did>
          <unittitle>TML - Drugs for Parasitic Infections</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="810dffe3a6be216e4c6a90f7b82ed4ed" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="f81fcf90923d1e1da9990de59508379a" parent="810dffe3a6be216e4c6a90f7b82ed4ed" type="folder">1-3</container>
        </did>
        <accessrestrict id="efd535a28d84b26cb3f39bdbca07f951">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="c768307fb6b27100b14034cebd5227a9" level="file">
        <did>
          <unittitle>TML, 40-43 - Toremifene and Letrozole for advance breast cancer</unittitle>
          <unitdate type="inclusive">1998 April 10</unitdate>
          <container id="84a0d6d12ecfc41fcdb75c872dc5c81c" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="044a6acc136f757675cce7d10bf2406e" parent="84a0d6d12ecfc41fcdb75c872dc5c81c" type="folder">4-8</container>
        </did>
        <accessrestrict id="4fead382cbe8272480e24c54bdac4aa5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="edbc39d29ce93f5d2d89c1070b90a888" level="file">
        <did>
          <unittitle>TML, 40-95 - Brinzolamide for glaucoma</unittitle>
          <unitdate type="inclusive">1998 September 25</unitdate>
          <container id="1bf5033ba69453546c7e928d0422cb79" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="0d71cce5aa250ae8048bb193db11274c" parent="1bf5033ba69453546c7e928d0422cb79" type="folder">9-10</container>
        </did>
        <accessrestrict id="4761d1070aff6ae3d4f74655713baaa7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="6d7c66707bdf53045a7ff953d6e108d3" level="file">
        <did>
          <unittitle>TML, 40-45 - Tigabine for epilepsy</unittitle>
          <unitdate type="inclusive">1998 April 10</unitdate>
          <container id="465d7880429e2b48427995a54837e0da" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="c06f7ab44f29528123e8c3c7c727f42d" parent="465d7880429e2b48427995a54837e0da" type="folder">11-13</container>
        </did>
        <accessrestrict id="94fdedf900cf20f12d378b25deedc2ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="a07a54028f90ac0076d2802b57942911" level="file">
        <did>
          <unittitle>TML, 40-64 - A new rabies vaccine</unittitle>
          <unitdate type="inclusive">1998 June 14</unitdate>
          <container id="6c625658ff93f5ceb4db4cc86d84cbae" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="2f4eb440579a44ef7f0d5081edc62feb" parent="6c625658ff93f5ceb4db4cc86d84cbae" type="folder">14-15</container>
        </did>
        <accessrestrict id="47ed997eea8759fcee2c1c993e8bbb47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="3bd95f95656aa72b9a953a7b60fc1ff8" level="file">
        <did>
          <unittitle>TML, 40-29 - Raloxifene for postmenopausal osteoporosis</unittitle>
          <unitdate type="inclusive">1998 March 13</unitdate>
          <container id="51a22ed67aa51ae1ebc282d15234f4ee" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="39551add5e90cb4c9f3c269bad745707" parent="51a22ed67aa51ae1ebc282d15234f4ee" type="folder">16-18</container>
        </did>
        <accessrestrict id="072da8fc19d0e0c642d2808e0b9452ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="fa4c88d1fa307e4c1c36721c687359e5" level="file">
        <did>
          <unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="f5c587131fad611a7aaaca32b279b7e7" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="4cbe5d2a328a72a33d88ca1be844ec0a" parent="f5c587131fad611a7aaaca32b279b7e7" type="folder">19</container>
        </did>
        <accessrestrict id="4326873ad2b2259141a757cbab189cb2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="b31307f7682d799e34699487a403a926" level="file">
        <did>
          <unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="2c37a7d6ceb1149098740c325988f1a1" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="b8f7816e1cd0abf9bf815e25b0681036" parent="2c37a7d6ceb1149098740c325988f1a1" type="folder">1-2</container>
        </did>
        <accessrestrict id="2802926a9875868eb77bbf4162293dea">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="c0f605353f7f9186d9e181b0e5a7b35c" level="file">
        <did>
          <unittitle>TML, 40-15 - Budesonide turbuhaler for asthma</unittitle>
          <unitdate type="inclusive">1998 January 16</unitdate>
          <container id="db5b87e67815bfcc065c9a7f3a77a098" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="bbc4900eff2e4e84d1744a4f087908af" parent="db5b87e67815bfcc065c9a7f3a77a098" type="folder">3-8</container>
        </did>
        <accessrestrict id="63c818b79b8463447ba0a35c3ed08e0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="fc1c9413add7682bf34765d07e37871c" level="file">
        <did>
          <unittitle>TML - Cholesterol-Lowering - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="a39e742f1982797b65985a48cc80f70d" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="dd30ebe0b853d0a021bf4d9ff5d33fa8" parent="a39e742f1982797b65985a48cc80f70d" type="folder">9-10</container>
        </did>
        <accessrestrict id="263b366a38ae16d96e1447c8e1c8953b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="9212aaed4209e15330e340d1c8675d23" level="file">
        <did>
          <unittitle>TML - Parasitic Infections - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="1512b9ea78c089d5abe24d0765538223" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="102c73bec21d8551c294dc17d1a383a8" parent="1512b9ea78c089d5abe24d0765538223" type="folder">11-14</container>
        </did>
        <accessrestrict id="5db4f9b0242f10ed336d20896e08899c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="367ee47d6747fc683d4571ad991fcb28" level="file">
        <did>
          <unittitle>TML - Malaria - Drugs for parastic infections</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="ec48c6b490cf1687f08b2f109bff259c" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="b10c33acecf1ec555d8a43bcd3ad1c96" parent="ec48c6b490cf1687f08b2f109bff259c" type="folder">15-16</container>
        </did>
        <accessrestrict id="e3f66807c02c01517706efbf9eeaff5f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="d64c5c233f60d11993a1dd5cef9c5ec4" level="file">
        <did>
          <unittitle>TML - Antimicrobial drugs - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="420a567cf115e0f4e36a16fd8ebf7ae2" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="d6f2cd8760b4fd1e5a095b150b066bdb" parent="420a567cf115e0f4e36a16fd8ebf7ae2" type="folder">17</container>
        </did>
        <accessrestrict id="f6a6fff3786ff1d521cdf342567849ee">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="3d41d005cf4c13e14913cd67a32a5047" level="file">
        <did>
          <unittitle>TML - Antimicrobial drugs - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="c0725c157c5cbbb081e28cac7491bb67" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="afad515f98d4bb59ed32f76baa2fb17c" parent="c0725c157c5cbbb081e28cac7491bb67" type="folder">1-2</container>
        </did>
        <accessrestrict id="8075ff059f0d4d931fa3535cefb097fc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="a70dd9355ee98a30aebc26b8daacffc8" level="file">
        <did>
          <unittitle>TML - Psychiatric Symptoms - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="6a7c95dcd4d69ac45d02e8a77741984e" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="b5cda48bf9417a0c2eb2c6b6f7d14ed2" parent="6a7c95dcd4d69ac45d02e8a77741984e" type="folder">3</container>
        </did>
        <accessrestrict id="9dfab18fed33b99b2f9c6ca42c51a487">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="878b0cb8e4fc058b68a1ed9db09469eb" level="file">
        <did>
          <unittitle>TML, 40-109 - Candesartan</unittitle>
          <unitdate type="inclusive">1998 November 20</unitdate>
          <container id="a5d19b4be5e35fb9d30095137eaf1ee4" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="c7450ad0fdfa9b9d497823e85bb23997" parent="a5d19b4be5e35fb9d30095137eaf1ee4" type="folder">4-6</container>
        </did>
        <accessrestrict id="ba7cc6a8281cf2cb771c412c8f89cd3f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="e61911867cf616602aa72255f38dc9ba" level="file">
        <did>
          <unittitle>TML, 40-77 - Interleukin-11</unittitle>
          <unitdate type="inclusive">1998 July 31</unitdate>
          <container id="2ba16c603cb21f0b5f1684c86ff38dcc" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="f669784c5f48f9840a118a939a975ad5" parent="2ba16c603cb21f0b5f1684c86ff38dcc" type="folder">7-9</container>
        </did>
        <accessrestrict id="4f66d0ee0cc0c75d98d5ce57dfee6a86">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="4f7233bf7c77fcfc22d806ea70169968" level="file">
        <did>
          <unittitle>TML, 40-85 - Cefdinir</unittitle>
          <unitdate type="inclusive">1998 August 28</unitdate>
          <container id="b73ed18a3fdc59492b4a68d7479986e0" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="4698d8929684853c412b32b74703fb23" parent="b73ed18a3fdc59492b4a68d7479986e0" type="folder">10-12</container>
        </did>
        <accessrestrict id="028c35e32d1addf3672d48cb03ad70d7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="910ff3d576f61dcba1783abe6210dff1" level="file">
        <did>
          <unittitle>TML, 40-79 - Drugs for pain</unittitle>
          <unitdate type="inclusive">1998 August 14</unitdate>
          <container id="58cdf1ac4e1462bc6937cc3037dda419" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="b55d3b0587df877cc33b391ac91a8b6d" parent="58cdf1ac4e1462bc6937cc3037dda419" type="folder">13-17</container>
        </did>
        <accessrestrict id="72993e3876c2683037ab6df23f908193">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="960c1722fd9da508635b32ac38c60f80" level="file">
        <did>
          <unittitle>TML, 40-87 - Risedronate</unittitle>
          <unitdate type="inclusive">1998 August 28</unitdate>
          <container id="dfa7d3f3ba9ad591b69d95850d2be689" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="56714674c2ea4b1fb28a63220a891975" parent="dfa7d3f3ba9ad591b69d95850d2be689" type="folder">18-19</container>
        </did>
        <accessrestrict id="c3d8c6875a01ba6968c3fea93fe65185">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="8e8879c55ee8242081f7f64851b4db08" level="file">
        <did>
          <unittitle>TML, 40-87 - Risedronate</unittitle>
          <unitdate type="inclusive">1998 August 28</unitdate>
          <container id="571597e226d6d21adbeec28cf4a25361" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="273100b81747f944ea67bda5aa27e81f" parent="571597e226d6d21adbeec28cf4a25361" type="folder">1-2</container>
        </did>
        <accessrestrict id="54d5c0c828c3316a8382b3f15461804c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="5d664f33dcd2cabbe962a4227379c390" level="file">
        <did>
          <unittitle>TML, 40-94 - Lepirudin for heparin-induced thrombocytopenia</unittitle>
          <unitdate type="inclusive">1998 September 25</unitdate>
          <container id="59dea37ba12acb66a4c0dd82485ab90c" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="cab5ec7ae777e174764b8a7b2371a65b" parent="59dea37ba12acb66a4c0dd82485ab90c" type="folder">3-4</container>
        </did>
        <accessrestrict id="df311ee9e0d78fb33b148774389da7c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="3d76a36572332e4c480702f762cc9918" level="file">
        <did>
          <unittitle>TML, 40-25 - Propecia and Rogaine Extra Stength for Alopecia</unittitle>
          <unitdate type="inclusive">1998 February 27</unitdate>
          <container id="a56cb508694bfb4afa22fbb28cb62998" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="f80c90f7c29a8c7acc267175e31bb6ba" parent="a56cb508694bfb4afa22fbb28cb62998" type="folder">5-8</container>
        </did>
        <accessrestrict id="c3ab3185c9cf9153482322e821491aa5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="affe7599f3c787d823e95823bfc0cbfc" level="file">
        <did>
          <unittitle>TML, 40-106 - Capecitabine for metastatic breast cancer</unittitle>
          <unitdate type="inclusive">1998 November</unitdate>
          <container id="870b33c5c0f522da5179a0e6a5777bd6" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="79c76bbae67eb320069bb954444c3a19" parent="870b33c5c0f522da5179a0e6a5777bd6" type="folder">9-10</container>
        </did>
        <accessrestrict id="544789c77c743995f3e1041b8e18aab6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="2e2e66929019d8531954a7ad095700fb" level="file">
        <did>
          <unittitle>TML, 40-13 - Cerivastatin for hypercholesterolemia</unittitle>
          <unitdate type="inclusive">1998 January 16</unitdate>
          <container id="ef4030baefcc7cb4783f99827787c4ff" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="3fb7ccebb2f61eab98706e14ed0884ed" parent="ef4030baefcc7cb4783f99827787c4ff" type="folder">11-13</container>
        </did>
        <accessrestrict id="c00a8622a08054369fa43b3f435559cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="4043d39a1cb0cf7a9edea397c7574337" level="file">
        <did>
          <unittitle>TML, 40-101 - Tolterodine for overactive bladder</unittitle>
          <unitdate type="inclusive">1998 October 23</unitdate>
          <container id="cf09ab2a9cecdc5d383a6837ed7f37f5" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="f30093076d70f60ad088d7faa7015684" parent="cf09ab2a9cecdc5d383a6837ed7f37f5" type="folder">14-16</container>
        </did>
        <accessrestrict id="5ed653620eb193653bb7be17c3823301">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="e5341af61e6a0539c242e29242b615c6" level="file">
        <did>
          <unittitle>TML, 40-102 - An Emergency Contraceptive Kit</unittitle>
          <unitdate type="inclusive">1998 October 23</unitdate>
          <container id="8097a89ae7ca63f7f0b7630ddff19e14" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aefd6fbdabf0af1e8122fd3c516e8bb3" parent="8097a89ae7ca63f7f0b7630ddff19e14" type="folder">17-18</container>
        </did>
        <accessrestrict id="5f3dbedbdfcd288cd297f8d578fd4ced">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="3f39fb343e118836671bfce7c8c9e0be" level="file">
        <did>
          <unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle>
          <unitdate type="inclusive">1998 July 17</unitdate>
          <container id="5a2598bf7862e4ac780af36fca1c3eea" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="9692a680d23ba8be81c8d0bf7bb73dc6" parent="5a2598bf7862e4ac780af36fca1c3eea" type="folder">19</container>
        </did>
        <accessrestrict id="a3bdebd3c863cd5e8915acd5b9e97a95">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="e43a7710b28863a0de4803cfd4c0b542" level="file">
        <did>
          <unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle>
          <unitdate type="inclusive">1998 July 17</unitdate>
          <container id="a3116c68afcc4fc37e855b0b04ddee63" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="2b6ba91eec851cade7233a019f2dccc7" parent="a3116c68afcc4fc37e855b0b04ddee63" type="folder">1-2</container>
        </did>
        <accessrestrict id="4b8fa308ff1db3b9b6869466f7f0fe98">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="f487b7ea1e7909af55b4d7eeee8db68c" level="file">
        <did>
          <unittitle>TML, 40-103 - Thalidomide</unittitle>
          <unitdate type="inclusive">1998 October 23</unitdate>
          <container id="21fda2a4950a676d01cc64823dad20b5" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="deeb24c6d64f2adbe6d40ab9abfddca3" parent="21fda2a4950a676d01cc64823dad20b5" type="folder">3-6</container>
        </did>
        <accessrestrict id="afd021cfb4388a63de5e218998fd47c7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="31cfa0b79a02b7866aa0dc7e48743280" level="file">
        <did>
          <unittitle>TML, 40-97 - New Triptans and other drugs for migraine</unittitle>
          <unitdate type="inclusive">1998 October 9</unitdate>
          <container id="88b15e467ce09ed173aca5eb98a85de8" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="4ab9700ea0c650606005a26050b90477" parent="88b15e467ce09ed173aca5eb98a85de8" type="folder">7-12</container>
        </did>
        <accessrestrict id="43083e8c7ccdb0aa74b842657cd508ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="f35138cee47bea646beb32b2995d4598" level="file">
        <did>
          <unittitle>TML, 40-91 - Influenza vaccine, 1998-1999</unittitle>
          <unitdate type="inclusive">1998 September 11</unitdate>
          <container id="fdd87e0f505c37699f0066a476841d43" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="883d49522bbab877eb07797efde5d6ec" parent="fdd87e0f505c37699f0066a476841d43" type="folder">13</container>
        </did>
        <accessrestrict id="a29dd57181aa1c5e6c3a1e5d3b488af7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="7c2b7e050833f74d66d0b600d186eae5" level="file">
        <did>
          <unittitle>TML, 40-105 - Creatine and Androstenedione - two "dietary supplements"</unittitle>
          <unitdate type="inclusive">1998 November 6</unitdate>
          <container id="2584809c8dd7808d92713c14e89dc1ad" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="0d5f3be7f95fb1749b0cd0a8389f6355" parent="2584809c8dd7808d92713c14e89dc1ad" type="folder">14-16</container>
        </did>
        <accessrestrict id="bcbeeba99d41f442379b4633e1dc7778">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="a4342729d9ef2567742167972402009f" level="file">
        <did>
          <unittitle>TML, 39-107 - St. John's Wort</unittitle>
          <unitdate type="inclusive">1997 November 21</unitdate>
          <container id="aa9424d145e1553459b5d7cdeb940a6d" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="7ad6d8f5007243a86a8f53654835049c" parent="aa9424d145e1553459b5d7cdeb940a6d" type="folder">17-18</container>
        </did>
        <accessrestrict id="f27838dbfd9cecfa9e71bf77f07fe682">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="ddfb397d4b944785854d8ea719c202bd" level="file">
        <did>
          <unittitle>TML, 41-73 - Malathion for treatment of head lice</unittitle>
          <unitdate type="inclusive">1999 August 13</unitdate>
          <container id="4db3cf6326341fe0b64d720e9896b3a2" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="0e916204680d1a25383bf78f4ec44839" parent="4db3cf6326341fe0b64d720e9896b3a2" type="folder">1-2</container>
        </did>
        <accessrestrict id="854b0f58396665c4e2d4a0465f949fd7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="35b97709b422b46ecdc94c987c5952ec" level="file">
        <did>
          <unittitle>TML, 41-39 - Advice for travelers</unittitle>
          <unitdate type="inclusive">1999 April 23</unitdate>
          <container id="5d4caf4ac5f0b7fa54f45a3ea0833639" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="edaf2f84bb5fd249d39cc7a097ac39e0" parent="5d4caf4ac5f0b7fa54f45a3ea0833639" type="folder">3-4</container>
        </did>
        <accessrestrict id="04ad6f830bf72709637049c7b301499d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="f916a9e5c338ff7fc1707311815267f1" level="file">
        <did>
          <unittitle>TML, 41-30 - Modafinil for narcolepsy</unittitle>
          <unitdate type="inclusive">1999 March 26</unitdate>
          <container id="30e3be4b2c94ce6d0e2bbec89c58c5a4" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="65d785b1c1734202982c9ebe9c6466a6" parent="30e3be4b2c94ce6d0e2bbec89c58c5a4" type="folder">5-7</container>
        </did>
        <accessrestrict id="113f676d893d247079b5e4ff614aec1e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="2fc16ae414cf9dd501de68ee706014d5" level="file">
        <did>
          <unittitle>TML, 41-51 - Levalbuterol for asthma</unittitle>
          <unitdate type="inclusive">1999 June 4</unitdate>
          <container id="813846e897eb5bf2e4c616c0b7c248ac" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="5612c8fe0379ce2ebfd6c3b38ec9543f" parent="813846e897eb5bf2e4c616c0b7c248ac" type="folder">8-10</container>
        </did>
        <accessrestrict id="17d7935132e18e8bac890aeefcb5960f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="3922b9c381c0b19cb3d63cbe803305a6" level="file">
        <did>
          <unittitle>TML, 41-16 - Mometasone furoate nasal spray for allergic rhinitis</unittitle>
          <unitdate type="inclusive">1999 February 12</unitdate>
          <container id="cbeace7f39228d473c51be32155424e8" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="13c344957c569e6cfab02ddc23ebb4b4" parent="cbeace7f39228d473c51be32155424e8" type="folder">11-12</container>
        </did>
        <accessrestrict id="481e161096febedcc11b1ed837e0109b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="4d4ebb415f82a62d6c6b5091a9afeb7a" level="file">
        <did>
          <unittitle>TML, 41-50 - Vaccine for rotavirus</unittitle>
          <unitdate type="inclusive">1999 May 21</unitdate>
          <container id="060add7e84bbcc08206693b247f44049" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="d7aa05a1e27648d4e68caf292fc46d89" parent="060add7e84bbcc08206693b247f44049" type="folder">13-14</container>
        </did>
        <accessrestrict id="b72eb586cf031b15f2ce8b6037f013b2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="65d972dc57e884b250ec76744f2d84f9" level="file">
        <did>
          <unittitle>TML, 41-91 - Two neuraminidase inhibitors for treatment of influenza</unittitle>
          <unitdate type="inclusive">1999 October 8</unitdate>
          <container id="5cfd4970e1c5ec2ebc7a9b6e94126e26" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="22755a2ea37bfa429c032a04499241b5" parent="5cfd4970e1c5ec2ebc7a9b6e94126e26" type="folder">15-17</container>
        </did>
        <accessrestrict id="6e3fe48fdf68db20082fc8bad62e904f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="26fd68ebafc0d8085fe92d2eb77fcbf6" level="file">
        <did>
          <unittitle>TML, 41-93 - Zaleplon for insomnia</unittitle>
          <unitdate type="inclusive">1999 October 8</unitdate>
          <container id="4a8fd7f37ace4f0a3b4022a42df5123a" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="6bcb3ae48d87c2293adae77b6a5ba461" parent="4a8fd7f37ace4f0a3b4022a42df5123a" type="folder">1-4</container>
        </did>
        <accessrestrict id="b25acf713bbbe8621cf294856e16ba28">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="ec877eb8397cacf7d82d77f65b127412" level="file">
        <did>
          <unittitle>TML, 41-1 - Tamoxife for the prevention of breast cancer</unittitle>
          <unitdate type="inclusive">1999 January 1</unitdate>
          <container id="93bf5894372506a00442319e99742295" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="2503c56ab8ac9528b560d86a3caf4c73" parent="93bf5894372506a00442319e99742295" type="folder">5-6</container>
        </did>
        <accessrestrict id="5090105f2f60079c4d3f971adf860516">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="94ff8cec3e58b5c4d7bd8582a705f051" level="file">
        <did>
          <unittitle>TML, 41-123 - Temozolomide</unittitle>
          <unitdate type="inclusive">1999 December 17</unitdate>
          <container id="5c01f51cbdd10e692f0b49ddb3023134" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="4b3133c7f4b771aa8f198e6b02b1cc15" parent="5c01f51cbdd10e692f0b49ddb3023134" type="folder">7-8</container>
        </did>
        <accessrestrict id="7a64776358d5df180bb0a5ddbff0bef7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="a4b43b9f4b92e02c161ee56d03e178c9" level="file">
        <did>
          <unittitle>TML, 41-53 - Interferon plus ribavirin for chronic hepatitis C</unittitle>
          <unitdate type="inclusive">1999 June 4</unitdate>
          <container id="1d5c18a79649c6093933e19def7183f1" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="d03d00aa3008a5b8f6ca8edf65508218" parent="1d5c18a79649c6093933e19def7183f1" type="folder">9-11</container>
        </did>
        <accessrestrict id="af177345fcae67c9d255185c0a10e870">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="024012e8b7f7de531d716961ead029ce" level="file">
        <did>
          <unittitle>TML, 41-49 - Miglitol for Type 2 diabetes mellitus</unittitle>
          <unitdate type="inclusive">1999 May 21</unitdate>
          <container id="106182952a9fa6a69260446135fd9cf8" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="4b88e6f573c994b22c3441545a0972cb" parent="106182952a9fa6a69260446135fd9cf8" type="folder">12-13</container>
        </did>
        <accessrestrict id="d6f81a58c2dc3eaf1f79b5dc23f9a66b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="a9621527ed50246d7a862b61f10afb79" level="file">
        <did>
          <unittitle>TML, 41-110 - Rabeprazole</unittitle>
          <unitdate type="inclusive">1999 November 9</unitdate>
          <container id="0c21096bd7622842d0fac36177920fe5" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="2c862ca696215ade8b6ea4b0e5c82c48" parent="0c21096bd7622842d0fac36177920fe5" type="folder">14-15</container>
        </did>
        <accessrestrict id="fa2239be1fca64f3de4ed0688d43b5a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="fcec222c26512f8ebe8b672bf459fbe9" level="file">
        <did>
          <unittitle>TML, 41-21 - Rifapentine for tuberculosis</unittitle>
          <unitdate type="inclusive">1999 February 26</unitdate>
          <container id="a37cd58bd32af9e507064980ab31e325" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="5e6099e04e7e62e8821aa2644401fd4b" parent="a37cd58bd32af9e507064980ab31e325" type="folder">16-17</container>
        </did>
        <accessrestrict id="5eabb94693fe31a0f053df4c9645327d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="c2530250616ca691ba7d71e8d92ca5e1" level="file">
        <did>
          <unittitle>TML, 41-109 - Quinupristin (Dalfopristin)</unittitle>
          <unitdate type="inclusive">1999 November 19</unitdate>
          <container id="1598642327b77313505190463173112c" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="d7a45c442ac888f1b410ab87682c4ca6" parent="1598642327b77313505190463173112c" type="folder">18-19</container>
        </did>
        <accessrestrict id="96db099c24d150d666b7ebe07b50d611">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="e80acff708763c79ba27fdf7b90311e5" level="file">
        <did>
          <unittitle>TML, 41-71 - Rosiglitazone for Type 2 diabetes mellitus</unittitle>
          <unitdate type="inclusive">1999 August 13</unitdate>
          <container id="418199505f41a9618019501cbe452e0e" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="0c7ca6907c6074f121748a8d8e54a21e" parent="418199505f41a9618019501cbe452e0e" type="folder">1-3</container>
        </did>
        <accessrestrict id="165ec4ab5ea0c075fdbea5fe2e192f3d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="703b499487840917db1eeb7a3bbf97c3" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Rheumatoid Arthritis</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="dc4ecea922871c681bec0eb411a61db6" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="b089ffd1291e793d19ebca7fbed68a00" parent="dc4ecea922871c681bec0eb411a61db6" type="folder">4-7</container>
        </did>
        <accessrestrict id="15f525d3017c59fe2b80a8ae96ac839d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="d1121bbf04acf6873bc6f6be66e80e1c" level="file">
        <did>
          <unittitle>TML, 41-59 - Rofecoxib for osteoarthritis and pain</unittitle>
          <unitdate type="inclusive">1999 July 2</unitdate>
          <container id="ac1bb762b821f75e54738f206b1b2374" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="90769e89d27a83515087fdbaf4956772" parent="ac1bb762b821f75e54738f206b1b2374" type="folder">8-10</container>
        </did>
        <accessrestrict id="11221f9e1bc9230aebbe4b8afe4c8c85">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="755deaec93a3a8f46413cdb9d38a9847" level="file">
        <did>
          <unittitle>TML, 41-84 - Pneumococcal vaccine</unittitle>
          <unitdate type="inclusive">1999 September 10</unitdate>
          <container id="848124f1b0f79cdbf83078a2712e118a" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="5266c35216e1042c7dafee73bfedb117" parent="848124f1b0f79cdbf83078a2712e118a" type="folder">11-13</container>
        </did>
        <accessrestrict id="ad40d9598ad03e97e0de7ff5b12324c2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="0ee2e8ec8ef4a025a102da4125d330c6" level="file">
        <did>
          <unittitle>TML, 41-20 - Homeopathic products</unittitle>
          <unitdate type="inclusive">1999 February 26</unitdate>
          <container id="46092a2481571b66e3fec7d4da0f37df" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="b9dba4a3e1f75b332598de2389f7a5b0" parent="46092a2481571b66e3fec7d4da0f37df" type="folder">14-16</container>
        </did>
        <accessrestrict id="1d27c989e3d0f4c9ca2d59fcac0ed578">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="0f8ace5b9ab967ce17459254fb17ca75" level="file">
        <did>
          <unittitle>TML, 41-55 - Orlistat for obesity</unittitle>
          <unitdate type="inclusive">1999 June 18</unitdate>
          <container id="cd6cad8b1cf32268b5431cee5c02b795" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="ca262e7f0d045064a808063728afaf78" parent="cd6cad8b1cf32268b5431cee5c02b795" type="folder">17</container>
        </did>
        <accessrestrict id="3afad4f5d733d9716d22ba16c44983fc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="b2928e0b146edbf6a03684604b2f6230" level="file">
        <did>
          <unittitle>TML, 41-69 - Prosorba column for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">1999 July 30</unitdate>
          <container id="5379e32b4c869d00db5cd46b0f3a203f" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="318340612a95c2161a46e0dac841634a" parent="5379e32b4c869d00db5cd46b0f3a203f" type="folder">18</container>
        </did>
        <accessrestrict id="f89d8a299f3aa1cb78fdeda3584f26e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="e394fdb910a180949b33fcfe30e8b17c" level="file">
        <did>
          <unittitle>TML, 41-23 - Drugs for hypertension</unittitle>
          <unitdate type="inclusive">1999 March 12</unitdate>
          <container id="18420ca94dee42ca4f473cb272b8c604" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="f121b63a81f9e3ac09927a149e7b5f2e" parent="18420ca94dee42ca4f473cb272b8c604" type="folder">1-6</container>
        </did>
        <accessrestrict id="a85ce10fe729a0b9b0f29f163788bcd8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="1a3e95e6f5eb2cbf5b0cdb530d4df8b2" level="file">
        <did>
          <unittitle>TML, 41-113 - Drugs for non-HIV viral infection</unittitle>
          <unitdate type="inclusive">1999 December 3</unitdate>
          <container id="b2f7ca2bde1a80a07125ba89ffc46d81" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="78edba497bc5db6260f5a8fa15f72882" parent="b2f7ca2bde1a80a07125ba89ffc46d81" type="folder">7-10</container>
        </did>
        <accessrestrict id="ddc058cf574899e5d0347e37efa9598e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="e42d2f63edb58feb20931053061b1339" level="file">
        <did>
          <unittitle>TML, 41-112 - Pioglitazone (Actos)</unittitle>
          <unitdate type="inclusive">1999 November 19</unitdate>
          <container id="10f335319e2fde76db5301edc56f2b57" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="62bdf43ceaeb8d93ac32a85edf82dc33" parent="10f335319e2fde76db5301edc56f2b57" type="folder">11</container>
        </did>
        <accessrestrict id="2bf75590065032d73df0e0fa13732a7d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="28427104a307e9895b1500110c4ba78c" level="file">
        <did>
          <unittitle>TML, 41-43 - Suncreens - Are they safe and effective</unittitle>
          <unitdate type="inclusive">1999 May 7</unitdate>
          <container id="a5cf505a4af667d65571d9e9f82fb959" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="433ea1cc454deb6e2df6d9de47227953" parent="a5cf505a4af667d65571d9e9f82fb959" type="folder">12-16</container>
        </did>
        <accessrestrict id="d50144a362c7ab5f8c046503c10ecf2a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="a4c7b991a97b85bed8305af27776e491" level="file">
        <did>
          <unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle>
          <unitdate type="inclusive">1999 June 18</unitdate>
          <container id="61e043c136a8a5bb0bd99dc5f24c2c9b" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="be46d68154af0b2c1776f53985fc2db8" parent="61e043c136a8a5bb0bd99dc5f24c2c9b" type="folder">17-18</container>
        </did>
        <accessrestrict id="9b77ea87c2f2795c19e71f426864b471">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="efd202ef6564adfebc4106108c9561f2" level="file">
        <did>
          <unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle>
          <unitdate type="inclusive">1999 June 18</unitdate>
          <container id="5e5d2873bb8a107cf16477db4472b651" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="6da90b79fc5fd4005e56b012a2d1a799" parent="5e5d2873bb8a107cf16477db4472b651" type="folder">1-2</container>
        </did>
        <accessrestrict id="6304e26af10a0e94e7ef043fee53ad70">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="5422bbde47d91ace2df22b5b7527a0e6" level="file">
        <did>
          <unittitle>TML, 41-105 - A new ACE inhibitorand two new angiotensin receptor blockers for hypertension</unittitle>
          <unitdate type="inclusive">1999 November 5</unitdate>
          <container id="1563f96dbd75bf836bffac2cb5d69b86" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="883600c0efbee0ec56385460b33820d9" parent="1563f96dbd75bf836bffac2cb5d69b86" type="folder">3-6</container>
        </did>
        <accessrestrict id="e16a540da639162df21cb6fa8cf623e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="087aeda452bdc8c1f70b599b752d152a" level="file">
        <did>
          <unittitle>TML, 41-67 - A new conjugated estrogen</unittitle>
          <unitdate type="inclusive">1999 July 30</unitdate>
          <container id="68280f264ab37571f8686e73ed36fbde" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="f804e52e667d3a075ee8d631e837f6f4" parent="68280f264ab37571f8686e73ed36fbde" type="folder">7-8</container>
        </did>
        <accessrestrict id="3dd21eec3f06c65a80aa71eae6b88575">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="e1ba3784eccce1db97752b63119a9737" level="file">
        <did>
          <unittitle>TML, 41-15 - Drugs and vaccines against biological warfare</unittitle>
          <unitdate type="inclusive">1999 February 12</unitdate>
          <container id="d7be1d0d080ba643246242b94bdbd2b4" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="2f646b0df438fe62e022ca75ae08a555" parent="d7be1d0d080ba643246242b94bdbd2b4" type="folder">9</container>
        </did>
        <accessrestrict id="a078c6c919634b8920e26478d73bef6a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="ee9f72d21997962aa5e1d76e60f28954" level="file">
        <did>
          <unittitle>TML, 41-68 - Laser hair removal</unittitle>
          <unitdate type="inclusive">1999 July 30</unitdate>
          <container id="71ac31da6d290592783c66a071630b28" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="e1e74a0ac232da24bd2cca3da4575168" parent="71ac31da6d290592783c66a071630b28" type="folder">10-11</container>
        </did>
        <accessrestrict id="0797b526bde059f59517ea165bdcb518">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="0f4d6a53975d9232738144f364667da0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="ef94ea33172fd762294ccc03cbf5e8b9" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="5cbbc561da0499b0fb7564353f9d5710" parent="ef94ea33172fd762294ccc03cbf5e8b9" type="folder">12-16</container>
        </did>
        <accessrestrict id="ca7184a59b6ddfe5ef00a19434c19c48">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="5db523527161519d86f176dd07137b4b" level="file">
        <did>
          <unittitle>TML, 41-5 - Drugs for Asthma</unittitle>
          <unitdate type="inclusive">1999 January 15</unitdate>
          <container id="4b247a6305f4b24200f3371739c2dfcd" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="12fe37de36e422ba951dcf85383e6232" parent="4b247a6305f4b24200f3371739c2dfcd" type="folder">1-5</container>
        </did>
        <accessrestrict id="24b467056399b27bd316ca395f5c8a5e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="3c1f55d592280bce047dbd773f816697" level="file">
        <did>
          <unittitle>TML, 41-12 - Drugs for chronic heart failure</unittitle>
          <unitdate type="inclusive">1999 January 29</unitdate>
          <container id="23167298b93b5fdaf3e38dade1cc8b42" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="31c7972166ed2406a2220697f31410ea" parent="23167298b93b5fdaf3e38dade1cc8b42" type="folder">6-8</container>
        </did>
        <accessrestrict id="a82b9541fad7707df8ff8e0ecec045a1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="a5ef95fdd53a4ad00be13d575b720a90" level="file">
        <did>
          <unittitle>TML, 41-32 - Valrubicin for bladder cancer</unittitle>
          <unitdate type="inclusive">1999 March 26</unitdate>
          <container id="dfbfbe9759beb1eb560e0f404d69589f" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="f2c253511a17d4a8d6e9596684e360b4" parent="dfbfbe9759beb1eb560e0f404d69589f" type="folder">9</container>
        </did>
        <accessrestrict id="1246d47b99a5b28275ca7ac909e04e17">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="c9b5394af1307b91512bebaa47987a03" level="file">
        <did>
          <unittitle>TML, 41-19 - Infliximab (Remicade) for Crohn's disease</unittitle>
          <unitdate type="inclusive">1999 February 26</unitdate>
          <container id="b2411db40d3e162ff89885711f0349a2" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="7918f770168545203593cca98fa0282c" parent="b2411db40d3e162ff89885711f0349a2" type="folder">10-11</container>
        </did>
        <accessrestrict id="bceed6a85bb227d8a5c9b54693104fa7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="9431f5004a39b8a0d9a05be98633933b" level="file">
        <did>
          <unittitle>TML, 41-82 - Influenza vaccine, 1999-2000</unittitle>
          <unitdate type="inclusive">1999 September 10</unitdate>
          <container id="92584173ca43c931092cc1068aedf852" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="0cb0c0f70af9d4c51a41344daed97487" parent="92584173ca43c931092cc1068aedf852" type="folder">12-13</container>
        </did>
        <accessrestrict id="cab250b6e8f335e1e9356ce49870aa0f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aa75d744d2b7b8eae4e0c83305434171" level="file">
        <did>
          <unittitle>TML, 41-81 - Spironolactone for heart failure</unittitle>
          <unitdate type="inclusive">1999 September 10</unitdate>
          <container id="81f286d4744144b75f39cd1c7088564c" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="29c70a738cc31e75ea4bed8cb5d4daf4" parent="81f286d4744144b75f39cd1c7088564c" type="folder">14-15</container>
        </did>
        <accessrestrict id="4baffc7980c89aadb8cef585c345f731">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="12a411c26719cadf670414ea9db35b3a" level="file">
        <did>
          <unittitle>TML, 41-2 - Growth-hormone-releasing factor for growth hormone deficiency</unittitle>
          <unitdate type="inclusive">1999 January 1</unitdate>
          <container id="5f073ef9c2cb4b1f571af0302c594e7d" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="8e0026951bab01a2a2b68c577c794ea3" parent="5f073ef9c2cb4b1f571af0302c594e7d" type="folder">16-18</container>
        </did>
        <accessrestrict id="f46608e112550ebc9f422dd17a55e3b3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="50fdbec047db8cdec50f09ae8f09ce33" level="file">
        <did>
          <unittitle>TML, 41-18 - Saw Palmetto for benign prostatic hyperplasia</unittitle>
          <unitdate type="inclusive">1999 February 12</unitdate>
          <container id="fcd79a5eb0c52f58c63aee45c62bff49" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="ccc4e5231409360c0728f525c0f37a22" parent="fcd79a5eb0c52f58c63aee45c62bff49" type="folder">1-3</container>
        </did>
        <accessrestrict id="ebda9b553416d292abf3337874edf243">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="12974761e15d5b5a631f8a1708a1d0e6" level="file">
        <did>
          <unittitle>TML, 41-107 - SAMe for depression</unittitle>
          <unitdate type="inclusive">1999 November 5</unitdate>
          <container id="f5a19b746374e4ebb1a7b6af2feb16d8" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="3be8abbb29c878b4148c770c13de7461" parent="f5a19b746374e4ebb1a7b6af2feb16d8" type="folder">4-7</container>
        </did>
        <accessrestrict id="9f6ccc892b5225ac4e542904aba616bf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="2891c6463578c91c35a01dfbc0867c34" level="file">
        <did>
          <unittitle>TML, 41-3 - Palivizumab (Synagis) for prevention of RSV infection</unittitle>
          <unitdate type="inclusive">1999 January 1</unitdate>
          <container id="a54bfbac2d3cd92a67e03e2f33c5de02" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="a36991358214b73982c026152ac547fb" parent="a54bfbac2d3cd92a67e03e2f33c5de02" type="folder">8-9</container>
        </did>
        <accessrestrict id="b084224a8b4665a510e8da9d5962cae8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aa2d0e7ffb5da88f1ad0bda04c4f91da" level="file">
        <did>
          <unittitle>TML, 41:47 - Generic Drugs</unittitle>
          <unitdate type="inclusive">1999 May 21</unitdate>
          <container id="97d5345f093bcd5c6c8e44987640941b" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="dcd52260f4fbc1d13dcef5a940e3610c" parent="97d5345f093bcd5c6c8e44987640941b" type="folder">10-15</container>
        </did>
        <accessrestrict id="d25ac57dbed224f7c437f5c406d80bfb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="d463206ca7312a03520c55b4035d6d7c" level="file">
        <did>
          <unittitle>TML, 41-64 - Amprenavir - a new HIV protease inhibitor</unittitle>
          <unitdate type="inclusive">1999 July 16</unitdate>
          <container id="82305952ba1a3d028e3b34a9383e05ab" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="ccfaefa17e590eac1931269f1a6bfab2" parent="82305952ba1a3d028e3b34a9383e05ab" type="folder">16-17</container>
        </did>
        <accessrestrict id="bebb6703e7e1148e21f6bff4883b5f0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="dacba7e70abbc68ca64fcd4963a6f95a" level="file">
        <did>
          <unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">1999 August 27</unitdate>
          <container id="57539a58f539b0656fd5276cdf3f875f" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="4b574f7ad963367a67cf879c8fe4464b" parent="57539a58f539b0656fd5276cdf3f875f" type="folder">18</container>
        </did>
        <accessrestrict id="a555f10f258ebdc237376c5bf299600d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="813dc879c0e4261b5ae728f45f81e536" level="file">
        <did>
          <unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">1999 August 27</unitdate>
          <container id="4e9d1a6590fbb1682df45c7bfc5a4ec5" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="1ad54b5f570c83f802b245d2298569fb" parent="4e9d1a6590fbb1682df45c7bfc5a4ec5" type="folder">1-3</container>
        </did>
        <accessrestrict id="64327b946a10f94bc40f30737c8f1cd2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="bdc50b4955f16ee4564f9a2f1ecc15ee" level="file">
        <did>
          <unittitle>TML, 41-95 - The Choice of antibacterial drugs</unittitle>
          <unitdate type="inclusive">1999 October 22</unitdate>
          <container id="a2fd01689811765a0510e4ff3ae59df2" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="34bf5fddfcb7f89affadf23eb8f60371" parent="a2fd01689811765a0510e4ff3ae59df2" type="folder">4-8</container>
        </did>
        <accessrestrict id="6b1bb72d82bf5bc8c23cfe7d730b6597">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="9edd35ab1f22644cf6c65fedb0f5fd9d" level="file">
        <did>
          <unittitle>TML, 41-63 - Cosmetic use of botulinum toxin</unittitle>
          <unitdate type="inclusive">1999 July 16</unitdate>
          <container id="d5467702b0d449e237330b550f94f547" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="bb1bb2535978941a98b76bea5455ad40" parent="d5467702b0d449e237330b550f94f547" type="folder">9-12</container>
        </did>
        <accessrestrict id="dfa20e59cc18902aef49d7b5c22d5eb5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="cadd4aba2aafedf04d2457bcd20ecb68" level="file">
        <did>
          <unittitle>TML, 41-29 - Lyme disease vaccine</unittitle>
          <unitdate type="inclusive">1999 March 26</unitdate>
          <container id="8d7c89fba741a32e50619558bdae5ac1" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="ca1067aed9567b2d2c8af6c23fdd7b3a" parent="8d7c89fba741a32e50619558bdae5ac1" type="folder">13-16</container>
        </did>
        <accessrestrict id="ebb5315c0e462b0e2629b5dcb90203c8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="bb27af27ca7507bfd777f78da0d17147" level="file">
        <did>
          <unittitle>TML, 41-121 - Rapid diagnostic tests for influenza</unittitle>
          <unitdate type="inclusive">1999 December 17</unitdate>
          <container id="8164eef6db520d8f82e1e6c01fa98a76" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="13f11ea60086ef3a798a95f32924a327" parent="8164eef6db520d8f82e1e6c01fa98a76" type="folder">17-18</container>
        </did>
        <accessrestrict id="86662934e660af89d7aeaa4e4d013446">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="cf44b51a4bbfd2f5063743b63c4a93e3" level="file">
        <did>
          <unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">1999 September 24</unitdate>
          <container id="ab0a3a558bdb561233a6c06b434fa2de" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="7716c77c472a56413bf29265e79ebb44" parent="ab0a3a558bdb561233a6c06b434fa2de" type="folder">19</container>
        </did>
        <accessrestrict id="53ace92e24d776a3c07d0e679ac418eb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="98fd7e915d5c04bccf9bfee05be98149" level="file">
        <did>
          <unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">1999 September 24</unitdate>
          <container id="507f351308a68a63f6d6f41f18a9a95b" label="Mixed Materials (A0000000075886)" type="box">44</container>
          <container id="fc5f5b0811b4dd61b115d7c9544c7dfe" parent="507f351308a68a63f6d6f41f18a9a95b" type="folder">1-3</container>
        </did>
        <accessrestrict id="4fa538c8b0c22de3e0eea7db981ae287">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="47b865bf089a172b75b4d43ce7a1e447" level="file">
        <did>
          <unittitle>TML, 41-33 - Depression and anxiety</unittitle>
          <unitdate type="inclusive">1999 April 9</unitdate>
          <container id="9fb05686fd881e1ec439ec38b85a95b1" label="Mixed Materials (A0000000075886)" type="box">44</container>
          <container id="c0df35913ae06024915d726973c7201f" parent="9fb05686fd881e1ec439ec38b85a95b1" type="folder">4-13</container>
        </did>
        <accessrestrict id="b0f422d658f31862e120da53fa05b6f9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="71225c0666898a85e784b2cb281888c6" level="file">
        <did>
          <unittitle>TML, 41-122 - Corneal surgery for correction of refractive errors</unittitle>
          <unitdate type="inclusive">1999 December 17</unitdate>
          <container id="2c1ce9401efb95804aeac1fff91ea931" label="Mixed Materials (A0000000075886)" type="box">44</container>
          <container id="780ea00ff6d2245621c5617400bfd381" parent="2c1ce9401efb95804aeac1fff91ea931" type="folder">14-16</container>
        </did>
        <accessrestrict id="383c5c203f77ebf4dd9e3dfe67c24cf7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="45f2b2be0a5f877794d8dab41d1e2c89" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="84617bad4f5fd4d0b51d6cfdcab1dc7e" label="Mixed Materials (A0000000075886)" type="box">44</container>
          <container id="0c2dd154c0d4f500ea317e94177d3738" parent="84617bad4f5fd4d0b51d6cfdcab1dc7e" type="folder">17-18</container>
        </did>
        <accessrestrict id="149a9e74e2c2eb4d35105c1043e77fd1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="59f39d33e558df2c7a53b2df2d17a4ae" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="489e642d0247cce48307041302fd04f7" label="Mixed Materials (A0000000075887)" type="box">45</container>
          <container id="5bd6dd699616d6155554cafdd7adba3e" parent="489e642d0247cce48307041302fd04f7" type="folder">1-3</container>
        </did>
        <accessrestrict id="6cab2eae0fd66d97ea7c349b2f4718db">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="8d82b612550e56f5febd997b649248f6" level="file">
        <did>
          <unittitle>TML - Drugs for Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="eb82522a8a0dc32df5eb4a73a7db5cd8" label="Mixed Materials (A0000000075887)" type="box">45</container>
          <container id="57fd69c6449604b3cf6b19cc6db41eea" parent="eb82522a8a0dc32df5eb4a73a7db5cd8" type="folder">4-9</container>
        </did>
        <accessrestrict id="9ea5dcafb096eb9d1dba6ab8571932c7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="729c9bb0e1660ceb032fe6da8350333c" level="file">
        <did>
          <unittitle>TML - Drugs of Choice for cancer chemotherapy</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="352fc421883b9f8bf6b211f3834c3652" label="Mixed Materials (A0000000075887)" type="box">45</container>
          <container id="664a73d1f0bcd141430afba6f7911fb0" parent="352fc421883b9f8bf6b211f3834c3652" type="folder">10-16</container>
        </did>
        <accessrestrict id="5ad67e35d3361f03756bfe78c6e60019">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="737148b055ba101acbd8ee7df7c07e4c" level="file">
        <did>
          <unittitle>TML, 41-44 - Cilostazol for intermittent claudication</unittitle>
          <unitdate type="inclusive">1999 May 7</unitdate>
          <container id="84e0bae1bdd0a595e479ab92ba139042" label="Mixed Materials (A0000000075887)" type="box">45</container>
          <container id="a94505f1f47dd41dc8ed750efad5a51c" parent="84e0bae1bdd0a595e479ab92ba139042" type="folder">17-20</container>
        </did>
        <accessrestrict id="91985532c77a98b2be6619b3829a2c87">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="6e0f28a2b5a8cac84be32ec338816dac" level="file">
        <did>
          <unittitle>TML, 41-11 - Celecoxib for arthritis</unittitle>
          <unitdate type="inclusive">1999 January 29</unitdate>
          <container id="8ef157f8db7d9b1bd65545ac1a491611" label="Mixed Materials (A0000000075888)" type="box">46</container>
          <container id="bdc3ebd442604d82579181e68c5de232" parent="8ef157f8db7d9b1bd65545ac1a491611" type="folder">1-4</container>
        </did>
        <accessrestrict id="5220646ffa341e43aaef650d57ef5cbb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="47ee2aa0e1414311aab659a0b7791d48" level="file">
        <did>
          <unittitle>TML, 41-61 - Drug interactions</unittitle>
          <unitdate type="inclusive">1999 July 2</unitdate>
          <container id="e9465dbac7e79efc3b5d0822a0a8c92d" label="Mixed Materials (A0000000075945)" type="box">103</container>
          <container id="7121c1fbc7ac679ebe6b29b94e3ed177" parent="e9465dbac7e79efc3b5d0822a0a8c92d" type="folder">1-4</container>
        </did>
        <accessrestrict id="2310dca3aaada449df04e476753e097f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="ca7a582ccc3762635c6b2b1ab49c2e38" level="file">
        <did>
          <unittitle>TML, 42-51 - Ciclopirox (Penlac) nail lacquer for onychomysis</unittitle>
          <unitdate type="inclusive">2000 June 12</unitdate>
          <container id="9eeb47e34046ccf7d75bc1da26c2df9d" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="175bb51b7ab600e8ec99a509dfc96b22" parent="9eeb47e34046ccf7d75bc1da26c2df9d" type="folder">1-2</container>
        </did>
        <accessrestrict id="9580c594e1986354a883d0b4d0b71bc3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="4b13f0ecb976a0758dff29129231c5ab" level="file">
        <did>
          <unittitle>TML, 42-70 - Cevimeline (Evoxac) for dry mouth</unittitle>
          <unitdate type="inclusive">2000 August 7</unitdate>
          <container id="5718d781dcc013d840e8883630330da9" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="56828a165896a7c4576af5cda6d37460" parent="5718d781dcc013d840e8883630330da9" type="folder">3</container>
        </did>
        <accessrestrict id="ab5ca835a64facd8b0328a6bddeaa9db">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="65fedbec948e0fc83c65d93e86ad6afd" level="file">
        <did>
          <unittitle>TML, 42-13 - Sirolimus (Rapamune) for transplant rejection</unittitle>
          <unitdate type="inclusive">2000 February 7</unitdate>
          <container id="b817b796e2da9782adcaebf2b6e0027b" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="ca42d520cbbe6379435443430e60008b" parent="b817b796e2da9782adcaebf2b6e0027b" type="folder">4-6</container>
        </did>
        <accessrestrict id="7082abcbc2a52e308ef67322853d8731">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="43b3f1afcb8ce7fdcc73ea538a9dcaef" level="file">
        <did>
          <unittitle>TML, 42-56 - Drug interactions with St. John's Wort</unittitle>
          <unitdate type="inclusive">2000 June 26</unitdate>
          <container id="aa0d19f4e577b1b084cad5828582d399" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="8d84baf979444726580101c6265ea529" parent="aa0d19f4e577b1b084cad5828582d399" type="folder">7-9</container>
        </did>
        <accessrestrict id="fc05579a4affa53f15f6bf7701c8c36c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="13d9761c756a2fe7adb0ccd2bd89e5c3" level="file">
        <did>
          <unittitle>TML, 42-27 - Curosurf</unittitle>
          <unitdate type="inclusive">2000 March 20</unitdate>
          <container id="7a0aa473db546203aae02fca5fcf2e37" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="c849820b00a9344f8025139f054e0dc2" parent="7a0aa473db546203aae02fca5fcf2e37" type="folder">10-12</container>
        </did>
        <accessrestrict id="a42091b45287859d025abbb92f4814dc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="c1fd925b81d971c06ec273ef08f3cb74" level="file">
        <did>
          <unittitle>TML, 42-81 - Photodynamic therapy with veterfporfin (Visudyne) for macular degeneration</unittitle>
          <unitdate type="inclusive">2000 September 4</unitdate>
          <container id="5a1dca3f22af04e2c56496fa7313d5ee" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="cb5db3945056776e6807c9eaec1ea82b" parent="5a1dca3f22af04e2c56496fa7313d5ee" type="folder">13-15</container>
        </did>
        <accessrestrict id="25831287c40dd007e7ad4f179aa90da2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="259c3ccf591bab51ffdaba3a9994e765" level="file">
        <did>
          <unittitle>TML, 42-57 - Drugs for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">2000 July 10</unitdate>
          <container id="5df4816f9dab0cc4087679e9b8e55953" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="9517000ee7a989acab4059c08ac579d5" parent="5df4816f9dab0cc4087679e9b8e55953" type="folder">16-20</container>
        </did>
        <accessrestrict id="162cb0e7647f4a98954f5445c257c882">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="62b6871b865b6d75c47266161b21cb21" level="file">
        <did>
          <unittitle>TML, 42-113 - Phenylpropanolamine</unittitle>
          <unitdate type="inclusive">2000 December 11</unitdate>
          <container id="5c6c01f7609b69a31e91a76da13ac45e" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="79188752458bc015e5c6a1781631ed75" parent="5c6c01f7609b69a31e91a76da13ac45e" type="folder">1</container>
        </did>
        <accessrestrict id="3a8380c96fc7714fa7d33e8fc9eda5f1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="7e8cf0d2095db89bdcf602dcfa388b37" level="file">
        <did>
          <unittitle>TML, 42-94 - Zonisamide (Zonegran) for epilepsy</unittitle>
          <unitdate type="inclusive">2000 August 1</unitdate>
          <container id="19ae997cf04839b51305e540f903a7e6" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="d56c4bc75d8f22a82e778f5e78f7f1b3" parent="19ae997cf04839b51305e540f903a7e6" type="folder">2-4</container>
        </did>
        <accessrestrict id="af9a344f43755a6c943435e3e709888a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="505b60f40ff960c724ff856e304ce951" level="file">
        <did>
          <unittitle>TML, 42-10 - Emergency Contraception - Plan B</unittitle>
          <unitdate type="inclusive">2000 January 24</unitdate>
          <container id="7cca3df96a711eed21283c28869ecdaf" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="064895901087077a3a41cea348eb5844" parent="7cca3df96a711eed21283c28869ecdaf" type="folder">5</container>
        </did>
        <accessrestrict id="3cd71612bf2f98b55022fa5ad125e9e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="86b41328d3a3f3bd0b39258221d169af" level="file">
        <did>
          <unittitle>TML, 42-42 - Oral contraceptives</unittitle>
          <unitdate type="inclusive">2000 May 15</unitdate>
          <container id="f167b0655270ff2f431f4bbc2da26ceb" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="b9a9124970899223c3fb669798131fb9" parent="f167b0655270ff2f431f4bbc2da26ceb" type="folder">6-11</container>
        </did>
        <accessrestrict id="362a441b3fc8d8a82b31585a57ea0665">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="5af9d8711bf691d44ab3b1e5bb256681" level="file">
        <did>
          <unittitle>TML, 42-17 - Phytoestrogens</unittitle>
          <unitdate type="inclusive">2000 February 21</unitdate>
          <container id="5c3ddb1dafe278b960a7ba5133a81955" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="b121f9c412325bec8a1f485cee001583" parent="5c3ddb1dafe278b960a7ba5133a81955" type="folder">12-14</container>
        </did>
        <accessrestrict id="b6923da0f1e80e36ed724d7930240ab0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="408be2b8c6034a613b1211f2ecf9b661" level="file">
        <did>
          <unittitle>TML, 42-29 - Calcium citrate vs Calcium carbonate calcium supplements</unittitle>
          <unitdate type="inclusive">2000 April 3</unitdate>
          <container id="e562d1061856abac0b7bcf61b68de569" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="49893dd5d42cbfc876612f8261a40091" parent="e562d1061856abac0b7bcf61b68de569" type="folder">15-16</container>
        </did>
        <accessrestrict id="f012aa712ae69a791944518eafe15ae9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="3335c85c5f584c0623918d305860bba9" level="file">
        <did>
          <unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle>
          <unitdate type="inclusive">2000 May 29</unitdate>
          <container id="5212ce95ad84ecea9d057312f67e183a" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="df3527f6041276081de84fa106c2bded" parent="5212ce95ad84ecea9d057312f67e183a" type="folder">17-18</container>
        </did>
        <accessrestrict id="55427e8bb48ad2b8315333c1ff339476">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="c6d41dc2321b4992a2ce79264290f903" level="file">
        <did>
          <unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle>
          <unitdate type="inclusive">2000 May 29</unitdate>
          <container id="fb0332de4f4828f89d525ac11729d170" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="32c62286d7fc8416446e00f42793999a" parent="fb0332de4f4828f89d525ac11729d170" type="folder">1</container>
        </did>
        <accessrestrict id="a4945089c03fcb0a219bdaccf387431a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="1ff03efd208b21a2efb1beeeca59fbe2" level="file">
        <did>
          <unittitle>TML, 42-41 - Dofetilide for atrial fibrillation</unittitle>
          <unitdate type="inclusive">2000 May 15</unitdate>
          <container id="d4a0cc3ef52d7fe83fe085fb95fff0be" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="6730118664e8cea47530ad4a2bc6eae9" parent="d4a0cc3ef52d7fe83fe085fb95fff0be" type="folder">2-4</container>
        </did>
        <accessrestrict id="f05aa84b2f28b6ffb33fe96ec43cd992">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="97e9932d34799dd8520be9e13f8a01ce" level="file">
        <did>
          <unittitle>TML, 40-102 - Colesevelam (Welchol) for hypercholesterolemia</unittitle>
          <unitdate type="inclusive">2000 October 30</unitdate>
          <container id="b23b1f9e5b77a748b3f97434d1a1d1df" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="a8a0992b3d2faf365b3a98b6b540997d" parent="b23b1f9e5b77a748b3f97434d1a1d1df" type="folder">5</container>
        </did>
        <accessrestrict id="349dee1a0f2981a7afaffa486ad92400">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="b1e989f44b7978ab2b1aaaf201f34aeb" level="file">
        <did>
          <unittitle>TML, 42-108 - Docosanal cream (Abreva) for recurrent herpes labialis</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="44d7392d92c4681e0641aee185d02ce9" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="c1e3ede5c0a459078808b96c2061d8c2" parent="44d7392d92c4681e0641aee185d02ce9" type="folder">6</container>
        </did>
        <accessrestrict id="086b94bfdd5ebcae1564c66a07d71bf4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="e0e61fb5a1e14299b5769bb3645966af" level="file">
        <did>
          <unittitle>TML, 42-106 - Temecteplase (TNKASE) for thrombolysis</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="b6d6bc0f1e3aa5f83d552f2b5e2838b7" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="6c6b6c64105ac14019adfbb05490af55" parent="b6d6bc0f1e3aa5f83d552f2b5e2838b7" type="folder">7-10</container>
        </did>
        <accessrestrict id="6881f1eb6305a22e4485bcca7bf92f20">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="3d342507f2c128f34587c4f458c47ae3" level="file">
        <did>
          <unittitle>TML, 42-113 - Valproate and other anticonvulsants for psychiatric disorders</unittitle>
          <unitdate type="inclusive">2000 December 11</unitdate>
          <container id="67a08ec923b10fd40f596eb390d58ee8" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="b79865471b9be595db2a6ec2d9a6430b" parent="67a08ec923b10fd40f596eb390d58ee8" type="folder">11-14</container>
        </did>
        <accessrestrict id="175706ce1b1be1373cdbf4234daea11e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="89f1be4de95ddec6822bda7f0e83b385" level="file">
        <did>
          <unittitle>TML, 42-8 - Prevention of malaria</unittitle>
          <unitdate type="inclusive">2000 January 24</unitdate>
          <container id="de9128e8260cbbdff4539a1284299b10" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="5957e091a894484d3f25a8766c577b40" parent="de9128e8260cbbdff4539a1284299b10" type="folder">15</container>
        </did>
        <accessrestrict id="9af6ac60aa40dc6005ce4edb57dc6970">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="da557a8aeefe93b11b7b65ef3275ee26" level="file">
        <did>
          <unittitle>TML, 42-37 - Lyme disease</unittitle>
          <unitdate type="inclusive">2000 May 1</unitdate>
          <container id="e344f6331f7ae4a36790cd0af631fcde" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="9b161e8800544ece3aaaf916fcf02c04" parent="e344f6331f7ae4a36790cd0af631fcde" type="folder">16-18</container>
        </did>
        <accessrestrict id="50f594b6d9dec7b83b3b83386b475dcd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="b9d25758af7747ace6aaf80757aac85f" level="file">
        <did>
          <unittitle>TML, 42-18 - Aspirin for primary prevention of cardiovascular disease</unittitle>
          <unitdate type="inclusive">2000 February 21</unitdate>
          <container id="90a1667ce8414ed64eb979be9823fae9" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="83404e8b60de51f557eaf2b349606d8a" parent="90a1667ce8414ed64eb979be9823fae9" type="folder">19-20</container>
        </did>
        <accessrestrict id="bd7e6d6a5d2765181060a6c4e5bc8024">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="8827ef8acb277df2d477589d43015ed3" level="file">
        <did>
          <unittitle>TML, 42-73 - Drugs for pain</unittitle>
          <unitdate type="inclusive">2000 August 21</unitdate>
          <container id="4fe976d1d1d97f740854df3f881cd10c" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="7907a1335705c3a163792a2b461f915b" parent="4fe976d1d1d97f740854df3f881cd10c" type="folder">1-6</container>
        </did>
        <accessrestrict id="45351d67ab671d76012768894632e65f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="7ca68fc3cc569b193dc410a094f9a61f" level="file">
        <did>
          <unittitle>TML, 42-19 - Drugs for Asthma</unittitle>
          <unitdate type="inclusive">2000 March 6</unitdate>
          <container id="29c4a8357b25c37a092049793d2acf89" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="00069a94a8190b9ce9d634f85168116a" parent="29c4a8357b25c37a092049793d2acf89" type="folder">7-10</container>
        </did>
        <accessrestrict id="843840cc3a1f4f944dcd68fb679ac778">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="11f2fac87764b93bfe43bd87321c6e78" level="file">
        <did>
          <unittitle>TML, 42-49 - Androgel</unittitle>
          <unitdate type="inclusive">2000 June 1</unitdate>
          <container id="a02ab7ef17943a41dd26d2da04a5bf36" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="56f00a7906454f99f5fab5ee824a68d6" parent="a02ab7ef17943a41dd26d2da04a5bf36" type="folder">11-13</container>
        </did>
        <accessrestrict id="373b10f2aaf453294914d4fe78b9487f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="f519c54c8f624fc16003fa1c04fa88f0" level="file">
        <did>
          <unittitle>TML, 42-97 - Drugs for prevention and treatment of postmenopausal osteoporosis</unittitle>
          <unitdate type="inclusive">2000 October 16</unitdate>
          <container id="448e584e4f68b8279d674f679e6eb00b" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="e6a229c5a27bfc8ee7245e9feedd6efd" parent="448e584e4f68b8279d674f679e6eb00b" type="folder">14-18</container>
        </did>
        <accessrestrict id="f6c66097c55fc7906c4f0813a2f589d8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="da9eaff7a676c3ce93fb52a83c4df992" level="file">
        <did>
          <unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2000 October 2</unitdate>
          <container id="1a1cc4ae8076cac1619f1e1b775a9ec2" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="deec385545c970c4035a139f37f2d9ba" parent="1a1cc4ae8076cac1619f1e1b775a9ec2" type="folder">19-20</container>
        </did>
        <accessrestrict id="0b717ab0083f68384631636b834fec64">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="f307fe5a6bafa6083a914965f47c224f" level="file">
        <did>
          <unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2000 October 2</unitdate>
          <container id="18e220bbccc0452105699f715647504a" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="41883e969fe9e6cfab6a0683a46dcca5" parent="18e220bbccc0452105699f715647504a" type="folder">1</container>
        </did>
        <accessrestrict id="dc26934d88198182e177b592f4868a43">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0d88056c01b79b6a4d890ffb52ef26d7" level="file">
        <did>
          <unittitle>TML, 42-31 - Bexrotene</unittitle>
          <unitdate type="inclusive">2000 April 3</unitdate>
          <container id="96f36e5247fbcac1339597c7020381d0" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="3501fa7d8b5def6ad9d541038890ace7" parent="96f36e5247fbcac1339597c7020381d0" type="folder">2-4</container>
        </did>
        <accessrestrict id="9a8c86a85c6d5ea077e55d9b7597d55f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="78aad480d71976b1ac63856f8414b2de" level="file">
        <did>
          <unittitle>TML, 42-116 - Portable Defibrillators</unittitle>
          <unitdate type="inclusive">2000 December 11</unitdate>
          <container id="b278bb01bc973b3661e4b7ea8f28d76c" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="4ad8f02627f25ab67e7b219fab5727f9" parent="b278bb01bc973b3661e4b7ea8f28d76c" type="folder">5-6</container>
        </did>
        <accessrestrict id="da50ccc68a37dbb555145dfbcf8f1e7c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="8856ac6d297ba039f5f59b8393406463" level="file">
        <did>
          <unittitle>TML, 42-111 - Drugs that may cause cognitive disorders in the elderly</unittitle>
          <unitdate type="inclusive">2000 November 27</unitdate>
          <container id="23e95a16d42e19e0b34a7d9b8d751195" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="c488009b5427afa666d0f5e30fcbf12c" parent="23e95a16d42e19e0b34a7d9b8d751195" type="folder">7-10</container>
        </did>
        <accessrestrict id="2247b3013b5d4bd66554d265282ec46f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="d791d0f324ea7d0ebc4dcab430fc3a36" level="file">
        <did>
          <unittitle>TML, 42-36 - Substituting for troglitazone (Rezulin)</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="f80d3add77da13bb19c52d87f54f1396" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="954a698dc8225733238c8c40ea737e83" parent="f80d3add77da13bb19c52d87f54f1396" type="folder">11</container>
        </did>
        <accessrestrict id="35757c84324de4837de836a4d664e4bd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="390553fd7a4eea2f5cbee5002f2322bc" level="file">
        <did>
          <unittitle>TML, 42-109 - Atovaquone - Proguanil (Malarone) for malaria</unittitle>
          <unitdate type="inclusive">2000 November 27</unitdate>
          <container id="45eba38761354220edf45f223a0fb6cf" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="623f2bc9b14cd6e920f20222deebe033" parent="45eba38761354220edf45f223a0fb6cf" type="folder">12-15</container>
        </did>
        <accessrestrict id="717bd1e1f90c70ff656382467cc26f89">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="102174d0143d0b7b46d5dbdfb6ee2e6c" level="file">
        <did>
          <unittitle>TML, 42-39 - Ketotifen and Pemirlostat - New drugs for allergic conjunctivitis</unittitle>
          <unitdate type="inclusive">2000 May 1</unitdate>
          <container id="5db32aaf22719dd1183aedcec7005739" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="64b9a4ea1c10ff2e88666a0a2ef60492" parent="5db32aaf22719dd1183aedcec7005739" type="folder">16-17</container>
        </did>
        <accessrestrict id="c0dedfa65ff00b42eaec283e7dbe5ee3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="968dfa06d929ab040463fb621fb94e15" level="file">
        <did>
          <unittitle>TML - HAT - Systemic antifungal</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="90239df88763204a636ee8da0ee777d5" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="cfcb27dd86422407ee8b8646fc04fdba" parent="90239df88763204a636ee8da0ee777d5" type="folder">18-19</container>
        </did>
        <accessrestrict id="a7608b2e6d21017e82cac99f4c300d04">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="ffb773729eccb5c024461cb32728a1f5" level="file">
        <did>
          <unittitle>TML - HAT - Systemic antifungal</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="9b9f7c46f78a923b33b0cbe8caa58135" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="dc4cd25cd5c1cbbc8ada9c55161c0d92" parent="9b9f7c46f78a923b33b0cbe8caa58135" type="folder">1-2</container>
        </did>
        <accessrestrict id="fc274c9d6d48168ac3a11ea6067869e0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="b5adf750afaa8fb0be9aa2061a43e3b8" level="file">
        <did>
          <unittitle>TML, 42-96 - Eflornithine cream for facial hair reduction</unittitle>
          <unitdate type="inclusive">2000 October 2</unitdate>
          <container id="2e5fd384c04489bf2a8e03e067d5b641" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="f6ca3688c9cba0891cb1d1638323ef29" parent="2e5fd384c04489bf2a8e03e067d5b641" type="folder">3</container>
        </did>
        <accessrestrict id="97998d665049bfafbdf7f044ef962ac2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="c88b481d9cf92fe516e086aa696f2759" level="file">
        <did>
          <unittitle>TML, 42-67 - Gemtuzumab for relapsed acute myeloid leukemia</unittitle>
          <unitdate type="inclusive">2000 July 24</unitdate>
          <container id="b39f1c7a9a3907ffdec500b97c0619cd" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="a4bc3e7fae799a09532521ceaa367bd3" parent="b39f1c7a9a3907ffdec500b97c0619cd" type="folder">4-5</container>
        </did>
        <accessrestrict id="8158423ad1861ed096a1f762bea5ed19">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="d316d036d1c1c8b5e65cc5a3309c50cf" level="file">
        <did>
          <unittitle>TML, 42-52 - Atkin's diet</unittitle>
          <unitdate type="inclusive">2000 June 12</unitdate>
          <container id="85ea4ebcbc4c1cd7430410991a838aa7" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="7cf6d4e611ea3b61dc30cf17871aafd2" parent="85ea4ebcbc4c1cd7430410991a838aa7" type="folder">6-8</container>
        </did>
        <accessrestrict id="0024c5f9b90643b42da0ff940f490484">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="f039186b802088d6736b63d8692ff877" level="file">
        <did>
          <unittitle>TML, 42-71 - Hypnotic drugs</unittitle>
          <unitdate type="inclusive">2000 August 7</unitdate>
          <container id="3262b2262519c8bc9cf17633b6a0fb9e" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="44b74aedf9851f8f167d8893bfdaed55" parent="3262b2262519c8bc9cf17633b6a0fb9e" type="folder">9-12</container>
        </did>
        <accessrestrict id="66081d4df14137512de48118dd485bfc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="ddaac639270ba0e3369ea6c5bef18c02" level="file">
        <did>
          <unittitle>TML, 42-79 - Influenza update 2000-2001</unittitle>
          <unitdate type="inclusive">2000 September 4</unitdate>
          <container id="b692b29c3b10e407a1d014b2c4de5c8e" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="0a8ba0394c145e914643907b8e3b97ed" parent="b692b29c3b10e407a1d014b2c4de5c8e" type="folder">13-14</container>
        </did>
        <accessrestrict id="2370a9ec5de5c8b19f6823b89c720366">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="3b89f483901c2a204aeb8a707d5f619e" level="file">
        <did>
          <unittitle>TML, 42-35 - Exemestane for advanced breast cancer</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="0378eb26c2bbe429b79ea785bc03307a" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="dbc44e1ce6a965f22d7061b4ec1abdbd" parent="0378eb26c2bbe429b79ea785bc03307a" type="folder">15-17</container>
        </did>
        <accessrestrict id="908ae2bf04aa596e7e5c1b4a0b435a1a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="5b4d37f27c36f2cf78b12c02f16d9dd0" level="file">
        <did>
          <unittitle>TML, 42-12 - Epirubicin for adjuvant therapy in node-positive breast cancer</unittitle>
          <unitdate type="inclusive">2000 February 7</unitdate>
          <container id="1e9221ce6b785c8a5212ada99bbeb7de" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="9c1cf1bcc7f7afe6615fbf85760afc12" parent="1e9221ce6b785c8a5212ada99bbeb7de" type="folder">18-20</container>
        </did>
        <accessrestrict id="231c8f3761cd29bf8b9da59c1db76773">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="ea21c93279b7213ac4ebcf26ac90ac01" level="file">
        <did>
          <unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="d32b96a600e94e2cde2bfc69739c2ceb" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="3d3001974968fbcc4ff9d39005d9d3cf" parent="d32b96a600e94e2cde2bfc69739c2ceb" type="folder">21</container>
        </did>
        <accessrestrict id="ecde6f626cda50967973b161a20fcc74">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0670855c3da978011ef91e63b94b8614" level="file">
        <did>
          <unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="4d8fdfddeca1aeb50938a922a473451f" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="8560ad0c6f4a1768d4b8d8d74587dff5" parent="4d8fdfddeca1aeb50938a922a473451f" type="folder">1-2</container>
        </did>
        <accessrestrict id="b1545fba52ccf81c38c8688169dab34a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="b9f3b0c3756751d471fc83952e9cdb9e" level="file">
        <did>
          <unittitle>TML - HAT - Adverse Effects</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="10b44919c9849ab430338de6e0957b33" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="f201d3597ffe4cd0a87d4df70ac628d8" parent="10b44919c9849ab430338de6e0957b33" type="folder">3-4</container>
        </did>
        <accessrestrict id="f035a5812a9a5ba9f187b537f909316a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0f64e1cb70a81058fe2a570f1ccb8c4a" level="file">
        <did>
          <unittitle>TML - Perinopril - A new ACE inhibitor for hypertension</unittitle>
          <unitdate type="inclusive">2000 May 26</unitdate>
          <container id="e163204c9d528d96e0efe2cd302e80ee" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="97517ed1d3ee30052c332657f329d4b2" parent="e163204c9d528d96e0efe2cd302e80ee" type="folder">5-8</container>
        </did>
        <accessrestrict id="8e19dab12d3196a7486bcf0f13a7475f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="9370ffe6e8855002d778fc797c644238" level="file">
        <did>
          <unittitle>TML, 42-65 - Pantoprazole (Protonix)</unittitle>
          <unitdate type="inclusive">2000 July 24</unitdate>
          <container id="da680c53445511035f4c451ed74c01c8" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="b57cfe129d241cf6722f1d13c14d9d23" parent="da680c53445511035f4c451ed74c01c8" type="folder">9-12</container>
        </did>
        <accessrestrict id="a1015b3acc8c847466def1105f15644b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="354614b4cdeb7c25dce7323acfe3837f" level="file">
        <did>
          <unittitle>TML, 42-15 - Gatifloxacin and Moxifloxacin - Two new fluoroquinolones</unittitle>
          <unitdate type="inclusive">2000 February 21</unitdate>
          <container id="811a4dcd7d9e41a0399f2904cd8b4606" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="91b15c2d60ab1f91d7bfc5ff339dcc79" parent="811a4dcd7d9e41a0399f2904cd8b4606" type="folder">13-18</container>
        </did>
        <accessrestrict id="5bf74d558644f64e23255ce061463c78">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="ee26dc57604d2e8beb15f5282094c199" level="file">
        <did>
          <unittitle>TML, HAT - Antimicrobial Dosage</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="673dbeb47cbe88544b16b844b4613de2" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="22654255e602f1ab7c24d5ac4bb25821" parent="673dbeb47cbe88544b16b844b4613de2" type="folder">19</container>
        </did>
        <accessrestrict id="11c3455a2f2e87c2b16773aa9e6aea7c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="a088080df443869d26625b88cfb8357c" level="file">
        <did>
          <unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="daad91d42a7006768a612bddfddeaedd" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="31bdb286c4a5a3075bd45b46b5988580" parent="daad91d42a7006768a612bddfddeaedd" type="folder">20</container>
        </did>
        <accessrestrict id="204852f90f3648c6b6e5e6274cb652ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="4786db2a3aa9c724f7f60dcf4fcf9164" level="file">
        <did>
          <unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="265bda35f3f0c0964af6bca86beeb118" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="03985cd86a42670a95c55b76b8996923" parent="265bda35f3f0c0964af6bca86beeb118" type="folder">1-2</container>
        </did>
        <accessrestrict id="19470d2540faf3143d53c5e0f0f04553">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="ff8898d4bdb05f23855cdb33eaefc878" level="file">
        <did>
          <unittitle>TML, 42-53 - Alosetron (Lotronex) for irritable bowel syndrome</unittitle>
          <unitdate type="inclusive">2000 June 26</unitdate>
          <container id="0ce2b01e1325d6c02a923ed719a87231" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="3d4a335acf1cfdb67301533254a1cf20" parent="0ce2b01e1325d6c02a923ed719a87231" type="folder">3-4</container>
        </did>
        <accessrestrict id="a92fba8d7b374bd5ed2b6377d7f5dfcf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="c83dbfe7a53fd4d335c81b6902eff92d" level="file">
        <did>
          <unittitle>TML, 42-25 - Conjugated pneumococcal vaccine for infants and children</unittitle>
          <unitdate type="inclusive">2000 March 20</unitdate>
          <container id="44a01b29a7b32a3ef23ef6739cf8bac6" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="814fa486b168b9d868566d9832d3cd8e" parent="44a01b29a7b32a3ef23ef6739cf8bac6" type="folder">5-7</container>
        </did>
        <accessrestrict id="aee461894cb0482b20c2792522b46e12">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0c6944c64d3e895d17a92cb7a840b2cc" level="file">
        <did>
          <unittitle>TML, 42-69 - Meningococcal vaccine - College students</unittitle>
          <unitdate type="inclusive">2000 August 7</unitdate>
          <container id="2f272c3206b2eb0bdad875359104f174" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="80eee7f9736e1d9b96dd6d4020f6fdae" parent="2f272c3206b2eb0bdad875359104f174" type="folder">8-9</container>
        </did>
        <accessrestrict id="df37cebc2f1268161ba89264e0aa24c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="f8521e46162fc0e16135537e8fe60e0e" level="file">
        <did>
          <unittitle>TML, 42-80 - A new long-acting methylphenidate</unittitle>
          <unitdate type="inclusive">2000 September 4</unitdate>
          <container id="54ad26bbc5d4c90c342ce23666643706" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="4a601448e48c89888e960533038f1656" parent="54ad26bbc5d4c90c342ce23666643706" type="folder">10-11</container>
        </did>
        <accessrestrict id="a4aa4fa7be7331aba5f8a5db5ecf9418">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="77d873ab9fa6653d75e07ecd29388474" level="file">
        <did>
          <unittitle>TML, 42-17 - Entacapone for Parkinson's disease</unittitle>
          <unitdate type="inclusive">2000 January 24</unitdate>
          <container id="5933208267ca056ba60bc5cfce164cfc" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="ef46f3438a1ab7b732673e2ba33d3874" parent="5933208267ca056ba60bc5cfce164cfc" type="folder">12-14</container>
        </did>
        <accessrestrict id="c4cc72e54e77645b47ebceda334dae90">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="2c3c36361f7d26d6245b10967d53cba6" level="file">
        <did>
          <unittitle>TML, 42-45 - Linezolid (Zyvox)</unittitle>
          <unitdate type="inclusive">2000 May 29</unitdate>
          <container id="52f7437dba55ed915f79694d9dd78ab3" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="9777c1d2151cde9010a35ab8f2f2d553" parent="52f7437dba55ed915f79694d9dd78ab3" type="folder">15-18</container>
        </did>
        <accessrestrict id="134bd94a116d4a00868b6be7c821b669">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="f3db800fbd8c30fd18c0ce7421c0675c" level="file">
        <did>
          <unittitle>TML, 42-1 - Drugs for HIV</unittitle>
          <unitdate type="inclusive">2000 January 10</unitdate>
          <container id="6c2b2d2cbc5e3a5efca01f6285925f0b" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="65f4e291c2f9fa7753d40d08a88d714f" parent="6c2b2d2cbc5e3a5efca01f6285925f0b" type="folder">19-21</container>
        </did>
        <accessrestrict id="6357a8604ec2f14301f33a46a3a3ee64">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="c29c016865d236b6f578b647c46a6676" level="file">
        <did>
          <unittitle>TML, 42-1 - Drugs for HIV</unittitle>
          <unitdate type="inclusive">2000 January 10</unitdate>
          <container id="b04b15f93d00d411bb92e3e5cd135be9" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="24e05565c98ebe87802a7c9c48920441" parent="b04b15f93d00d411bb92e3e5cd135be9" type="folder">1-2</container>
        </did>
        <accessrestrict id="8e3afc9c0897bcf7957059afb787d613">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0ef84e9be7c32e14ccb4cf39bfd45359" level="file">
        <did>
          <unittitle>TML - Rheumatoid Arthritis - Reprints</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="5cbaff9da987ef958f19cf5f08d653d7" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="a4ea2068a0bffe7c924eb096748f6785" parent="5cbaff9da987ef958f19cf5f08d653d7" type="folder">3-6</container>
        </did>
        <accessrestrict id="9bb37702887fbb2a3b6b04978a2797eb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="cc6bb16d28e33a08e3172f055c9bc2b1" level="file">
        <did>
          <unittitle>TML, 42-11 - Aggrenox - A combination of antiplatelet drugs for stroke prevention</unittitle>
          <unitdate type="inclusive">2000 February 7</unitdate>
          <container id="6961fecd1a562125de5cec6a8ff09e4f" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="6b271af336d00d7447210da84873e033" parent="6961fecd1a562125de5cec6a8ff09e4f" type="folder">7-8</container>
        </did>
        <accessrestrict id="b6c3f76765c91d59d07d1942830fb182">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="7fc91d920ef13c04bcd488ff67fb27eb" level="file">
        <did>
          <unittitle>TML - 42-54 - Beta Blockers for heart failure</unittitle>
          <unitdate type="inclusive">2000 June 26</unitdate>
          <container id="00383e80a502b51a9ce339ac1f0c12ee" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="e15114bd5b546d4727136c0541a13df7" parent="00383e80a502b51a9ce339ac1f0c12ee" type="folder">9-13</container>
        </did>
        <accessrestrict id="ddd4e956f4e4703f485c6e09538b3de5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="2659d96c29ea4c72cecf071a3ffe82cf" level="file">
        <did>
          <unittitle>TML, 42-83 - Drugs of Choice - Cancer chemotherapy</unittitle>
          <unitdate type="inclusive">2000 September 18</unitdate>
          <container id="a2885c46d0ffd8e2ef20b5ed01b29b64" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="247c509d5446d5924e4868a7c934eb68" parent="a2885c46d0ffd8e2ef20b5ed01b29b64" type="folder">14-18</container>
        </did>
        <accessrestrict id="fdc72de4846ddb965722a850fb816e7f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="85452dc178e1dadec0332fe42563215d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Tuberculosis</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="cd147adef895f599f71ae1694d864bf7" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="b183b3cfaec67f18e2bc97c1835fb2a8" parent="cd147adef895f599f71ae1694d864bf7" type="folder">1-4</container>
        </did>
        <accessrestrict id="f9bcd6fc9775a8cd44d753ed67359607">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="9c48a5236a35ed8f3ce7136401b6da9e" level="file">
        <did>
          <unittitle>TML, 42-101 - Mifepristone (RU 486)</unittitle>
          <unitdate type="inclusive">2000 October 30</unitdate>
          <container id="2a0a985d9a9dd0bb0fcc623cd96949ae" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="fc4c388d98a111bdadcb91abe2fce98b" parent="2a0a985d9a9dd0bb0fcc623cd96949ae" type="folder">5-8</container>
        </did>
        <accessrestrict id="512097af868e6310c2ef7aa3a3ab7af5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="41cb55e32ff2281af228fcf98e48db43" level="file">
        <did>
          <unittitle>TML - Osteoporosis - Reprints</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="124d2a52acaba189547277113da14388" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="fef18e92791678a1ae78bd93c823b9f0" parent="124d2a52acaba189547277113da14388" type="folder">9-12</container>
        </did>
        <accessrestrict id="a1eb04973eb4447d22f3324b1056f9bf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="669d4a856fe8af2c5b04130d94fa8d3e" level="file">
        <did>
          <unittitle>TML - Asthma - Reprints</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="7fa587b00b1835766beddf11aee98f6b" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="93ecb687af5372214e31ac31b13954d4" parent="7fa587b00b1835766beddf11aee98f6b" type="folder">13-16</container>
        </did>
        <accessrestrict id="38e2af006895a52bd2de3eb894293ec3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0ec6c4e753e63df5926b6bb8dc0ec41d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="7bb7aa1bc0fe29592f1770cec71a525b" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="8b221a959d99fc84f0ea51d067e5ea67" parent="7bb7aa1bc0fe29592f1770cec71a525b" type="folder">17-20</container>
        </did>
        <accessrestrict id="d8d94d63528159d44953c7215892b5f2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="1716a9979d5479baf368216eb3017f50" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="688c73aa553bbbc3eb585b8a51cff007" label="Mixed Materials (A0000000075899)" type="box">57</container>
          <container id="4bc27311d946a8651c486f8ec0f34a80" parent="688c73aa553bbbc3eb585b8a51cff007" type="folder">1-4</container>
        </did>
        <accessrestrict id="7be18115960dc69ccd463738ce3438d7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="296856f8c0a6139989dec83e2967a3f6" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="d0327d0d1a53b2b6012f7b8b0fe96f47" label="Mixed Materials (A0000000075899)" type="box">57</container>
          <container id="fc581ffd7e6ad1d3622a0cfb0f87d6f5" parent="d0327d0d1a53b2b6012f7b8b0fe96f47" type="folder">5</container>
        </did>
        <accessrestrict id="44a20fdcc0c5ee5bc8f27d1eb7439095">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="41a4f1b5ec21dcacfcb1590a26be0255" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="0300d0ab8863283379c6d29927624763" label="Mixed Materials (A0000000075900)" type="box">58</container>
          <container id="21268366b7d60df0241b5fa66462def1" parent="0300d0ab8863283379c6d29927624763" type="folder">1-3</container>
        </did>
        <accessrestrict id="aae3719b7a851cb67c17470197b044d1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="8d745390980b9c7fe7639600ac855496" level="file">
        <did>
          <unittitle>TML, 43-92 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">2001 October 29</unitdate>
          <container id="5e42325c7cfa744dd11f0c8901e91f54" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="7baa833cdc2772fb49b6b31aff8011ab" parent="5e42325c7cfa744dd11f0c8901e91f54" type="folder">1-3</container>
        </did>
        <accessrestrict id="08c08b71a5f549bb03c9e539391bf0c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="c8e27cfe3b70673df671446dc0f171dd" level="file">
        <did>
          <unittitle>TML, 43-43 - Choice of Lipid-lowering drugs</unittitle>
          <unitdate type="inclusive">2001 May 28</unitdate>
          <container id="0a09917e6dc043769ad5beb1fa774c76" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="33f14318b12488f4e401db4e785e0d03" parent="0a09917e6dc043769ad5beb1fa774c76" type="folder">4-10</container>
        </did>
        <accessrestrict id="12c485e70ce77057b564f5f005de3180">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="b12b140d39cce8b86f62018ce31197dd" level="file">
        <did>
          <unittitle>TML, 43-1 - Lopinavir - Ritonavir - A protease-inhibitor combination</unittitle>
          <unitdate type="inclusive">2001 January 8</unitdate>
          <container id="d9fce03c0c166f78d70fe63faff9035d" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="173be126aa903b085efeaabf4d0322bd" parent="d9fce03c0c166f78d70fe63faff9035d" type="folder">11-13</container>
        </did>
        <accessrestrict id="cb4f314cadf4551b7cb834b70eadf1cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="f3e4fd1faa4faa99ba52ed68b8dde6c9" level="file">
        <did>
          <unittitle>TML, 43-87 - Drugs and vaccines against biological warfare</unittitle>
          <unitdate type="inclusive">2001 October 19</unitdate>
          <container id="2a67cce777a27c9c049c8c7043aa7256" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="3c9865cef0b947d701dc1b8281657dea" parent="2a67cce777a27c9c049c8c7043aa7256" type="folder">14-17</container>
        </did>
        <accessrestrict id="19d192e97e549e2b446276124a3eb6b6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="f8fecc1cfd922fa2df867ba43e2d95e6" level="file">
        <did>
          <unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="834508385b539e620d09c1d2e7d912c1" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="b53286225755870af669a1175dc94d9a" parent="834508385b539e620d09c1d2e7d912c1" type="folder">18</container>
        </did>
        <accessrestrict id="bf0a0b9053f30a04f40935cc85ba1264">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="3283e79cbed2dd24ba8423865f0e23c0" level="file">
        <did>
          <unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="f7758e94047dda50cb803da419e3081c" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="1f018c662b515a06af8b3e8b0dab0d84" parent="f7758e94047dda50cb803da419e3081c" type="folder">1</container>
        </did>
        <accessrestrict id="f2c531fe46fbd0a55fbf3a371d0cfb12">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="b08aa5d6ed86fd5fceee0126fd84fd06" level="file">
        <did>
          <unittitle>TML, 43-9 - Beta-Blockers</unittitle>
          <unitdate type="inclusive">2001 February 5</unitdate>
          <container id="bfd3808bacd74f83a296be0c05e836b9" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="42552ebf81d0b9ac57de9bc15c35c8f7" parent="bfd3808bacd74f83a296be0c05e836b9" type="folder">2-6</container>
        </did>
        <accessrestrict id="6048933eb3a55f5f2d6a90721d4dd65f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="efb930d3872ae9d77c1298a07d7d5921" level="file">
        <did>
          <unittitle>TML, 43-62 - Balsalazide (Colazal) for ulcerative colitis</unittitle>
          <unitdate type="inclusive">2001 July</unitdate>
          <container id="0e2e8ed6fe9be5a7161f884f3b328400" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="04a336a4def0fc4d9b71f95c56b4dd0e" parent="0e2e8ed6fe9be5a7161f884f3b328400" type="folder">7-9</container>
        </did>
        <accessrestrict id="a454b4aa29b54507db7a4b31bd4c8d5f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="b522bd1a5159bd2d2194d2263cc22904" level="file">
        <did>
          <unittitle>TML, 43-11 - Argatroban for treatment of heparin-induced thrombocytopenia</unittitle>
          <unitdate type="inclusive">2001 February 5</unitdate>
          <container id="a16181f43216c94f68dc1df9418bcf3a" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="0539580434338bc27c691b995eb5354b" parent="a16181f43216c94f68dc1df9418bcf3a" type="folder">10-12</container>
        </did>
        <accessrestrict id="a20e6edf2b912e65b1924e6cbfaf7256">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="46514d81205269c17a4b19d49a573235" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="321894980462cf7c19c932f0200e7ef8" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="9dea26bb6ff4b727f2d0ea714f95e573" parent="321894980462cf7c19c932f0200e7ef8" type="folder">13-15</container>
        </did>
        <accessrestrict id="0ac715d063832982eec2283c964a4110">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="6dc4850ed3f15e6085336df184251532" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Osteoporosis</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="a7266c0f8a66366e9a146ccbdb19a2c0" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="0cfc93f02a134b793285f4e707bfbe24" parent="a7266c0f8a66366e9a146ccbdb19a2c0" type="folder">16</container>
        </did>
        <accessrestrict id="a5d61d385919f6ecefd5058c2bf3e8d5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="02fc378d7f3b4b93e45c3eef89379858" level="file">
        <did>
          <unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle>
          <unitdate type="inclusive">2001 August 20</unitdate>
          <container id="daeccc214d7853df87d6b00034d574b2" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="1ce9c8433ec5c7dac90992c7d6d04272" parent="daeccc214d7853df87d6b00034d574b2" type="folder">17-18</container>
        </did>
        <accessrestrict id="a1e5c73ef6115e61a317948cb85a9927">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2c6bff42d1f14c6a829324e9782c498a" level="file">
        <did>
          <unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle>
          <unitdate type="inclusive">2001 August 20</unitdate>
          <container id="dc662d8bc15dc20ae3e66114060cde6d" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="a48d601f4b8334d94c21180484e64493" parent="dc662d8bc15dc20ae3e66114060cde6d" type="folder">1-3</container>
        </did>
        <accessrestrict id="5b52a18cd7491854824957b6528aa161">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="6bf6928a0695a21bf35c621f43a5b338" level="file">
        <did>
          <unittitle>TML - Antimicrobial prophylaxis and Endocarditis - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="3e5f0b013de857ade9a6ad025cfff3f6" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="99df2e4e8ede91b43e54624182164ae5" parent="3e5f0b013de857ade9a6ad025cfff3f6" type="folder">4-6</container>
        </did>
        <accessrestrict id="7c855f662c00758a77e6169900e656ac">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="e83ae1dbb9d2dcd79b2efc11e8415787" level="file">
        <did>
          <unittitle>TML - AIDS - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="702fdde299cd06af01f77ae0ea3c8c50" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="5a81a5874fe9b132be7df9ebbc6432f1" parent="702fdde299cd06af01f77ae0ea3c8c50" type="folder">7-11</container>
        </did>
        <accessrestrict id="6f3b8da68a968edcf7612c6c7ab0d96d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="c6e64d3eb72280cbc65604fd0d1ef63b" level="file">
        <did>
          <unittitle>TML, 43-91 - Post Exposure Anthrax prophylaxis</unittitle>
          <unitdate type="inclusive">2001 October 29</unitdate>
          <container id="ed8cd6d3bf14adf5cc7a11b7416131ad" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="b59ba28ef922b7e40db88f405e41bfaf" parent="ed8cd6d3bf14adf5cc7a11b7416131ad" type="folder">12-13</container>
        </did>
        <accessrestrict id="c107fed35cdd31085f732308990ad842">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="41aa0763a7e36f6ce380706ce01181e3" level="file">
        <did>
          <unittitle>TML, 43-54 - PEG-Intron for chronic Hepatitis C</unittitle>
          <unitdate type="inclusive">2001 June 25</unitdate>
          <container id="0f33d98b6b886f788b7b5783047fd893" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="96afb511b95bbe8a86cf48997a3d965f" parent="0f33d98b6b886f788b7b5783047fd893" type="folder">14-16</container>
        </did>
        <accessrestrict id="10b78f31b326647359759629918503ac">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="21f79f7c6b4acd8a596b33dacb48841b" level="file">
        <did>
          <unittitle>TML, 43-110 - Insulin Glargine - a new long-acting insulin</unittitle>
          <unitdate type="inclusive">2001 August 6</unitdate>
          <container id="76c2188486eb224c46417f21b910afba" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="0a3c5def497900cc80b6537bca1a18d8" parent="76c2188486eb224c46417f21b910afba" type="folder">17-19</container>
        </did>
        <accessrestrict id="ce544613fec94a632b764ccaa6155e27">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2eed515acb400c24339036029a7a8f49" level="file">
        <did>
          <unittitle>TML, 43-29 - Nateglinide for Type 2 diabetes</unittitle>
          <unitdate type="inclusive">2001 April 2</unitdate>
          <container id="141d53d16deb8d81efcb4217b74fbb9d" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="87de4bc37e3a217ec56e137ed3fbe583" parent="141d53d16deb8d81efcb4217b74fbb9d" type="folder">1-3</container>
        </did>
        <accessrestrict id="7bf007b3c2f616cf82e76b675923a0ae">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ccba2cedcccf56cdefa0e205fc19e877" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cancer</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="e82ef8082931b14f629b863c60eea58d" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="4f05deb39f3286edcc5a454f2f046f68" parent="e82ef8082931b14f629b863c60eea58d" type="folder">4-5</container>
        </did>
        <accessrestrict id="d687a473729a78247a1c380123065159">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="8b4de852b3dcabc7ad6e003cb57745bf" level="file">
        <did>
          <unittitle>TML, 43-100 - Nesiritide for decompensated congestive heart failure</unittitle>
          <unitdate type="inclusive">2001 November 12</unitdate>
          <container id="b7ab09f8b6b725bf6ed2581a8c1f12ad" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="8b708e004df0a0da819a4d79756b9591" parent="b7ab09f8b6b725bf6ed2581a8c1f12ad" type="folder">6-9</container>
        </did>
        <accessrestrict id="60722a1253dc5c989a1fb84363bf8347">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ae81e26ee03016b7e8a19efe2323b2b6" level="file">
        <did>
          <unittitle>TML, 43-35 - Non-Sedating Antihistamines</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="5372ffd503d846c56f28dfb61a91173d" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="bc7d903854279b1796b1830d2282f917" parent="5372ffd503d846c56f28dfb61a91173d" type="folder">10-13</container>
        </did>
        <accessrestrict id="e3c9df3f442f047a5b6b393b36042f5b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ebbf6e65860c02f436f6ca0982c14e3e" level="file">
        <did>
          <unittitle>TML, 43-17 - Drugs for hypertension</unittitle>
          <unitdate type="inclusive">2001 March 5</unitdate>
          <container id="74fc117c6b54736dcf9657cf2fdb74cd" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="c975590507b2ca4a36940543c8382eb0" parent="74fc117c6b54736dcf9657cf2fdb74cd" type="folder">14-18</container>
        </did>
        <accessrestrict id="3e2fa8d34c5d3f85b91b8b755235d673">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="dc20397e0f8fc97006ecdf0d5f679b73" level="file">
        <did>
          <unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle>
          <unitdate type="inclusive">2001 July 23</unitdate>
          <container id="1fcc4883e9e11f6a77df198bb3f65525" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="ef939d5e5bfb24d2c2e796d91e7a215d" parent="1fcc4883e9e11f6a77df198bb3f65525" type="folder">19</container>
        </did>
        <accessrestrict id="bedf8436e8ecc88cef43b4466703321f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2a3e11c7291578855058677f583ba4cc" level="file">
        <did>
          <unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle>
          <unitdate type="inclusive">2001 July 23</unitdate>
          <container id="1d658c67f5cb0f8c653fdbfe2ce61823" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="9270abb0a8c1b9dedba8e1aff80244a9" parent="1d658c67f5cb0f8c653fdbfe2ce61823" type="folder">1-2</container>
        </did>
        <accessrestrict id="1faf2fbe4c747499b17f777c7da8d367">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="7aeba34ec44547fe9581d43a0fc4043e" level="file">
        <did>
          <unittitle>TML, 43-6 - Nebulized Budesonide for Asthma in children</unittitle>
          <unitdate type="inclusive">2001 January 27</unitdate>
          <container id="e94e5c5e15095153605695d81304d3a8" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="8c9f74eee274473134ae0beb9a1a2deb" parent="e94e5c5e15095153605695d81304d3a8" type="folder">3-7</container>
        </did>
        <accessrestrict id="d1f83bcd9d1dba630ab83fe624589365">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9011b2319d9d385461bdca83ff03a269" level="file">
        <did>
          <unittitle>TML, 42-2 - Cool Click - a needle-free device for growth hormone delivery</unittitle>
          <unitdate type="inclusive">2001 January 8</unitdate>
          <container id="af79be05a5bb26a4fcba862a65fec3fc" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="e104be7960c3dafff508fef8ce32d765" parent="af79be05a5bb26a4fcba862a65fec3fc" type="folder">8-10</container>
        </did>
        <accessrestrict id="d1142cfc576dc71445c5513786f60e47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="43f128e719abd7716a8b552dab41b4ca" level="file">
        <did>
          <unittitle>TML, 43-84 - Cord Blood Banks</unittitle>
          <unitdate type="inclusive">2001 October 1</unitdate>
          <container id="a822a199c8d72df5006749b5d2d842d6" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="330ec1a066560c29458083bd6bf3d1a2" parent="a822a199c8d72df5006749b5d2d842d6" type="folder">11-14</container>
        </did>
        <accessrestrict id="d355e32a24f6cffb35162f5a565f8aad">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2ca4ec46f32a50a21f55760304d5080b" level="file">
        <did>
          <unittitle>TML, 43-59 - Initital treatment of Parkinson's disease</unittitle>
          <unitdate type="inclusive">2001 July 9</unitdate>
          <container id="a8be0ed5fcc0d27391bb8186e3d65fed" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="9f410973141ccf4f63c55eaaa4779546" parent="a8be0ed5fcc0d27391bb8186e3d65fed" type="folder">15-16</container>
        </did>
        <accessrestrict id="12449f363aa33b967622999d1c656f25">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="f4881e412a79293a02fce06ab7ada62d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="6dcb74606a9e2ffa19ca13835c212955" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="849d85d74c82ba4a6d727710d5a144e5" parent="6dcb74606a9e2ffa19ca13835c212955" type="folder">17-20</container>
        </did>
        <accessrestrict id="762520a711ae5cf2f881c37d75c585e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="076a7f8b55c4644de3dc62c6db843a72" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="c783d573cb215bda00597fbcfbdabef5" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="27222b4a2995b02bdbb328f8a4aa9e62" parent="c783d573cb215bda00597fbcfbdabef5" type="folder">1-2</container>
        </did>
        <accessrestrict id="0e6e931602cabb1fe060a758f1e09d3e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="98d5e522f0e12ef676f68b6296b375c4" level="file">
        <did>
          <unittitle>TML, 43-61 - Lung Cancer screening</unittitle>
          <unitdate type="inclusive">2001 July 23</unitdate>
          <container id="4d770879ee67a381a59e41c96ec89339" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="1d4f88e825bcd7a66089eccb78d6057b" parent="4d770879ee67a381a59e41c96ec89339" type="folder">3-5</container>
        </did>
        <accessrestrict id="1fa9376a18b8cabf3a1ced8db4bc6995">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="bbfbf04fd92af083cfe5f2803138df54" level="file">
        <did>
          <unittitle>TML, 43-7 - Mirena</unittitle>
          <unitdate type="inclusive">2001 January 22</unitdate>
          <container id="88cee0fa553ce6f53ddaea9e2a1f6b65" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="4061420f3347c0889eed1989e3be20f2" parent="88cee0fa553ce6f53ddaea9e2a1f6b65" type="folder">6-8</container>
        </did>
        <accessrestrict id="6eb2c131de0d820a3d57bfd6b90300e6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="3b86dfd5896dc8ed385111ad16cbd218" level="file">
        <did>
          <unittitle>TML, 43-109 - Darbopoetin (Aranesp) - a long acting erythropoietin</unittitle>
          <unitdate type="inclusive">2001 December 10</unitdate>
          <container id="a7add6f5a6afa3a169801c9687b4755b" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="e53641b67fe85b9ba265a45150b8264d" parent="a7add6f5a6afa3a169801c9687b4755b" type="folder">9-10</container>
        </did>
        <accessrestrict id="f505d3982f99b3e642ccbf40fbd75883">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="0f9927bdf850374dd901cc030c68dc7c" level="file">
        <did>
          <unittitle>TML - Drugs for chronic heart failure</unittitle>
          <unitdate type="inclusive">2001 April 6</unitdate>
          <container id="a978c149d1e2c4d5fbfcb9b861380108" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="85d912ac795c4adce702900cc17c6f4d" parent="a978c149d1e2c4d5fbfcb9b861380108" type="folder">11-14</container>
        </did>
        <accessrestrict id="6be4b2a90096d23f4c7270994aa74f17">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="97fc093a6a8e4909bb2c604168b0b754" level="file">
        <did>
          <unittitle>TML, 43-58 - Caspofungin (Candidas) for aspergillosis</unittitle>
          <unitdate type="inclusive">2001 July 9</unitdate>
          <container id="3f59908f80ea75cf3ae81d7b499b4162" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="4fd791c0907931af65b79a8adce797ee" parent="3f59908f80ea75cf3ae81d7b499b4162" type="folder">15-18</container>
        </did>
        <accessrestrict id="f836855e02f4d6fe9f63b628886a4c85">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="6da20ff4a72dc0604ae511c5634291e7" level="file">
        <did>
          <unittitle>TML, 43-55 - A new snake antivenin</unittitle>
          <unitdate type="inclusive">2001 June 25</unitdate>
          <container id="f4581bef030ffdda0d7b53ce6594c241" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="c658ea54efda8a729555a846ee1f011e" parent="f4581bef030ffdda0d7b53ce6594c241" type="folder">19-20</container>
        </did>
        <accessrestrict id="f08173f37c2607c4d273372be7fedab1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ede8d569017eb650ffb86947aa817ebe" level="file">
        <did>
          <unittitle>TML, 43-110 - Zometa (Zoledronic Acid) for injection</unittitle>
          <unitdate type="inclusive">2001 December 10</unitdate>
          <container id="ddcb0769b8a5cc618446fb779238354a" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="2f4b9bce25fde758b66f63b169d89451" parent="ddcb0769b8a5cc618446fb779238354a" type="folder">1-3</container>
        </did>
        <accessrestrict id="3a54c329c0d6d0bc229bdd0616332d9d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="a2f1959db87c3ed2aeb2a70eafd0d767" level="file">
        <did>
          <unittitle>TML, 43-51 - Ziprasidone (Geodon) for schizophrenia</unittitle>
          <unitdate type="inclusive">2001 June 11</unitdate>
          <container id="01b8a7df02514b5b0cb04a3cca144ad7" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="5f3d5bb85061c9b5eb02f26d565903da" parent="01b8a7df02514b5b0cb04a3cca144ad7" type="folder">4-7</container>
        </did>
        <accessrestrict id="810ad5d825ba01f69c55af09b52e33af">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="8068f52546b65b321ac2f5fa6a731f4c" level="file">
        <did>
          <unittitle>TML, - Drugs for depression and anxiety</unittitle>
          <unitdate type="inclusive">2001 February 14</unitdate>
          <container id="6e4be9d8b82c89ebe22c0096f3fca461" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="22dfc2ba32b99305096f098c0dd5b395" parent="6e4be9d8b82c89ebe22c0096f3fca461" type="folder">8-10</container>
        </did>
        <accessrestrict id="67940cb71724cb07bb1c047808a223cf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="55a8ca16b598343eb87537a2d296ecd1" level="file">
        <did>
          <unittitle>TML, 43-15 - PC-Spes</unittitle>
          <unitdate type="inclusive">2001 February 19</unitdate>
          <container id="4750769920819f720b13f3c1427c8c79" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="0585671866fb2b0d3d064399d0564f02" parent="4750769920819f720b13f3c1427c8c79" type="folder">11-12</container>
        </did>
        <accessrestrict id="75c2794ebd1f11660bcef03019daccd2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ebe0e5315e3cdfa6495aed9cdada44d6" level="file">
        <did>
          <unittitle>TML, 43-83 - Metadate (Extended-Release Methylphenidate)</unittitle>
          <unitdate type="inclusive">2001 October 1</unitdate>
          <container id="6db28afda62adf36ac194006538d9349" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="a882a6a43d32fa5527a7ba43f54ea976" parent="6db28afda62adf36ac194006538d9349" type="folder">13-16</container>
        </did>
        <accessrestrict id="07f8b933648e23ed47138c1bef096df8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="833ebff3fb7c7c45c0c064414304d04f" level="file">
        <did>
          <unittitle>TML, 43-49 - Gleevec (STI-571) for chronic myeloid leukemia</unittitle>
          <unitdate type="inclusive">2001 June 11</unitdate>
          <container id="12037a664d2732605da2ee932b21a59c" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="ef13359f4d33123dea8022b22faa9939" parent="12037a664d2732605da2ee932b21a59c" type="folder">17-18</container>
        </did>
        <accessrestrict id="8a48c9bb323707808cd2699c098b90df">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="e579c81ba72fe1f002ea554c42ec0eb7" level="file">
        <did>
          <unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="1b56d6ecfce6939149bdf0bed8e5a4b5" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="e96d9a99d727389f94aabe40e1172d17" parent="1b56d6ecfce6939149bdf0bed8e5a4b5" type="folder">19</container>
        </did>
        <accessrestrict id="5b72b0c715fd854e87ba957e71353a88">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2c8e55774a1bb77e5eb47e4cd5592dca" level="file">
        <did>
          <unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="57ecda5dc066438f9441318a1115b194" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="853acbc9948740bb93300ff86e520213" parent="57ecda5dc066438f9441318a1115b194" type="folder">1</container>
        </did>
        <accessrestrict id="45e2eef135b65b2a4bc8bfac6895eae6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="a3e98844edbadfd1126f96dcee9fa072" level="file">
        <did>
          <unittitle>TML, 43-89 - Insulin Aspart - a new rapid-acting insulin</unittitle>
          <unitdate type="inclusive">2001 October 15</unitdate>
          <container id="cc318a4bd9a20413adb963c081a49378" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="0d2fd963cb8a7290e7e398ba4f0fcfac" parent="cc318a4bd9a20413adb963c081a49378" type="folder">2-3</container>
        </did>
        <accessrestrict id="95db9e419544c222951aae12dd139e45">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2330e815d4bdfd9c12c459306864dcca" level="file">
        <did>
          <unittitle>TML, 43-103 - Drugs for HIV infection</unittitle>
          <unitdate type="inclusive">2001 November 26</unitdate>
          <container id="21181957b45a40427f581e533d45f3ad" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="1c316ced8d8821784b018c75d5ab196c" parent="21181957b45a40427f581e533d45f3ad" type="folder">4-7</container>
        </did>
        <accessrestrict id="ba5d1519c239af0bb83357cd9431cc00">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="c9e718e37292bcb43f7c0f24dd8175bb" level="file">
        <did>
          <unittitle>TML, 43-26 - Once-a-Week Alendronate (Fosamaz)</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="26d86c7d0deb238b95ec679f611c977e" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="fcfa998b6beb9f81359c63004c6858ba" parent="26d86c7d0deb238b95ec679f611c977e" type="folder">8</container>
        </did>
        <accessrestrict id="3aaad115d37c1f7c6a8b419cea0284e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ce9f44342b0f523de0bfcb639e0134e8" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Migraine - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="83ca2e05f2db1cc7e151256e09688eb8" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="9814aa26eda2bf97f51d0fa1f6c8ca24" parent="83ca2e05f2db1cc7e151256e09688eb8" type="folder">9-10</container>
        </did>
        <accessrestrict id="9d4ad8765f4f79883181f256eb7f9879">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="8c50daa78ebe0875cf14c75e503ea1c1" level="file">
        <did>
          <unittitle>TML, Drugs of Choice - Pain</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="0b2d106c5406631ba3f3e92acad551fd" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="b99769a958dab372665636be1bc490dd" parent="0b2d106c5406631ba3f3e92acad551fd" type="folder">11</container>
        </did>
        <accessrestrict id="3b2728fff814b6aa47a93b6386e34381">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="468e734f765a9be3853dd86c21c17c5d" level="file">
        <did>
          <unittitle>TML, 43-25 - Direct-to-Consumer advertisements for Glucophage XR</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="d1dce4b6bf78af65f6cd5d663db52420" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="8d3eb43ddb3ee2aa113e3df7773161f3" parent="d1dce4b6bf78af65f6cd5d663db52420" type="folder">12</container>
        </did>
        <accessrestrict id="82bce5eadd0f640bbbd014ce96f624b7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="d63b61dd440fbe48748ed3adaaa153a3" level="file">
        <did>
          <unittitle>TML, 43-13 - Palivizumab update</unittitle>
          <unitdate type="inclusive">2001 February 19</unitdate>
          <container id="1f5e125f6166f9eb69465d3d63d293b9" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="4cdc17ac4653752d6fa32f5fabfb0ed9" parent="1f5e125f6166f9eb69465d3d63d293b9" type="folder">13-14</container>
        </did>
        <accessrestrict id="a7dd4884d34880dfc26867a2d2428bf1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="07c5a88addbecee925056539789a95ce" level="file">
        <did>
          <unittitle>TML, 43-14 - Tinzaparin for treatment of deep vein thrombosis</unittitle>
          <unitdate type="inclusive">2001 February 19</unitdate>
          <container id="7f217af16b55d56b9b1dba870d14e339" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="6fccc04e62c567313119a3556708fc4b" parent="7f217af16b55d56b9b1dba870d14e339" type="folder">15-17</container>
        </did>
        <accessrestrict id="e9948bb5cd6966ff6405e6dc4196d47e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="3c99102c3cbe6573776800745f8ae469" level="file">
        <did>
          <unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="62f223261c4c733806b7dae42231aea3" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="e68eef6237a353ec71e6387552ca26c3" parent="62f223261c4c733806b7dae42231aea3" type="folder">18-20</container>
        </did>
        <accessrestrict id="0e83e8dd8e86709df7f972ac81515598">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="c6baca4f86fe997597684780a50afb04" level="file">
        <did>
          <unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="9b3d021b7607628da66e351f9701fb54" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="8fd39b3bf3546da94dec981c3c64439a" parent="9b3d021b7607628da66e351f9701fb54" type="folder">1</container>
        </did>
        <accessrestrict id="a04d9293e94b60a9e39c9b4189abc925">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="21563c371ed6d15964e3cc6b122e8325" level="file">
        <did>
          <unittitle>TML, 43-31 - Advair "Diskus" - A combination of fluticasone and salmeterol for asthma</unittitle>
          <unitdate type="inclusive">2001 April 6</unitdate>
          <container id="35554bc50bb3f7a2a6a6b99354065ccf" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="76a5843bc7149836c4b3ba41b334e951" parent="35554bc50bb3f7a2a6a6b99354065ccf" type="folder">2-5</container>
        </did>
        <accessrestrict id="591f5ce0464ac805e58c930e1f206114">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="a56fc8ba008f5ec96cb059f94525d216" level="file">
        <did>
          <unittitle>TML, 43-5 - Fluoxetine (Sarafem) for premenstrual dysphoric disorder</unittitle>
          <unitdate type="inclusive">2001 January 22</unitdate>
          <container id="0de9b14eb0e6c57e75fa9d2135d1ae06" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="f5d196236207412107c95ebaf88fb09e" parent="0de9b14eb0e6c57e75fa9d2135d1ae06" type="folder">6-8</container>
        </did>
        <accessrestrict id="516c40c3c42f23a1ef834fac3280423d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="29dd0d00d8ca1ffa9497a61ade7fcac7" level="file">
        <did>
          <unittitle>TML, 43-57 - Levothyroxine</unittitle>
          <unitdate type="inclusive">2001 July 9</unitdate>
          <container id="c438d5c606b4de0cf750f3ee3e94672b" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="6990900a15e3a692243743abdc2acbb2" parent="c438d5c606b4de0cf750f3ee3e94672b" type="folder">9-11</container>
        </did>
        <accessrestrict id="5e4d50d8e1cee2179d409a4d58ebfe39">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="d2d95b76affb3a4c9b22a381ae08576d" level="file">
        <did>
          <unittitle>TML, 43-28 - Detrol LA and Ditropan XL for overactive bladder</unittitle>
          <unitdate type="inclusive">2001 April 2</unitdate>
          <container id="fc5c5cd28618b756cbf0c7a34cfe0175" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="099fc21d371d06031d1649a71f589ae8" parent="fc5c5cd28618b756cbf0c7a34cfe0175" type="folder">12-13</container>
        </did>
        <accessrestrict id="c2a600b167a1d8ec49922e49f096e4ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="bf76f78ab4a4977fe44b60003b8f05f2" level="file">
        <did>
          <unittitle>TML, 43-27 - Prozac Weekly</unittitle>
          <unitdate type="inclusive">2001 April 2</unitdate>
          <container id="f481f19411a5f56fa2eeb8a9bff33789" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="f14455a685ff2af9d746276ca1b0b3fc" parent="f481f19411a5f56fa2eeb8a9bff33789" type="folder">14</container>
        </did>
        <accessrestrict id="154ff78d3302dfb71a0c20f63e7f510f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="d6b0a2f70273ff0516f8b345cdc4f512" level="file">
        <did>
          <unittitle>TML - Drugs for migraine</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="5353ed6507b3e2190de00cefb3b9d529" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="edb0c888894ce9ef6bd23afb5d8a5574" parent="5353ed6507b3e2190de00cefb3b9d529" type="folder">15-17</container>
        </did>
        <accessrestrict id="81584269571599c2534c39747bee7f6e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ab3c9b20ba673d3a09626a2131dfbd70" level="file">
        <did>
          <unittitle>TML - Drugs for migraine</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="9360561a5d655338d62d6d20c37e391a" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="e61cb2456c512558bac26656e913d672" parent="9360561a5d655338d62d6d20c37e391a" type="folder">1</container>
        </did>
        <accessrestrict id="33ca4d5589e42adbdeba4c14888b39e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ce9d0ae7e21eaea0c4687dae309cfee9" level="file">
        <did>
          <unittitle>TML, 43-67 - Twinrix - A combination Hepatitis A and B vaccine</unittitle>
          <unitdate type="inclusive">2001 August 6</unitdate>
          <container id="6fd3bc848daef420008173a8855053ef" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="cfac30cfcc6402a13132d7d4706b285c" parent="6fd3bc848daef420008173a8855053ef" type="folder">2-4</container>
        </did>
        <accessrestrict id="c860c07bca67d0f682cba26ca6577767">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="50348bc86f79794dd7d3880f772dc9fb" level="file">
        <did>
          <unittitle>TML, 43-81 - Influenza prevention 2001-2002</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="0fbd5e7f6ac9ec1fab1ebd36f189f6e2" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="8f99f89b415888b90a9965c1fcaedad4" parent="0fbd5e7f6ac9ec1fab1ebd36f189f6e2" type="folder">5-8</container>
        </did>
        <accessrestrict id="1bbd28b63a91d7783c47a3da12aa5197">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="3b16d2ad8da51e66ff96ab39df1d0aac" level="file">
        <did>
          <unittitle>TML, 43-33 - Topical tacrolimus treatment for atopic dermatitis</unittitle>
          <unitdate type="inclusive">2001 April 16</unitdate>
          <container id="9bac93f0126ec531513d012bab490cf3" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="7f8517dfa30e1ca584c0cd392c7e8431" parent="9bac93f0126ec531513d012bab490cf3" type="folder">9-12</container>
        </did>
        <accessrestrict id="524857adc52fa0f183b069d3ae7050b5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="41122ea5a6e7981f0132dc387c47d526" level="file">
        <did>
          <unittitle>TML, 43-42 - Glucowatch Biographer - A noninvasive glucose monitoring device</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="01fe09d47137d1bdb72b5616db7b3dd0" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="0cce3ea71d39e0eff7880f647e006b7b" parent="01fe09d47137d1bdb72b5616db7b3dd0" type="folder">13-14</container>
        </did>
        <accessrestrict id="8a2f04b8e85fd19c93d31127f994912c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="1f33fb25dbc24b2e3a9cc4123daa4b4c" level="file">
        <did>
          <unittitle>TML, 43-99 - Cardiovascular Safety of COX-2 Inhibitors</unittitle>
          <unitdate type="inclusive">2001 November 12</unitdate>
          <container id="9241ce3ba21fe563cd69170e6ed064de" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="695cc82d11e6aa1b03c897d19a63f164" parent="9241ce3ba21fe563cd69170e6ed064de" type="folder">15-17</container>
        </did>
        <accessrestrict id="ed26092ce8449e46cf63b80b2a291816">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9c5905505fca4831e512fb2648100be7" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Hypertension and Heart Failure</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="649efff74a06c9de52f3540e8ecfcaae" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="2f1e0e7d83125730d988cc474dd7c3f9" parent="649efff74a06c9de52f3540e8ecfcaae" type="folder">18</container>
        </did>
        <accessrestrict id="75c6bb282a1bebd46a6a30af50403e35">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="d83158c1d6d2339140e8e837daa705b4" level="file">
        <did>
          <unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="bddb09e6552b5df71d1056d0dc54c515" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="6f6c024916e8be081edb3a86a12b9b74" parent="bddb09e6552b5df71d1056d0dc54c515" type="folder">19-21</container>
        </did>
        <accessrestrict id="a70ce5ed30190ec1d7686f21b89b6372">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="45a1a372dc6189c488cbf6dbf95adb8d" level="file">
        <did>
          <unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="d23eadac7ad95bfd196230094a956d24" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="41062ed3a9c262f35cc3f24be4f27b1c" parent="d23eadac7ad95bfd196230094a956d24" type="folder">1</container>
        </did>
        <accessrestrict id="a1903924a041556ee7b26f4c2b26ac5e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="4cdec89511203afd4fe2dc98bb7107a3" level="file">
        <did>
          <unittitle>TML, 43-3 - Drugs for Vulvovaginal Candidiasis</unittitle>
          <unitdate type="inclusive">2001 January 8</unitdate>
          <container id="463b7031247b2d123d2eda10ef470457" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="0ef474154b30e01ea22ddc1c63a6f231" parent="463b7031247b2d123d2eda10ef470457" type="folder">2-4</container>
        </did>
        <accessrestrict id="721d15062edf16474f8c9615e7343c9b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9c93f14bdbe03244367dc9260f841c8a" level="file">
        <did>
          <unittitle>TML, 43-40 - Epoetin - Erythropoietin (Procrit; Epogen) Revisited</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="51ab1b3b6ffc96036a42b31e90c95905" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="6d330c45fb6219bb81799f8f5dba008b" parent="51ab1b3b6ffc96036a42b31e90c95905" type="folder">5-8</container>
        </did>
        <accessrestrict id="0834865471315b83cd87445af0b5d964">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="8c1db8b64ee78c1dea2315fd90476615" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="e4c11dbac7b199e1f2db51c056ada0f8" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="c49468ff3cea1346c8b6b3504ca7a769" parent="e4c11dbac7b199e1f2db51c056ada0f8" type="folder">9-12</container>
        </did>
        <accessrestrict id="0b08c7f91d343d75d562eb65c74f54bc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="42c85fbc002a3352f01a11a7e4a6f54d" level="file">
        <did>
          <unittitle>TML, 43-36 - Esomeprazole (Nexium)</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="49fbb706c2fd9d6b4afadb62a0416b6f" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="8c1d1e4416bb7e7ee95633b358846fa4" parent="49fbb706c2fd9d6b4afadb62a0416b6f" type="folder">13-14</container>
        </did>
        <accessrestrict id="cc2db5a946dc97445662edf403135cfe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="dde7a8f4a1c15dd762a0160728804b73" level="file">
        <did>
          <unittitle>TML, 43-111 - Update on glucosamine for osteoarthritis</unittitle>
          <unitdate type="inclusive">2001 December 10</unitdate>
          <container id="1b100a65c52f60b1261c75579fc505c3" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="6c57015440db923e91481cf75f4d6995" parent="1b100a65c52f60b1261c75579fc505c3" type="folder">15-17</container>
        </did>
        <accessrestrict id="5b2a4f2cbe109ddd0b02adec46206e8d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9666394f9b7e1594ab6d9d740833bf6d" level="file">
        <did>
          <unittitle>TML, 43-53 - Galantamine (Reminyl) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2001 June 25</unitdate>
          <container id="469df40e3b3532c87166245282124050" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="1571a8efe17ff75aec289b5a568a2dc5" parent="469df40e3b3532c87166245282124050" type="folder">18-20</container>
        </did>
        <accessrestrict id="64351c947d34d22cef39ad4007296824">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9e514faa1eb026a69873e6b610137535" level="file">
        <did>
          <unittitle>TML, 43-80 - Oxycodone and Oxycontin</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="825318c90bcd0be07e4871d9041ae2c4" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="07b7c2889abf4c523970bed48fd50dda" parent="825318c90bcd0be07e4871d9041ae2c4" type="folder">1-4</container>
        </did>
        <accessrestrict id="71c26f172f9a9a3876c7b24d11cc0db1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9bf44e00458f50d0ecc17dc1d13c078a" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Asthma - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="110f019a83536e2da48d3832fa7d62ed" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="c336c4700266594b63821371e3028f32" parent="110f019a83536e2da48d3832fa7d62ed" type="folder">5-7</container>
        </did>
        <accessrestrict id="753a55d97a80d113ee2476718a3d1661">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="0dc13b68cd4edd9b7be7bd34aad97ff0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Hypertension - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="fc849860419c6d12deadd56c8e12d6db" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="9466290928a7d42915f27a00464a4e9e" parent="fc849860419c6d12deadd56c8e12d6db" type="folder">8-10</container>
        </did>
        <accessrestrict id="d504ebc62c5421f5e1d907042650019a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="28985057e383ceb12ff871b5d26e61da" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="12f3abe1e5cd3d09185a31fd43ce18d1" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="b9639397b6a68f845bbcc80b1147b2bd" parent="12f3abe1e5cd3d09185a31fd43ce18d1" type="folder">11-13</container>
        </did>
        <accessrestrict id="22fbfc715602ec37fdf0114b7cb13cbe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="e9eaa9b717e217af3529d05e6f9fbd9e" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Arthritis - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="3e01ae3d103ce91d5dd1eef83bfee132" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="a939d1a050b25929fa6c0526d95bd03e" parent="3e01ae3d103ce91d5dd1eef83bfee132" type="folder">14-15</container>
        </did>
        <accessrestrict id="b5d06faa04330361ca1ca75b21c017fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="a8579ee641a8d372e5b92c341780d2f0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Depression and Anxiety</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="b30aeec7e0acfc12886246d9489e81ba" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="9094fb03bbd8997beebef6cc4862e921" parent="b30aeec7e0acfc12886246d9489e81ba" type="folder">16-17</container>
        </did>
        <accessrestrict id="85e3914a93c77fea32c035bd079cdf38">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="d1091da187ca03263e9fbe06a0c8e8b9" level="file">
        <did>
          <unittitle>TML, 44-105 - Adefovir (Hespera) for chronic Hepatitis B infection</unittitle>
          <unitdate type="inclusive">2002 December 9</unitdate>
          <container id="07cba6653ac756359105235ac9082975" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="a41ac4a715821b14ec6008fab6a99157" parent="07cba6653ac756359105235ac9082975" type="folder">1-4</container>
        </did>
        <accessrestrict id="5e9a358af553725b2b7a0e754e583db4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="a52ad11ec1e3f4d9273267e959212194" level="file">
        <did>
          <unittitle>TML, 44-67 - Alosetron (Lotronex) revisited</unittitle>
          <unitdate type="inclusive">2002 August 5</unitdate>
          <container id="6ac970991ac41f35aab6a6cadad82e83" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="641ee73c1e52804f75dbe6c829e3c5c6" parent="6ac970991ac41f35aab6a6cadad82e83" type="folder">5-8</container>
        </did>
        <accessrestrict id="44f937981b03e47fe5b48832e2bc3c06">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="524bcd1ef0983fc228db57fdceccbd8a" level="file">
        <did>
          <unittitle>TML, 44-1 - Prevention and treatment of injury from chemical biological warfare</unittitle>
          <unitdate type="inclusive">2002 January 7</unitdate>
          <container id="ef0a9c121783badebc4a3cf9c2c0caee" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="99ac80a589f1129f95139c08ce09317a" parent="ef0a9c121783badebc4a3cf9c2c0caee" type="folder">9-11</container>
        </did>
        <accessrestrict id="41a008738c8b0cf8972cf6b24432d838">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="bad1e6f9e4ec0f760e77c31253787c34" level="file">
        <did>
          <unittitle>TML, 44-18 - Anakinra (Kineret) for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">2002 February 18</unitdate>
          <container id="b82e204887461c68de048373241af622" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="e15e8b900598af754ccdbadf96d009e4" parent="b82e204887461c68de048373241af622" type="folder">12-13</container>
        </did>
        <accessrestrict id="5283c1dbc9ae363bd049db90b8c9f8d8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="ba78803aaafb030f1962308400163490" level="file">
        <did>
          <unittitle>TML, 44-19 - Almotriptan (Axert) and Frovatriptan (Friva) for migraine</unittitle>
          <unitdate type="inclusive">2002 February 18</unitdate>
          <container id="578d3ee1c7f116924a9605c91274d8f0" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="011effcd5cc4f1d69f4bbd1e4b7fcf58" parent="578d3ee1c7f116924a9605c91274d8f0" type="folder">14-16</container>
        </did>
        <accessrestrict id="261eac7e701cc4253a133eadd4895b0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="bb6077375b3a6ffeb4bb53556a4f4c3c" level="file">
        <did>
          <unittitle>TML, 44-110 - Hemolysis from Ceftriaxone</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="1dc78afef31a2f9da63fe8fceb11c3b9" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="6d8f5612b8e090337b340d0ee7be1db2" parent="1dc78afef31a2f9da63fe8fceb11c3b9" type="folder">17-19</container>
        </did>
        <accessrestrict id="06663a53b51c9f32469146874e6a53fd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="a4e45a144c74f16ab14378047e5576f1" level="file">
        <did>
          <unittitle>TML, 44-6 - Budesonide (Entocort EC) for Crohn's disease</unittitle>
          <unitdate type="inclusive">2002 January 21</unitdate>
          <container id="34f05e59151a71b868e03e62ae8d76b3" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="26b946be10a3b8228789f9b5b4842045" parent="34f05e59151a71b868e03e62ae8d76b3" type="folder">20-21</container>
        </did>
        <accessrestrict id="344623fd522ad204005bd4713a3a7eaa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="9f13d0adec34e41920a5e68ddd64292c" level="file">
        <did>
          <unittitle>TML, 44-109 - Dustateride (Avodart) for benign prostatic hyperplasia</unittitle>
          <unitdate type="inclusive">2002 December 23</unitdate>
          <container id="b560fcd287b33da04d934b6709523319" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="227b55d2ebfae593d656b6d884c42220" parent="b560fcd287b33da04d934b6709523319" type="folder">1</container>
        </did>
        <accessrestrict id="867284bb3e82161ed3ce13cf85bb50cf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="9263ee3a396996d1f6c92f91c990e8b4" level="file">
        <did>
          <unittitle>TML, 44-55 - Yasmin - an oral contraceptive with a new progestin</unittitle>
          <unitdate type="inclusive">2002 June 24</unitdate>
          <container id="14d8f742d2b6f91b25f43041ba740085" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="fd4e892fdbdb2b92e1cb9db6759e0b7c" parent="14d8f742d2b6f91b25f43041ba740085" type="folder">2-7</container>
        </did>
        <accessrestrict id="c400e4bb55cfe7ea165cfb2d2dc99c6b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="fec2a29720e66cc581b066877ffa632d" level="file">
        <did>
          <unittitle>TML, 44-8 - Othro Evra - A contraceptive patch</unittitle>
          <unitdate type="inclusive">2002 January 21</unitdate>
          <container id="6625fda48019f840250b36bbd976e3f0" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="b2caa4a912150824ccb327659ae2f78f" parent="6625fda48019f840250b36bbd976e3f0" type="folder">8-9</container>
        </did>
        <accessrestrict id="f89be5a42a6e7c9142c05161a1bb4330">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="ea19cfea9c41aa789e87a27139849cc9" level="file">
        <did>
          <unittitle>TML, 44-42 - Copyright violations</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="856da69150b4ab27e383f4b5a9681ac7" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="db7c705e8322463b354829a7d8b090f4" parent="856da69150b4ab27e383f4b5a9681ac7" type="folder">10</container>
        </did>
        <accessrestrict id="ec1aa5a5bbffa7071d0ee4e1725ec096">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="573b9aa7949c2b6064549d58f22d1ef4" level="file">
        <did>
          <unittitle>TML, 44-89 - Generic drugs</unittitle>
          <unitdate type="inclusive">2002 October 14</unitdate>
          <container id="6930ddab415d43471f00f5ba3e9e8ad4" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="00dc98e82f10dd289c930dea977e02da" parent="6930ddab415d43471f00f5ba3e9e8ad4" type="folder">11-13</container>
        </did>
        <accessrestrict id="5b1243a2f3ac837601682945b4ad6a9e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="eca6e6e8880da77ade266c114c4c3ef8" level="file">
        <did>
          <unittitle>TML, 44-77 - Gefitinib (Iressa) for advanced non-small cell lung cancer</unittitle>
          <unitdate type="inclusive">2002 September 2</unitdate>
          <container id="39d6ea2d75c2857bc480efa30b949f0f" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="4f3c270735095a2b3c2812c1eaa64e9e" parent="39d6ea2d75c2857bc480efa30b949f0f" type="folder">14-16</container>
        </did>
        <accessrestrict id="e52979497dde6f1c31a59d9d3764a403">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="a5125bf7e9b481c9cf3b474c751ee55e" level="file">
        <did>
          <unittitle>TML, 44-103 - GHB for nacolepsy</unittitle>
          <unitdate type="inclusive">2002 December 9</unitdate>
          <container id="60e5bea2aeb0f1fc3c85a7d2ffecfdaf" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="9ca8a878cfc0b1780d55c0a8f1aef611" parent="60e5bea2aeb0f1fc3c85a7d2ffecfdaf" type="folder">17-19</container>
        </did>
        <accessrestrict id="0fce222a44f0f4d669d6446bfe4d0948">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="5f1f43a60e3a918e61f1524dd78e1670" level="file">
        <did>
          <unittitle>TML - Fungal Infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="92d987f5f201d4c29581d71601399429" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="f48debc698641f827a3ed15d4163ec1e" parent="92d987f5f201d4c29581d71601399429" type="folder">20</container>
        </did>
        <accessrestrict id="43b31e9dd0e56b4393c587638541da8a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="d0277fd8830f2d769496c88f15bb859c" level="file">
        <did>
          <unittitle>TML - Fungal Infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="275d9b17d1838a1140c8ba1acbbe43ac" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="fd8578960db0b0b5f2e448bfd77b74bc" parent="275d9b17d1838a1140c8ba1acbbe43ac" type="folder">1</container>
        </did>
        <accessrestrict id="0374c695f899676ae2f0f4ab46c32079">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="38f15317a1ab04ccab7ddf87c59865ca" level="file">
        <did>
          <unittitle>TML, 44-65 - Fulvestrant (Faslodex) for advanced breast cancer</unittitle>
          <unitdate type="inclusive">2002 July 22</unitdate>
          <container id="81d9b6e2e775a18cdb520224153aef39" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="913bc93bcc69d9a50aa48125a51f24ff" parent="81d9b6e2e775a18cdb520224153aef39" type="folder">2-4</container>
        </did>
        <accessrestrict id="ce879f9aa1fe59c4646fb8a958d249d1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="c2dd44962d67176662e4db78dd0a66d1" level="file">
        <did>
          <unittitle>TML, 44-5 - Cefditoren (Spectracef) - A new oral cephalosporin</unittitle>
          <unitdate type="inclusive">2002 January 21</unitdate>
          <container id="95ffad5a6c8c8931369905fce7401997" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="cf7e966bd899d8e538f10b0763a55124" parent="95ffad5a6c8c8931369905fce7401997" type="folder">5-7</container>
        </did>
        <accessrestrict id="a137a040fd97e7017313ae9a82d2fe86">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="70993f6f906adca6d28b7cec87c5cbab" level="file">
        <did>
          <unittitle>TML, 44-93 - Drugs past their expiration date</unittitle>
          <unitdate type="inclusive">2002 October 28</unitdate>
          <container id="6e927c80dc7dbcb8c1609706c636b245" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="f1127b8796b7c449e049217617c0b6af" parent="6e927c80dc7dbcb8c1609706c636b245" type="folder">8-10</container>
        </did>
        <accessrestrict id="e06690c5813977cdcc6c8a5a7653718f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="f9bc602671296cc3d2de922401f1986e" level="file">
        <did>
          <unittitle>TML, 44-83 - Escitalopram (Lexapro) for depression</unittitle>
          <unitdate type="inclusive">2002 September 30</unitdate>
          <container id="59010935dec31ade5d51754f1a3a8350" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="e783da991bdd1f7aa398e441c7916fae" parent="59010935dec31ade5d51754f1a3a8350" type="folder">11-12</container>
        </did>
        <accessrestrict id="fdb13be24c2193fa8c3289e7d5ad654a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="88bf2c423e244a87d79645badbf2e9f3" level="file">
        <did>
          <unittitle>TML, 44-43 - Fondaparinux (Arixtra) - a new anticoagulant</unittitle>
          <unitdate type="inclusive">2002 May 13</unitdate>
          <container id="488fa217a649a1f79da586fa4759355a" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="5eedfc0a817b00e3fdef089a8a9d73af" parent="488fa217a649a1f79da586fa4759355a" type="folder">13-15</container>
        </did>
        <accessrestrict id="bbbdd53df2b8ebd0612902a21d46a748">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="05b64e3022467a23598c9201bc74dfdf" level="file">
        <did>
          <unittitle>TML - Cefepime</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="c2ff6d8b7c95e2d24360904fbb4d3a7e" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="9379b1bb0a239e13fda0cf0f0f45eff8" parent="c2ff6d8b7c95e2d24360904fbb4d3a7e" type="folder">16-18</container>
        </did>
        <accessrestrict id="394b3115bcff39760eac5c39dc81bdb6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0b79a2b45ac5a48beb03988b3255f34c" level="file">
        <did>
          <unittitle>TML, 44-126 - Eratapenem - a new parenteral carbapenem</unittitle>
          <unitdate type="inclusive">2002 March 18</unitdate>
          <container id="57ab4af74cb82183fdcfdd0092278e9e" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="36463c0c76ec7354a9d3fcb2ff74da92" parent="57ab4af74cb82183fdcfdd0092278e9e" type="folder">19-21</container>
        </did>
        <accessrestrict id="556a688586b09ef7523a269879e4d606">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="2ab8dcb85ae9ce0ddd2d1fdc51a02ee6" level="file">
        <did>
          <unittitle>TML - Echinacea</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="7619c78e991b792f84345117078b76ad" label="Mixed Materials (A0000000075916)" type="box">74</container>
          <container id="9092a17428c415ec9a91be255f51e745" parent="7619c78e991b792f84345117078b76ad" type="folder">1-3</container>
        </did>
        <accessrestrict id="dc18fb2ef4fb05f2fdaba6355d199ff6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="af85bd11efe07fd729751c8c218f32d2" level="file">
        <did>
          <unittitle>TML, 44-47 - Botulinum Toxin (Botox Cosmetic) for frown lines</unittitle>
          <unitdate type="inclusive">2002 May 27</unitdate>
          <container id="1c8c661e929d0d0f41cb01aff7fa0403" label="Mixed Materials (A0000000075916)" type="box">74</container>
          <container id="b85fcd2d77c82b9c23c7e85fa0334eb5" parent="1c8c661e929d0d0f41cb01aff7fa0403" type="folder">4-6</container>
        </did>
        <accessrestrict id="e67c688500af00baeca0146003fa4b6f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="45aa8fe42fd0ddc4536be77350df4b57" level="file">
        <did>
          <unittitle>TML - Fungal Infections - Reprints</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="f675e9979a6d10ef12833577ef41ff3f" label="Mixed Materials (A0000000075916)" type="box">74</container>
          <container id="322d72cbd9dd6da94d82ca88f9142298" parent="f675e9979a6d10ef12833577ef41ff3f" type="folder">7</container>
        </did>
        <accessrestrict id="1f1099e38699970b363bae0c6975a70b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="2e47b4ee1607009a90bcdea23b07a404" level="file">
        <did>
          <unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="694ff609e1082a7cf718e457a16e669b" label="Mixed Materials (A0000000075916)" type="box">74</container>
          <container id="db82c474ee08f820066b82aee7b5debb" parent="694ff609e1082a7cf718e457a16e669b" type="folder">8-19</container>
        </did>
        <accessrestrict id="831283e78ef78563e6f6b9e3060a60fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="f41b47c09c3e11ca72cf6fe9fcfca8b2" level="file">
        <did>
          <unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="d1b5fc0f86e92c35489f459dac93866c" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="5098e86fe3e8b50a5262d44681910617" parent="d1b5fc0f86e92c35489f459dac93866c" type="folder">1-2</container>
        </did>
        <accessrestrict id="37075cc131616efa32d821ddec70e19a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0785dbde88fe25acb019e68e53796851" level="file">
        <did>
          <unittitle>TML, 44-73 - Neotame - a new artificial sweetner</unittitle>
          <unitdate type="inclusive">2002 August 19</unitdate>
          <container id="f3161b2c4262fc0491d3233ade817267" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="ba6e2bb631cb39065b6db42aaa71ca1c" parent="f3161b2c4262fc0491d3233ade817267" type="folder">3-4</container>
        </did>
        <accessrestrict id="423a699022dfc41e5a19356b8ede358f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="daec721a5877ed667e3be025c5b3972b" level="file">
        <did>
          <unittitle>TML, 44-95 - Valacyclovir (Valtrex) for herpes labialis</unittitle>
          <unitdate type="inclusive">2002 November 11</unitdate>
          <container id="fd111c9afb89a350fe7ca92e944a76a3" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="1a90fda97bf97334c23cff384488cce6" parent="fd111c9afb89a350fe7ca92e944a76a3" type="folder">5-6</container>
        </did>
        <accessrestrict id="65275a0edfafc2779f6f3b12b167613d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="daaa98dacc14a33f7dd8c3607f43fabe" level="file">
        <did>
          <unittitle>TML - Drugs for prevention and treatment of postmenopausal osteoporosis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002 November 1</unitdate>
          <container id="05b1a7ee4bdc463c39bf57069e08bcaf" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="b4189903d25aadec737b6f505cfffe7f" parent="05b1a7ee4bdc463c39bf57069e08bcaf" type="folder">7-10</container>
        </did>
        <accessrestrict id="66fca14cfc643877b243d938549ef683">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="6c5c80d095e7afd1c721854326e0f8cc" level="file">
        <did>
          <unittitle>TML, 44-9 - Drugs for Non-HIV viral infections</unittitle>
          <unitdate type="inclusive">2002 February 4</unitdate>
          <container id="66039585d7d491a57430b1b6e2e3eede" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="a46774b6df58c964faadcdb621f6a48f" parent="66039585d7d491a57430b1b6e2e3eede" type="folder">11-17</container>
        </did>
        <accessrestrict id="bdf05fc38d86db9b72f37658b33c4730">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="bcfed60146a9353c15a7810e066eb562" level="file">
        <did>
          <unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="f503a45771883def84603365a0a72afd" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="08a9f3d8570b4d8f0db47b574dda1ce7" parent="f503a45771883def84603365a0a72afd" type="folder">18-19</container>
        </did>
        <accessrestrict id="3f36d4c0ac7dd42dca225464d90a4a7b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="26f9f680797154013e700d36b1ee02cc" level="file">
        <did>
          <unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="242fab9a620e3ed6509432766ca6d9fa" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="6973814ac2f66b7c2d2f460e3103e303" parent="242fab9a620e3ed6509432766ca6d9fa" type="folder">1-2</container>
        </did>
        <accessrestrict id="538e6db36155fc336b5cd7453b267830">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="87edb03339d8ce2c8587c9b08fa0c33c" level="file">
        <did>
          <unittitle>TML, 44-52 - Tazarotene (Tazorac) for acne</unittitle>
          <unitdate type="inclusive">2002 June 10</unitdate>
          <container id="542777eef8af75b245a8fdf2c1b63687" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="9e4905908a2006ae8b22f2973f71a171" parent="542777eef8af75b245a8fdf2c1b63687" type="folder">3-5</container>
        </did>
        <accessrestrict id="009827e7a43d5b337cbe6459416c7913">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="4e2f11c3afbd278cc01889db51cc3594" level="file">
        <did>
          <unittitle>TML - Safety of antimicrobials in pregnancy</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="1b377c59abb10c815190ac5d23399227" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="a24618d3da2df472221cafe2fb6a93c2" parent="1b377c59abb10c815190ac5d23399227" type="folder">6-9</container>
        </did>
        <accessrestrict id="4077280e1fc84a55fa2f33342e312820">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="d9af5da201c75753edd17152b98006c9" level="file">
        <did>
          <unittitle>TML, 44-63 - Voriconazole</unittitle>
          <unitdate type="inclusive">2002 July 22</unitdate>
          <container id="96e86be5edcb4a9849c3f0049756c376" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="7cd83d34d0dd4c4ca07b968d93edc3ba" parent="96e86be5edcb4a9849c3f0049756c376" type="folder">10-14</container>
        </did>
        <accessrestrict id="7f7313cf1c86daf164b8b5b1d2c47390">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="f449d0ea0cb02a16dc4bb161afd0e8e1" level="file">
        <did>
          <unittitle>TML - Cardiovascular drugs in the ICU - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002 December</unitdate>
          <container id="99921ddbf4044bac0e0091f50908c253" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="46d9ebe207074afc9d5a86ed753f4cc7" parent="99921ddbf4044bac0e0091f50908c253" type="folder">15-20</container>
        </did>
        <accessrestrict id="d78727a12815fb45316cee4c1bb66369">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="4536f53d88709a34f9764f238002f522" level="file">
        <did>
          <unittitle>TML, 44-51 - Triptorelin Pamoate (Trelstar)</unittitle>
          <unitdate type="inclusive">2002 June 10</unitdate>
          <container id="af84397d4930a77c8fc4070ac0f7b3ea" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="1cad8cbe6fa0be5b856c4e94be8dea5a" parent="af84397d4930a77c8fc4070ac0f7b3ea" type="folder">1-4</container>
        </did>
        <accessrestrict id="3f564956f49faf84f827624973a86572">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="8319ac1e74f3772c55f953d49d1fe802" level="file">
        <did>
          <unittitle>TML - Drugs for Tuberculosis</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="ddc322c3e3e38354307d34ab2a58b0d5" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="cfef984e362c4c65aeddc6324f7371a0" parent="ddc322c3e3e38354307d34ab2a58b0d5" type="folder">5-8</container>
        </did>
        <accessrestrict id="6e3e6b2b8bab0f3a6559d5327bba741c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="c61123a9a767eb2a2f0665b7e710f056" level="file">
        <did>
          <unittitle>TML, 44-80 - Tepostinil (Remodulin) for pulmonary arterial hypertension</unittitle>
          <unitdate type="inclusive">2002 September 16</unitdate>
          <container id="8c5a7e38e7aee2a513921b9217549ea8" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="24a6ae1b29ecf963ad95c7ccb0700d8e" parent="8c5a7e38e7aee2a513921b9217549ea8" type="folder">9-11</container>
        </did>
        <accessrestrict id="96d0a14409c624606417824206c572f4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="9c1edb72ecb57f4a5cf544ab8a33f1ca" level="file">
        <did>
          <unittitle>TML, 44-59 - Drugs that may cause psychiatric symptoms</unittitle>
          <unitdate type="inclusive">2002 July 8</unitdate>
          <container id="16cd602cc7ae9bcd65f21cc908d3fd35" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="6b9267a8d4b9b34d1f97c133ead4ec2d" parent="16cd602cc7ae9bcd65f21cc908d3fd35" type="folder">12-16</container>
        </did>
        <accessrestrict id="049b266831555277c80bf92411b09f0b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="83c1e0a1fb9e3488cec1e298480b45b9" level="file">
        <did>
          <unittitle>TML, 44-79 - Tegaserod Maleate (Zelnom) for IBS with constipation</unittitle>
          <unitdate type="inclusive">2002 September 16</unitdate>
          <container id="d9c367598aa762da752a74a7b2c82921" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="6dd0df5594f408de7ab822feefd4f231" parent="d9c367598aa762da752a74a7b2c82921" type="folder">17-19</container>
        </did>
        <accessrestrict id="6b6e7ca2998642d620f912e4ae273e58">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="702df7b3933e28f25249b7010b1efc23" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="cfae68c919c09e73f9beeed03437c816" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="4f6aec5ffac30654fbcb6140700478e6" parent="cfae68c919c09e73f9beeed03437c816" type="folder">20</container>
        </did>
        <accessrestrict id="21f8d786633e1a74c8baaec02b6e69c6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="fbd9f3d2b393e963f637e86d90ca6f0c" level="file">
        <did>
          <unittitle>TML - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="5993b54c2fb251fecfd606483bdba3c6" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="cb6510d474989ceb68b4d20cb205f25e" parent="5993b54c2fb251fecfd606483bdba3c6" type="folder">21</container>
        </did>
        <accessrestrict id="8c19ab74e7734be86d15ccfc2ffd8632">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="3238875c71befee0c843bfb578b0af6f" level="file">
        <did>
          <unittitle>TML - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="500abbd03fe995d30de5a6a0b9095dd7" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="01b6892ebeeaebbf6ceacebf1d9034b4" parent="500abbd03fe995d30de5a6a0b9095dd7" type="folder">1-3</container>
        </did>
        <accessrestrict id="f07baa851539686de763d2f786c2177e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0f73f901dbd4ead91b01d80ceed67c30" level="file">
        <did>
          <unittitle>TML, 44-75 - Influenza prevention 2002-2003</unittitle>
          <unitdate type="inclusive">2002 September 2</unitdate>
          <container id="235a2d0fcfb3038e6f5b9441de001254" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="5676b5ad6bd4a9d45c4cc9e53806d232" parent="235a2d0fcfb3038e6f5b9441de001254" type="folder">4-6</container>
        </did>
        <accessrestrict id="f979eb1f784b0838d5a64de4d9ac9da1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="23ee674858aa228c8597cb11a5363b5d" level="file">
        <did>
          <unittitle>TML, 44-33 - Advice for travelers</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="a3dacd89c552a5b0dc09195922861f73" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="224c69d8cc0fb1b74363509ffeed642a" parent="a3dacd89c552a5b0dc09195922861f73" type="folder">7-9</container>
        </did>
        <accessrestrict id="687d9c16855007cc90b89408873e9116">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="c3ff86733b644974c019ea29b403f49f" level="file">
        <did>
          <unittitle>TML, 44-97 - Potassium Iodine for thyroid protection in a nuclear accident or attack</unittitle>
          <unitdate type="inclusive">2002 November 11</unitdate>
          <container id="08820a774dfab03b8bea4b42cb1c4b99" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="2dfab3b39344b1f9ad25282a1713f503" parent="08820a774dfab03b8bea4b42cb1c4b99" type="folder">10-11</container>
        </did>
        <accessrestrict id="ae3d1b9904d63ec7a442b7bf1ecd8dc5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="24af9a9128ef19b87942303f71c93a4b" level="file">
        <did>
          <unittitle>TML, 44-91 - Acetaminophen safety</unittitle>
          <unitdate type="inclusive">2002 October 28</unitdate>
          <container id="91e9bb30c833a1e75d94cd3d3a2613fe" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="48e6870f6fed51d9492e16c6d5ada36a" parent="91e9bb30c833a1e75d94cd3d3a2613fe" type="folder">12-16</container>
        </did>
        <accessrestrict id="7768a5d75ddf57469eb3bbdfec0f20af">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="b3aae1ba9f482e9eeee3c33251fd33f7" level="file">
        <did>
          <unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle>
          <unitdate type="inclusive">2002 June 24</unitdate>
          <container id="96c7fc1afd468337e182705913e2796b" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="182b1f7941c71f76578bd3f9f301005a" parent="96c7fc1afd468337e182705913e2796b" type="folder">17-19</container>
        </did>
        <accessrestrict id="afa4af3e07bce4f2fa04d79ed2a8e09b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="8104e8da1a3aff8455ce0008f38fee5a" level="file">
        <did>
          <unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle>
          <unitdate type="inclusive">2002 June 24</unitdate>
          <container id="183ad24bad36358b4161f8eeb389a1df" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="57c460d65f307dfcd3e08c906b7aac23" parent="183ad24bad36358b4161f8eeb389a1df" type="folder">1-2</container>
        </did>
        <accessrestrict id="aca0e4a78b7223c626fd6a43994f5d31">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="02479e2c1173076c05f34aa17007ba49" level="file">
        <did>
          <unittitle>TML, 44-21 - Acute reactions of drug abuse</unittitle>
          <unitdate type="inclusive">2002 March 4</unitdate>
          <container id="0bf7030730e3e70563b9d35fae0167df" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="cd19e019ff9b294686c31b5810dd5768" parent="0bf7030730e3e70563b9d35fae0167df" type="folder">3-6</container>
        </did>
        <accessrestrict id="c95f7f827b4be73752d104280c14ae0c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="d1098818233489d81f3ee9a35c491fda" level="file">
        <did>
          <unittitle>TML, 44-71 - Tests for drug abuse</unittitle>
          <unitdate type="inclusive">2002 August 19</unitdate>
          <container id="5f0b7d8781086ed41f52c3d05376cacc" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="90d7e6c908c492996c287a45e23b4ee5" parent="5f0b7d8781086ed41f52c3d05376cacc" type="folder">7-10</container>
        </did>
        <accessrestrict id="6b5deed194656d7a78e4584eaf23da1c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="a2d97df9926c22348169dc85fc2da466" level="file">
        <did>
          <unittitle>TML, 44-82 - Accutane</unittitle>
          <unitdate type="inclusive">2002 September</unitdate>
          <container id="035c40dde1ecb665908ef50e503e1820" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="9a2c3b6b1eb60e9565ba06a4c9efc502" parent="035c40dde1ecb665908ef50e503e1820" type="folder">11-12</container>
        </did>
        <accessrestrict id="811a73112a0f3db0c61460c6f50c3a83">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="77f6dda8f57e4d024c751d9255cb8084" level="file">
        <did>
          <unittitle>TML, 44-50 - Spinal Manipulation</unittitle>
          <unitdate type="inclusive">2002 May 22</unitdate>
          <container id="9e82ab2ed70b804fa67c04292631926d" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="b66cb5c4f9a7563a62ff1a11f5f1e0fb" parent="9e82ab2ed70b804fa67c04292631926d" type="folder">13-15</container>
        </did>
        <accessrestrict id="c6a5678b6a97ed4390bd98a720535a47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="09411c4ec2cd0e10526be529fdbb7c1d" level="file">
        <did>
          <unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="021cf37563c7f86b9d5396674d15d283" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="ba60afaeb4f9b4200f17a318d714b721" parent="021cf37563c7f86b9d5396674d15d283" type="folder">16-17</container>
        </did>
        <accessrestrict id="1fde5116b8525bf37872775d4c998b9e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="2af7784d4333e1386ceb5387b0141573" level="file">
        <did>
          <unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="db2940e08bb4a797339e2c671f94701f" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="3ef9aa0cd7b1586b4aefb036b3d68d22" parent="db2940e08bb4a797339e2c671f94701f" type="folder">1-2</container>
        </did>
        <accessrestrict id="b2d240752dac7c5d6b161365b06fbe2d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="45b86f5c46903225f479639e02061c91" level="file">
        <did>
          <unittitle>TML, 44-17 - Drotecogin - Activated Protein C (Xigris) for Severe Sepsis</unittitle>
          <unitdate type="inclusive">2002 February 18</unitdate>
          <container id="05d0e941a3d30f11a8f8bcc6b99d87ba" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="47b2776324e41e2ce5ab804445598da5" parent="05d0e941a3d30f11a8f8bcc6b99d87ba" type="folder">3-7</container>
        </did>
        <accessrestrict id="c6644b7dd17dbfbedd1d1af2963340f4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="2df9fa1b1dadedbd80d056c6d1eb7e1b" level="file">
        <did>
          <unittitle>TML, 44-78 - Hormone replacement therapy</unittitle>
          <unitdate type="inclusive">2002 September 2</unitdate>
          <container id="e2f43209dfea6c70acba5d9b28c6bc04" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="4d687cf87bfc1ae8e7924ad7904edfb2" parent="e2f43209dfea6c70acba5d9b28c6bc04" type="folder">8-9</container>
        </did>
        <accessrestrict id="25fbac45d92806e8263c700a8600b817">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="79ecc959704f5a99033f6383c71d5e2b" level="file">
        <did>
          <unittitle>TML, 44-30 -Bosentan (Tracleer) for pulmonary arterial hypertension</unittitle>
          <unitdate type="inclusive">2002 April 11</unitdate>
          <container id="7b37e6ee36365ab15e02058ea03d89d5" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="0c7ecb2c09fcda9540ebfdf8fc4c3719" parent="7b37e6ee36365ab15e02058ea03d89d5" type="folder">10-12</container>
        </did>
        <accessrestrict id="c218a513a6535a5ceb72241f53f1083c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="ebeb0b87fb29433a1b670b6a4d5aa5fc" level="file">
        <did>
          <unittitle>TML, 44-45 - Dexmethylphenidate (Focalin) for ADHD</unittitle>
          <unitdate type="inclusive">2002 May 13</unitdate>
          <container id="0bf5d989a3559e5d79fac53b3341b2fc" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="d44b0c03872e4d120c50f625b76aca07" parent="0bf5d989a3559e5d79fac53b3341b2fc" type="folder">13-14</container>
        </did>
        <accessrestrict id="daa9fc43588271721e9668e6387b1ecc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="9cf28c7502d38a3253794dc0aff81d12" level="file">
        <did>
          <unittitle>TML, 44-53 - Droperidol Risk - Arrhythmias</unittitle>
          <unitdate type="inclusive">2002 June 10</unitdate>
          <container id="f8cf1c9783cd6dffe0eb55e6805d7a10" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="52701669ec2aaacfead04a8940882583" parent="f8cf1c9783cd6dffe0eb55e6805d7a10" type="folder">15-16</container>
        </did>
        <accessrestrict id="9343665bbaab14cdc391de9fbda39aab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="037a4523e063f09b403c4b86b056b0b9" level="file">
        <did>
          <unittitle>TML, 44-84 - Herbal Products - Problems with dietary supplements</unittitle>
          <unitdate type="inclusive">2002 September 30</unitdate>
          <container id="4cf51ac422fa984722200a0a54d479ad" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="c7a5ad950d1414bc039ea00cb4a7026c" parent="4cf51ac422fa984722200a0a54d479ad" type="folder">17-19</container>
        </did>
        <accessrestrict id="2fdc328774c9f82ce8ebb61aee7387a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="606c2c7591fb4c21ba3d38fc6c7462b0" level="file">
        <did>
          <unittitle>TML, 44-96 - Rasburicase</unittitle>
          <unitdate type="inclusive">2002 November 11</unitdate>
          <container id="4502cf4066940ab38f26a78480ae0626" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="720f88b47834aac1d29390504e517a45" parent="4502cf4066940ab38f26a78480ae0626" type="folder">1-2</container>
        </did>
        <accessrestrict id="6dd42fdac95221294c398b8dad4d3a7e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="b3d8e525fd2c6ceabdefb1c16c80e100" level="file">
        <did>
          <unittitle>TML, 44-88 - Three beta-interferons for MS</unittitle>
          <unitdate type="inclusive">2002 October 14</unitdate>
          <container id="0513cfa8998d10739ea64dd651a2030b" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="5a69c9c23b68d913d400a4a9a165ee40" parent="0513cfa8998d10739ea64dd651a2030b" type="folder">3-6</container>
        </did>
        <accessrestrict id="de5073ebce08ff223cdc3bac4b44096d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="cd35b74adb66fbee3caa77d502914319" level="file">
        <did>
          <unittitle>TML, 44-99 - Indications for an implantable cardioverter defibrillator</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="ae70eb9079b513dcb7ed48e8c2989184" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="8264f3be1b22ad67c3f09ae4a4ca7e72" parent="ae70eb9079b513dcb7ed48e8c2989184" type="folder">7-9</container>
        </did>
        <accessrestrict id="44a756d7626a6484624c170f3c9fe601">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="caba3d20cbb6ac2bcf0fffb6486cd172" level="file">
        <did>
          <unittitle>TML - Drugs for Diabetes - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002 September</unitdate>
          <container id="bc88495ba2c1ebbcc6e81d7f9b3feb9a" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="3e26912a71b47d21448084843d9e3d89" parent="bc88495ba2c1ebbcc6e81d7f9b3feb9a" type="folder">10-13</container>
        </did>
        <accessrestrict id="27fb92f6dcd523eaebbcb18be6a423a5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0cdc8024ee854934a00a2e6cc658127c" level="file">
        <did>
          <unittitle>TML, 44-87 - Once-a-Week risedronate (Actonel)</unittitle>
          <unitdate type="inclusive">2002 October 14</unitdate>
          <container id="13d11c24a32acc658e969ac80f7dca20" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="3c20571c0bb68283a243ac7dd51e9d1f" parent="13d11c24a32acc658e969ac80f7dca20" type="folder">14-15</container>
        </did>
        <accessrestrict id="3c69c2eda4cf5e33f151894a6dae98fa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="6373e1ea574b03380381b604f8f317ea" level="file">
        <did>
          <unittitle>TML, 44-48 - Topical Primecrolimus (Elidel) for treatment of atopic dermatitis</unittitle>
          <unitdate type="inclusive">2002 May 27</unitdate>
          <container id="db652255efd7bdebdbc7eca047d1be75" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="8341764375d2491d9bca36667509c86b" parent="db652255efd7bdebdbc7eca047d1be75" type="folder">16-17</container>
        </did>
        <accessrestrict id="c8982cc8907e5273994dc146b1a74168">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0a43de1bea99678d0bd3f43b5c8e3aab" level="file">
        <did>
          <unittitle>TML, 44-107 - Metaglip and Avandamet for type 2 diabetes</unittitle>
          <unitdate type="inclusive">2002 December 23</unitdate>
          <container id="26e4ed76b76318fad96f84c03d5d5f2c" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="1f3ba3f7ed1cd39030084514fc2bfbb5" parent="26e4ed76b76318fad96f84c03d5d5f2c" type="folder">1-3</container>
        </did>
        <accessrestrict id="77f5cb2d5690ac4fb8b1401da5ce42c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0ad024dbe91f78abe8bfbef002c6b1ff" level="file">
        <did>
          <unittitle>TML, 44-27 - Desloratadine</unittitle>
          <unitdate type="inclusive">2002 March 18</unitdate>
          <container id="e17354ef710590af642401de42a1932c" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="ba89cfb34206fb87087f925deb860672" parent="e17354ef710590af642401de42a1932c" type="folder">4-6</container>
        </did>
        <accessrestrict id="36a5c8671473d8ebde644f9ea2a482bc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="b7991b9a56fe105d30e6587c04553698" level="file">
        <did>
          <unittitle>TML, 44-41 - Pantoprazole (Protonix IV)</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="c314ac5296646e735e47b3bc548ba1d2" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="1c62091570c2f03db9cb8077bd1f204b" parent="c314ac5296646e735e47b3bc548ba1d2" type="folder">7-8</container>
        </did>
        <accessrestrict id="ecf59515bb41f3b93d8d69d9976e28b0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="e886d7140f04a51e798f5685595d8a64" level="file">
        <did>
          <unittitle>TML, 44-69 - Olmesartan (Benicar) for hypertension</unittitle>
          <unitdate type="inclusive">2002 August 5</unitdate>
          <container id="104d140ac83543fe64afb1214e1a9fbf" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="4f089eb40b5bbb0caf8ca83422c9f695" parent="104d140ac83543fe64afb1214e1a9fbf" type="folder">9-12</container>
        </did>
        <accessrestrict id="74dedc4bdd750d18fabe19b677cbe4fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="a62ab234ffcd38be2c7ecb1b5105a478" level="file">
        <did>
          <unittitle>TML - Drugs for Parasitic Infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="f260cec7e9dfb4d862eafe7c0bdc64c3" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="21e5c12612d776c5eb06192015f5afd9" parent="f260cec7e9dfb4d862eafe7c0bdc64c3" type="folder">13-16</container>
        </did>
        <accessrestrict id="a1761f494a6aadd735240b5f6234da0c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="334f7d2fdf7bebf0df4dbded68f76c8d" level="file">
        <did>
          <unittitle>TML, 44-44 - Pegfilgrastin (Neulasta) for prevention of febrile neutropenia</unittitle>
          <unitdate type="inclusive">2002 May 13</unitdate>
          <container id="ba6d451e5abe206ea2b48bac7b35bc55" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="c1870e306e54df5fc415122e6c2adb66" parent="ba6d451e5abe206ea2b48bac7b35bc55" type="folder">17-19</container>
        </did>
        <accessrestrict id="a69e5af2889f08c295264781d0dc1080">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="f777550cceb72905734014265970ba2d" level="file">
        <did>
          <unittitle>TML, 45-25 - Adalimumab (Humira) for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">2003 March 31</unitdate>
          <container id="2b0918191790c985f5c1a0bae7a7fab0" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="994c3c7f8716f6f584cc552e7bc0173d" parent="2b0918191790c985f5c1a0bae7a7fab0" type="folder">1-3</container>
        </did>
        <accessrestrict id="843488d272c7cd2629b6cfaf3ea233ef">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="755a5cb278c5674c278d62217583d0dc" level="file">
        <did>
          <unittitle>TML, 45-31 - Alefacept (Amevive) for treatment of psoriasis</unittitle>
          <unitdate type="inclusive">2003 April 14</unitdate>
          <container id="68d3eae3a92b10d39cc5bd56842e4ed7" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="5af0dfe8a414d4242d5cb1ce5a6815fd" parent="68d3eae3a92b10d39cc5bd56842e4ed7" type="folder">4-6</container>
        </did>
        <accessrestrict id="a72cbce0a6c64d80126a119167b5dc50">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="9a2ad2a43a1bd9b6c3ff840aca327639" level="file">
        <did>
          <unittitle>TML, 45-43 - Alprazolam XR for panic disorder</unittitle>
          <unitdate type="inclusive">2003 May 26</unitdate>
          <container id="4f6ab3e9becac88a3e6a032f33b32aac" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="ec00cfc804a6aa9a3949e6d595d91c5e" parent="4f6ab3e9becac88a3e6a032f33b32aac" type="folder">7</container>
        </did>
        <accessrestrict id="7facc30ebfc92bd3e698021dbdeb21fe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="32827b05df08c432fb2cbb3d952c316a" level="file">
        <did>
          <unittitle>TML, 45-15 - Aripiprazole (Abilify) for schizophrenia</unittitle>
          <unitdate type="inclusive">2003 February 17</unitdate>
          <container id="334992e4635432e0d2f1256b6c7ac7dc" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="ccc6765c8d7fdce34277e79d643ef512" parent="334992e4635432e0d2f1256b6c7ac7dc" type="folder">8-10</container>
        </did>
        <accessrestrict id="e9db4aba5feb72c13178e46e3f2599e5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="2dcb5260bf184933786c79514811276a" level="file">
        <did>
          <unittitle>TML, 45-5 - Augmentin XR</unittitle>
          <unitdate type="inclusive">2003 January 20</unitdate>
          <container id="1301a177778333ff5076457738621756" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="4edc8f048a96e7369e6d907146f24852" parent="1301a177778333ff5076457738621756" type="folder">11-13</container>
        </did>
        <accessrestrict id="352c7f8bef5faa523d50be8830568d03">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="6719542efa0dd7e6ff2199fb0fc45784" level="file">
        <did>
          <unittitle>TML, 45-50 - Blue Light (Clearlight) for acne vulgaris</unittitle>
          <unitdate type="inclusive">2003 June 23</unitdate>
          <container id="c5a9c28af2d5f23ece906ff57066a768" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="9506e760f9478a205584484dbb694cd3" parent="c5a9c28af2d5f23ece906ff57066a768" type="folder">14-15</container>
        </did>
        <accessrestrict id="dd3798d0577bb9e1fc29332ed3c1ed16">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="face99254c656f96b64bf580e5f85bcf" level="file">
        <did>
          <unittitle>TML, 45-57 - Bortezomib for multiple myeloma</unittitle>
          <unitdate type="inclusive">2003 July 21</unitdate>
          <container id="b86c363b4727db68a9ddce625f2ff085" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="bdcece21ca760de8ce9524b530968512" parent="b86c363b4727db68a9ddce625f2ff085" type="folder">16-18</container>
        </did>
        <accessrestrict id="5b737b9395121e3828a6f6fa407666da">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="9ec231ed3611900061caae3128c95513" level="file">
        <did>
          <unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle>
          <unitdate type="inclusive">2003 December 22</unitdate>
          <container id="0ae594474d7a761cfef43a6b82b6bf0b" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="e74cbf5f9ec18538f0add52b1e2b0f11" parent="0ae594474d7a761cfef43a6b82b6bf0b" type="folder">19</container>
        </did>
        <accessrestrict id="e0dca88a43ebdabbfbf835cde2da0a4f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="c6404194bb02ecf2496bacd146a0cc60" level="file">
        <did>
          <unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle>
          <unitdate type="inclusive">2003 December 22</unitdate>
          <container id="566cb75edce695c2d96f336f00c2e03d" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="b9625e6088c2a05def2ac6687cb972a4" parent="566cb75edce695c2d96f336f00c2e03d" type="folder">1-3</container>
        </did>
        <accessrestrict id="ff3d2237bfc8f29c4712b54bf885e9be">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="2ddbc741772355d7dce54b4b63ef6749" level="file">
        <did>
          <unittitle>TML, 45-97 - Efalizumabe (Raptiva) for treatment of psoriasis</unittitle>
          <unitdate type="inclusive">2003 December 8</unitdate>
          <container id="ccd442969226408cc58368268903d2fd" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="d1bc962d6052970a0cbe766c17e137a5" parent="ccd442969226408cc58368268903d2fd" type="folder">4-5</container>
        </did>
        <accessrestrict id="6eb237f5b70a5174ed44b4dc845e1439">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="0f45b082b3a08c7cce74229a00644b02" level="file">
        <did>
          <unittitle>TML, 45-97 (45-333) - Eletriptan (Replax) for migraine</unittitle>
          <unitdate type="inclusive">2003 April 28</unitdate>
          <container id="c92a64f84153ba31fbbefd5e1b2c92b2" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="2a8509cd4382be61c48bcd69baf4e5eb" parent="c92a64f84153ba31fbbefd5e1b2c92b2" type="folder">6-8</container>
        </did>
        <accessrestrict id="f517a35e209156fcce5cddbc43b68b14">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="94948e6e42424f89ec840de91511a768" level="file">
        <did>
          <unittitle>TML, 45-49 - Enfuvirtide (Fuzeon) for HIV infection</unittitle>
          <unitdate type="inclusive">2003 June 23</unitdate>
          <container id="ea9f6b19ce0635e12bf9b323db7360d8" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="be973404720aa94d9bdc7142f4ab3bb7" parent="ea9f6b19ce0635e12bf9b323db7360d8" type="folder">9-11</container>
        </did>
        <accessrestrict id="a3551a188d335a0b903727fcd2a48fa4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="48f4b3c522fa705a3ae202735e45ac3b" level="file">
        <did>
          <unittitle>TML, 45-89 - Growth hormone for normal short children</unittitle>
          <unitdate type="inclusive">2003 November 10</unitdate>
          <container id="306f6d1a5dd0370ebad1f76a35006f66" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="5076b358485b7fb37e402db936eb2757" parent="306f6d1a5dd0370ebad1f76a35006f66" type="folder">12-14</container>
        </did>
        <accessrestrict id="3229644ce53e8795f97a65d5d61f18e8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="780d425bdbd53ceafd83133223d279a7" level="file">
        <did>
          <unittitle>TML, 45-67 - Omalizumab (Xolair) for Asthma</unittitle>
          <unitdate type="inclusive">2003 August 18</unitdate>
          <container id="b91179d8f5d353b0d1bd8e1a504cbbbd" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="4238a6bf8ece0ef5f0c458d08ead6510" parent="b91179d8f5d353b0d1bd8e1a504cbbbd" type="folder">15-18</container>
        </did>
        <accessrestrict id="12994eea68e1f09108df54e255ae8cff">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3e27a4c127b0269848618ade1805962f" level="file">
        <did>
          <unittitle>TML, 45-7 - Oxalipatin</unittitle>
          <unitdate type="inclusive">2003 January 20</unitdate>
          <container id="c95be422b0e85765a10f3ba16ff696e0" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="732fee3a271eb960456d3f272f736b18" parent="c95be422b0e85765a10f3ba16ff696e0" type="folder">19</container>
        </did>
        <accessrestrict id="319e1cb1c4d5a539efc2e6af94af005a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="732aaf61ce82ace45c4354ea0038b752" level="file">
        <did>
          <unittitle>TML, 45-7 - Oxalipatin</unittitle>
          <unitdate type="inclusive">2003 January 20</unitdate>
          <container id="15052bba72ea5189d3e16dd3e7ff0225" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="053e2680172a7e79b9a5a9696313712c" parent="15052bba72ea5189d3e16dd3e7ff0225" type="folder">1-2</container>
        </did>
        <accessrestrict id="c716c8d0ab4facf419cf7e7c4082202e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="c4617feb74a721aa21a7112babed977f" level="file">
        <did>
          <unittitle>TML, 45-38 - Oxbutynin trandermal (Oxytrol) for overactive bladder</unittitle>
          <unitdate type="inclusive">2003 May 12</unitdate>
          <container id="9e54bef7506cf5a65ccafdfc8b601e6f" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="644e69760f05f7034a2b8461c23631f1" parent="9e54bef7506cf5a65ccafdfc8b601e6f" type="folder">3-4</container>
        </did>
        <accessrestrict id="09ded828b852ae6c86297bc23c88adc0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="8486f3e9d9968bc9f1dce0df7483cd4b" level="file">
        <did>
          <unittitle>TML, 45-54 - Rapid tests for HIV infection</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="3b61010fb506d854edaad8dbb694ebd9" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="917f83a62c6f9f9cfa956a6106879ec5" parent="3b61010fb506d854edaad8dbb694ebd9" type="folder">5-8</container>
        </did>
        <accessrestrict id="9d74192e21e6502b4dff990dec4cbb50">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="e54b07dbb6cb8e75aad0e568c11cae0a" level="file">
        <did>
          <unittitle>TML, 45-77 - Vardenafil (Levitra) for erectile dysfunction</unittitle>
          <unitdate type="inclusive">2003 September 29</unitdate>
          <container id="f51abd60462e848fa817fd2fd36f96c1" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="2d7e366069885237eb740d0826e09b03" parent="f51abd60462e848fa817fd2fd36f96c1" type="folder">9-12</container>
        </did>
        <accessrestrict id="f6350ccd6ef35a9adb3c39e7c7bf3a3c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="fdd62d893c6f422fd7c183e65efa7835" level="file">
        <did>
          <unittitle>TML, 45-11 - Atomoxetine (Strattera)</unittitle>
          <unitdate type="inclusive">2003 February 3</unitdate>
          <container id="69c25498b6f8027e1426afb24320c8b4" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="eb5c1ad6a5926c5d8ca02203583b26f9" parent="69c25498b6f8027e1426afb24320c8b4" type="folder">13-15</container>
        </did>
        <accessrestrict id="36610a7149adbc1f92cfdc7751128db1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="35402d0a4356ba61f6f491a96f89217a" level="file">
        <did>
          <unittitle>TML, 45-15 - Buprenorphine - an alternative to methadone</unittitle>
          <unitdate type="inclusive">2013 February 17</unitdate>
          <container id="ab7e835ce53ee4784c5842a776c680db" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="195be370b9e0d86294e930c1267e081d" parent="ab7e835ce53ee4784c5842a776c680db" type="folder">16-20</container>
        </did>
        <accessrestrict id="136a1315a2303fa111e5d01cb0517e7d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3fc7a0238f453d851bcf8a694afaf2ab" level="file">
        <did>
          <unittitle>TML, 45-74 - Agalsidase beta (Fabrazyme) for Fabry disease</unittitle>
          <unitdate type="inclusive">2003 September 15</unitdate>
          <container id="5f8a7a5cc9c001bfa60e205add71f844" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="4f695ce418a6fab34f9fc64551de388e" parent="5f8a7a5cc9c001bfa60e205add71f844" type="folder">1-3</container>
        </did>
        <accessrestrict id="aab1089a7327f8fc78a2fc319190599a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="5569c52b23e7d7eeddf53f7c2b84a996" level="file">
        <did>
          <unittitle>TML, 45-39 - Eplerenone (Inspra)</unittitle>
          <unitdate type="inclusive">2003 May 12</unitdate>
          <container id="8a505404a773fcc7491a0f8d23258278" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="5b13fde3dfc9a9caa96474509405cff8" parent="8a505404a773fcc7491a0f8d23258278" type="folder">4-6</container>
        </did>
        <accessrestrict id="4fc1e68dd96cabb133f171a2e6a52471">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="19fc064c09e3806caaddbb51b70e4090" level="file">
        <did>
          <unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle>
          <unitdate type="inclusive">2003 December 8</unitdate>
          <container id="6c279c0a0879da3c9e22c8e77d13baf0" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="642fe2e2c3ec53f8305355fc45759293" parent="6c279c0a0879da3c9e22c8e77d13baf0" type="folder">5A-6A</container>
        </did>
        <accessrestrict id="60b6213d43e89633056c4a067f8c54e8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="f0a8b264973dfe8db5fe8da9b49f6e58" level="file">
        <did>
          <unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle>
          <unitdate type="inclusive">2003 December 8</unitdate>
          <container id="8583ec62ec8c8e47249811d61c7687e9" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="72fb4e2d601aadea07ad5a2b86b1baf9" parent="8583ec62ec8c8e47249811d61c7687e9" type="folder">7-9</container>
        </did>
        <accessrestrict id="7a45da012d9d8375ab9c62d057d20b13">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="d1e93fdc68ebf64e073b0d53c908f073" level="file">
        <did>
          <unittitle>TML, 45-101 - Tadalafil (Cialis) for Erectile dysfunction</unittitle>
          <unitdate type="inclusive">2003 December 22</unitdate>
          <container id="c548372fa58c04fbfdb09c74908e6c0f" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="6d019bd34df6ee222f4d7b86abc4822a" parent="c548372fa58c04fbfdb09c74908e6c0f" type="folder">10-11</container>
        </did>
        <accessrestrict id="a187e298156d35ecb24bf62acbaa2162">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="bf6ed6095bb9e6efdcac9a21b49e00e9" level="file">
        <did>
          <unittitle>TML, 45-95 - Tattoo Removal</unittitle>
          <unitdate type="inclusive">2003 November 24</unitdate>
          <container id="4b9fb590791999fe7a72ac36f495fef2" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="f8a514d82e2b9c97754ec886b063d905" parent="4b9fb590791999fe7a72ac36f495fef2" type="folder">12-13</container>
        </did>
        <accessrestrict id="1cb8774dfbec0195c1be0234b77205c6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="a857cbd537b23d5351b0c89499d70d8e" level="file">
        <did>
          <unittitle>TML, 45-51 - Priloscec, Nexium and stereoisomers</unittitle>
          <unitdate type="inclusive">2003 June 23</unitdate>
          <container id="a2667b68a50393237f1198f6e5a73026" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="5c4438390650513ca145d22bac49abfc" parent="a2667b68a50393237f1198f6e5a73026" type="folder">14</container>
        </did>
        <accessrestrict id="4b2308536bb701384ee28edb8995985a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="1ed11b7c73752bdb0689383a30c1baf5" level="file">
        <did>
          <unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle>
          <unitdate type="inclusive">2003 August 18</unitdate>
          <container id="caf9e55836a707cd54667d4082d285ff" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="a52a835471a1e666bb8b64da5a6fc29d" parent="caf9e55836a707cd54667d4082d285ff" type="folder">15-16</container>
        </did>
        <accessrestrict id="4ae7a8a3386cf59e0586622b1db28e61">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="c48f05a528d95bdfee4855de30cb54e2" level="file">
        <did>
          <unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle>
          <unitdate type="inclusive">2003 August 18</unitdate>
          <container id="a8480a35e90024da9ffe5baba5cde50c" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="29c02e99bc2483e476f31036c31f3223" parent="a8480a35e90024da9ffe5baba5cde50c" type="folder">1</container>
        </did>
        <accessrestrict id="d1a19b29c41ed450efa6dd0a35b030ad">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3e6aff84359c7cdd06669d9d72f8c12a" level="file">
        <did>
          <unittitle>TML, 45-21 - Montelukast (Singulair) for allergic rhinitis</unittitle>
          <unitdate type="inclusive">2003 March 17</unitdate>
          <container id="e83e11ec6f50d883058a102f9e1b9214" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="7557ae1e74ab239946ac75c87031d3e4" parent="e83e11ec6f50d883058a102f9e1b9214" type="folder">2-4</container>
        </did>
        <accessrestrict id="2b573db89b3a7e7ffb7bbe4571d64e85">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="7d40fbe976113721e79b64dd1d00e27d" level="file">
        <did>
          <unittitle>TML, 45-3 - OTC Loratadine</unittitle>
          <unitdate type="inclusive">2003 January 6</unitdate>
          <container id="e6f20cedf216f7a152c919225499270c" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="070967230d3afd8c012148417ee7d16e" parent="e6f20cedf216f7a152c919225499270c" type="folder">5</container>
        </did>
        <accessrestrict id="68d83db5324a44659c1dd3f51c2e2864">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="1823eedc9d0074c8a4265ac61efdfda5" level="file">
        <did>
          <unittitle>TML, 45-41 - Insect repellents</unittitle>
          <unitdate type="inclusive">2003 May 26</unitdate>
          <container id="112ad8a421f4a0aeda6a82c34ae0b79b" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="18829840c5a9843a682d3f0e138f0a51" parent="112ad8a421f4a0aeda6a82c34ae0b79b" type="folder">6-8</container>
        </did>
        <accessrestrict id="fd9f974ca565c85df29a51348d8fb4a7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="2f3bcea3a484b983f63233e648e58d71" level="file">
        <did>
          <unittitle>TML, 45-81 - Rosuvastatin - a new lipid-lowering drug</unittitle>
          <unitdate type="inclusive">2003 October 13</unitdate>
          <container id="9a4cdef0688d9de70907796185d2223e" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="25a98b71a0171cb011e9be446e23811f" parent="9a4cdef0688d9de70907796185d2223e" type="folder">9-12</container>
        </did>
        <accessrestrict id="43bf4f6f81d3fbdf04c68bbc454e9040">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="ba56ad48c3bef0d702fff7fdda72fa22" level="file">
        <did>
          <unittitle>TML, 45-35 - Insulin-sensitizing drugs for polycystic ovary syndrome</unittitle>
          <unitdate type="inclusive">2003 April 28</unitdate>
          <container id="fdb9b6813ad86ae992462f19d5a417bb" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="b733a964aa42f5cbb3e89dfe4ce66f2c" parent="fdb9b6813ad86ae992462f19d5a417bb" type="folder">13-15</container>
        </did>
        <accessrestrict id="68c074ca5c7b85d99e37109be8f03f26">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3d9fbb15ae7446c6c645d70bd47fbf3b" level="file">
        <did>
          <unittitle>TML, 45-73 - Memantine for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2003 September 15</unitdate>
          <container id="43475f4d664dd9662cf4bcecb80a05dd" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="1914d0766b6932cd48db4148dd89b61a" parent="43475f4d664dd9662cf4bcecb80a05dd" type="folder">16-18</container>
        </did>
        <accessrestrict id="349dea74056b705fe12a6e58b6be4a61">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="11bdec471c430a38763f1ea9a86eab38" level="file">
        <did>
          <unittitle>TML, 45-58 - Treatment of heat injury</unittitle>
          <unitdate type="inclusive">2003 July 21</unitdate>
          <container id="8f10fdf5c9e4c8b8bcf569bc4359ffcf" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="cacb7fcb143d7729783453ff730b7c83" parent="8f10fdf5c9e4c8b8bcf569bc4359ffcf" type="folder">1-2</container>
        </did>
        <accessrestrict id="b32e89185eafe8ec72db09448de5ce28">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="806d8942533d66de734e65e88b3304ee" level="file">
        <did>
          <unittitle>TML, 45-90 - Atazanavir (Reyataz) and Emtricitabine (Emtriva) for HIV infection</unittitle>
          <unitdate type="inclusive">2003 November 10</unitdate>
          <container id="abe5e1ee54fd273cf10bc698ac5d4014" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="40a5ac2bc790f6d9f068ec7e6ba89e2e" parent="abe5e1ee54fd273cf10bc698ac5d4014" type="folder">3-6</container>
        </did>
        <accessrestrict id="d90cbf0a7351c28f0b2d1347edc27949">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="04dee614a81cacb32c43ef5b0a88af03" level="file">
        <did>
          <unittitle>TML, 45-88 - Aldurazyme (Laronidase)</unittitle>
          <unitdate type="inclusive">2003 October 27</unitdate>
          <container id="a20934cdec968994d3efa52dcaf98d4b" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="3da71bc78d9a6fcfe43e793f5ff4b5b7" parent="a20934cdec968994d3efa52dcaf98d4b" type="folder">7-8</container>
        </did>
        <accessrestrict id="b53a56596e6cd54c520d93ec764edd68">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="9233509af152396c7a0be4f4a4690cec" level="file">
        <did>
          <unittitle>TML, 45-46 - Drug Interactions</unittitle>
          <unitdate type="inclusive">2003 June 9</unitdate>
          <container id="fa509f1777e7f6a0377fc78a54cbe36c" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="ca8cbe76fcd3b8dec1d8742049b867e3" parent="fa509f1777e7f6a0377fc78a54cbe36c" type="folder">9-12</container>
        </did>
        <accessrestrict id="7b355cfd23bf5faae7008b6d8dfcd613">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="95a2b9eb73be12648888070a03ead474" level="file">
        <did>
          <unittitle>TML, 45-85 - Lowering Plasma Homocystein</unittitle>
          <unitdate type="inclusive">2003 October 27</unitdate>
          <container id="5af1e363def56b44db6bd27d4b701230" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="cd5797a46c0d090e4424d06dda65ec8e" parent="5af1e363def56b44db6bd27d4b701230" type="folder">13-17</container>
        </did>
        <accessrestrict id="150bc9e4636bdbb6ef444d31120758f6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="dad27947e40b662edd3cc5a90a0be625" level="file">
        <did>
          <unittitle>TML, 45-83 - Lp-Pla2 - A new marker of Vasular Risk</unittitle>
          <unitdate type="inclusive">2003 October 13</unitdate>
          <container id="59bf2911477f4895ae9b6012fd7d27a2" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="ec63165425ced147f02f5078eb2434da" parent="59bf2911477f4895ae9b6012fd7d27a2" type="folder">18-19</container>
        </did>
        <accessrestrict id="7bacb749d5cace7b77c6d20686088469">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="e617e6eea5f9996628c705dd200e1ffa" level="file">
        <did>
          <unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle>
          <unitdate type="inclusive">2003 March 3</unitdate>
          <container id="29541ca30ea8f466b77b95203d75316f" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="f409c2d1b67843bea8ffc6567ecad881" parent="29541ca30ea8f466b77b95203d75316f" type="folder">20</container>
        </did>
        <accessrestrict id="8c291adc86b1ece8d63fe68ecf028b3e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="9fd8a0d9db61f711e261afe6ec4c49ea" level="file">
        <did>
          <unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle>
          <unitdate type="inclusive">2003 March 3</unitdate>
          <container id="ac2541691f3794f792b333e35a2ec78d" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="f53ae97ec39bd1c6e0047de83393cc87" parent="ac2541691f3794f792b333e35a2ec78d" type="folder">1-4</container>
        </did>
        <accessrestrict id="bce92c80f15ffaccbaa401c6170b83ed">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="edaf8bc319227fe95dce9ce1973f3621" level="file">
        <did>
          <unittitle>TML, 45-86 - Iodine-131 - Tositumomab (Bexxar) for treatment of Lymphoma</unittitle>
          <unitdate type="inclusive">2003 October 27</unitdate>
          <container id="f793a1ef3b078ca9a1435df447099b58" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="0505d6f061fc9b2a07ad42b4f9a29b17" parent="f793a1ef3b078ca9a1435df447099b58" type="folder">5-9</container>
        </did>
        <accessrestrict id="a9e5f083314a82f3692a841eac51a5ca">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="f8dc69e4bf109c9986cc722051633070" level="file">
        <did>
          <unittitle>TML, 45-27 - Pneumococcal Conjugate Vaccine</unittitle>
          <unitdate type="inclusive">2003 March 31</unitdate>
          <container id="6aad5931314afc25592a78513127c00e" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="f41bb2c70f360caa7636a55d8fa335d7" parent="6aad5931314afc25592a78513127c00e" type="folder">10-11</container>
        </did>
        <accessrestrict id="e59f218612780c21cd1831f3c38ec08e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="cc9f06be346fedef1f6102477bee9cb2" level="file">
        <did>
          <unittitle>TML, 45-78 - Influenza Prevention</unittitle>
          <unitdate type="inclusive">2003 September 29</unitdate>
          <container id="9961a8888ac9d49199077c949563b28a" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="9a4b2bf1e118dbbe86dd3cfb88d45c7d" parent="9961a8888ac9d49199077c949563b28a" type="folder">12-14</container>
        </did>
        <accessrestrict id="cc6daf505d9a0ea7ee4c3ea324aa8478">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="39d9d76dedec7d6057d3eb65d8744ded" level="file">
        <did>
          <unittitle>TML, 45-19 - Peginterferon alfa (Pegasys) for Chronic Hepatitis C</unittitle>
          <unitdate type="inclusive">2003 March 3</unitdate>
          <container id="1f235bfaeb35090864e47cd89a1a3891" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="05661a42b08dad4a367a6683b5c25a7a" parent="1f235bfaeb35090864e47cd89a1a3891" type="folder">15-16</container>
        </did>
        <accessrestrict id="4cfe15ffe7bdd2742771ed54d3c1d07c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="efd0e7eb3789a0bc30a68f63ca9b430c" level="file">
        <did>
          <unittitle>TML, 45-55 - Pegvisomant (Somavert) for Acromegly</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="04d1184f4ef40914657eec4784b65c42" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="787c00b2c6bf8e9fa6fe9d8dcf325336" parent="04d1184f4ef40914657eec4784b65c42" type="folder">17-20</container>
        </did>
        <accessrestrict id="565dbbbdc9cf527d50ca1536a406a58f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="e809ce901af88811ad1fd0cb5bc5882c" level="file">
        <did>
          <unittitle>TML, 45-9 - Teriparatide for Osteoporosis</unittitle>
          <unitdate type="inclusive">2003 February 3</unitdate>
          <container id="d7699eaf8f3fd54f42fd36e869a7fc94" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="2f8a6c2113361326a14cea3110e900b6" parent="d7699eaf8f3fd54f42fd36e869a7fc94" type="folder">1-4</container>
        </did>
        <accessrestrict id="662bdc9f7dbb54b08b4950ea34c176c4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="acd944256fa6e191f50b1c636b7b7bf4" level="file">
        <did>
          <unittitle>TML, 45-70 - Testim and Striant - two new testosterone products</unittitle>
          <unitdate type="inclusive">2003 September 1</unitdate>
          <container id="42fb1d4a74366d836ce6c5b1b271729e" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="e1169ade01f7075c68ce91796b550199" parent="42fb1d4a74366d836ce6c5b1b271729e" type="folder">5-8</container>
        </did>
        <accessrestrict id="56655a641344d4055a005097ec27c5cb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="fbdf4b7f30d77eaf33b84599e0a5e6e6" level="file">
        <did>
          <unittitle>TML, 45-1 - Smallpox vaccine</unittitle>
          <unitdate type="inclusive">2003 January 6</unitdate>
          <container id="ce8231ce76afb58cfa0bc56d675ced3b" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="4c5f1e49e08f177ada4db69a6db94458" parent="ce8231ce76afb58cfa0bc56d675ced3b" type="folder">9-12</container>
        </did>
        <accessrestrict id="df814d1bfcebe53223f1d57c2a6776e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="d9642438ec124cd82d8e135b0198ede7" level="file">
        <did>
          <unittitle>TML, 45-69 - Minimal surgery for treatment of GERD</unittitle>
          <unitdate type="inclusive">2003 September 1</unitdate>
          <container id="b76cf7175ce19a42d850e8b893996d2b" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="e8f372345698afeb5525af4342248ffe" parent="b76cf7175ce19a42d850e8b893996d2b" type="folder">13-16</container>
        </did>
        <accessrestrict id="572b2a0e74e3c89c9169b31576cc0b55">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="0e7f3c8cc41ff780e30caa2e1cd3c245" level="file">
        <did>
          <unittitle>TML, 45-23 - Drug-eluting Stents</unittitle>
          <unitdate type="inclusive">2003 March 17</unitdate>
          <container id="013fc6dc6611fe9d1bee4b57cc741d4a" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="cf3e0e392ea13dcb3e86e80ffa3f521f" parent="013fc6dc6611fe9d1bee4b57cc741d4a" type="folder">17-19</container>
        </did>
        <accessrestrict id="91472bcb765db5980f76960bca69f7bb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="4cbcc7808efc65afe1e68d84b33f1bea" level="file">
        <did>
          <unittitle>TML, 45-23 - Drug-eluting Stents</unittitle>
          <unitdate type="inclusive">2003 March 17</unitdate>
          <container id="77cd31b9a82cfad4046775893e80f2f2" label="Mixed Materials (A0000000075933)" type="box">91</container>
          <container id="8524c53c6c75c1278ea1ca4c87c0e7ab" parent="77cd31b9a82cfad4046775893e80f2f2" type="folder">1</container>
        </did>
        <accessrestrict id="ad37cdcd99a2044624e749e1cd39779d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="f9a9c4fc1896553a888be142b1758016" level="file">
        <did>
          <unittitle>TML, 45-61 - Omeprazole (Prilosec) (OTC)</unittitle>
          <unitdate type="inclusive">2003 August 4</unitdate>
          <container id="63f991d830816ca4a7628a28b4cd5621" label="Mixed Materials (A0000000075933)" type="box">91</container>
          <container id="80248e9d7c3f6b9904ccedc28252943a" parent="63f991d830816ca4a7628a28b4cd5621" type="folder">2-3</container>
        </did>
        <accessrestrict id="d9a5d8493c3334bb1cda4ff7afb8a52c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="839fb8691411f959bd1aac5c4ebf7d26" level="file">
        <did>
          <unittitle>TML, 45-29 - Nitazoxanide (Alina) - a new anti-protozoal agent</unittitle>
          <unitdate type="inclusive">2003 April 14</unitdate>
          <container id="b19b9478628b45ad53e4aa438fadfe94" label="Mixed Materials (A0000000075933)" type="box">91</container>
          <container id="dbdaf97854276a51f7e83378b5a4404b" parent="b19b9478628b45ad53e4aa438fadfe94" type="folder">4-5</container>
        </did>
        <accessrestrict id="ba825ee552c2bf91acd8b458e0a15d2d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="55365ce4b3ea2d58db64e9416965cb4e" level="file">
        <did>
          <unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="6b2a25a42990081be7b61ab08762b117" label="Mixed Materials (A0000000075933)" type="box">91</container>
          <container id="24e881d930b5d50181ead0925e8542df" parent="6b2a25a42990081be7b61ab08762b117" type="folder">6-17</container>
        </did>
        <accessrestrict id="0ed20f41fac45d1a638a3740752cb703">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="668d7e7e07b5750eb2c823e11c095964" level="file">
        <did>
          <unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="29c3c7b41fd29c3ec654fbff0906c1cd" label="Mixed Materials (A0000000075934)" type="box">92</container>
          <container id="d864b275beaa37c11ed59e840cd29f65" parent="29c3c7b41fd29c3ec654fbff0906c1cd" type="folder">1-4</container>
        </did>
        <accessrestrict id="c2b71f78c735a86ad9547e6e3d24546c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="c171f13c04b5ef1cf3b3fe5e96a9ef03" level="file">
        <did>
          <unittitle>TML - Weight Loss - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 December</unitdate>
          <container id="ad3cc3ace2ccb85516f63c803ffe745e" label="Mixed Materials (A0000000075934)" type="box">92</container>
          <container id="5d7991445f03c4438fe04c291c3a2fff" parent="ad3cc3ace2ccb85516f63c803ffe745e" type="folder">5-13</container>
        </did>
        <accessrestrict id="6dd9eece4a3c89e40bca2442781a600d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="ee60c4bf66a25475983425024da14c39" level="file">
        <did>
          <unittitle>TML - Heart Failure - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 April</unitdate>
          <container id="07d33baf07f91b6916afff17f0a1a2bc" label="Mixed Materials (A0000000075934)" type="box">92</container>
          <container id="cfbd5b14338ac7dbcf441f7044cc1416" parent="07d33baf07f91b6916afff17f0a1a2bc" type="folder">14-18</container>
        </did>
        <accessrestrict id="957488be5b6a3b3f5fb3aca8638e23b6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="0be1e684fc9e69b20bc9867cc0b7288f" level="file">
        <did>
          <unittitle>TML - Drugs for rheumatoid arthritis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 January</unitdate>
          <container id="cf5181af4a0619a29475b9e6ce26a6c5" label="Mixed Materials (A0000000075935)" type="box">93</container>
          <container id="61737dc4166d844c13025501e601bccc" parent="cf5181af4a0619a29475b9e6ce26a6c5" type="folder">1-7</container>
        </did>
        <accessrestrict id="fea0a477360238ce0c79c9e79ad6d39a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="c0978c508033828e366f1d55950a308e" level="file">
        <did>
          <unittitle>TML - Drugs for Psychiatric Disorders</unittitle>
          <unitdate type="inclusive">2003 July</unitdate>
          <container id="23673cc29414cda7f942e3747566b1e2" label="Mixed Materials (A0000000075935)" type="box">93</container>
          <container id="b46166b53282f149c6990cb0f8719831" parent="23673cc29414cda7f942e3747566b1e2" type="folder">8-18</container>
        </did>
        <accessrestrict id="03781a219ff982acf63e0290b3b87f0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="a9906d72f32382fa1bb39c1ccd388091" level="file">
        <did>
          <unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle>
          <unitdate type="inclusive">2003 January</unitdate>
          <container id="3fcb2d843977fd08e8ec0fbb66efda32" label="Mixed Materials (A0000000075935)" type="box">93</container>
          <container id="f241a835a951ad4db9a4e0e551bcbc7c" parent="3fcb2d843977fd08e8ec0fbb66efda32" type="folder">19</container>
        </did>
        <accessrestrict id="a19ba7012ef7e238dc26e208ad0c53df">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="9d1257d4a4ba512b1aa0bb0a4c07fdcd" level="file">
        <did>
          <unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle>
          <unitdate type="inclusive">2003 January</unitdate>
          <container id="f38a9b5cf87c158c3de1b043f27507ce" label="Mixed Materials (A0000000075936)" type="box">94</container>
          <container id="e648ad158393e18e9112891bffa4a66d" parent="f38a9b5cf87c158c3de1b043f27507ce" type="folder">1-4</container>
        </did>
        <accessrestrict id="2097ee7f9bd39cd5ea6f974d3df6ff1f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="380c664090534851fbc806e0558fde2f" level="file">
        <did>
          <unittitle>TML - Assisted Reproduction - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 October</unitdate>
          <container id="153d599666e31676d8836c8aea01865e" label="Mixed Materials (A0000000075936)" type="box">94</container>
          <container id="5efb1f205149f7b2610c93fa48c5d665" parent="153d599666e31676d8836c8aea01865e" type="folder">5-13</container>
        </did>
        <accessrestrict id="69fb416fcc934ed0c8b1f96140cd08e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="dfe820ca0d9eb165533f652cbc41ee32" level="file">
        <did>
          <unittitle>TML - Drugs for Hypertension - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 February</unitdate>
          <container id="69e476f2c952d401d14cd03e217bdfd8" label="Mixed Materials (A0000000075936)" type="box">94</container>
          <container id="b58b2d92c8314023ff260c0f302bb6ef" parent="69e476f2c952d401d14cd03e217bdfd8" type="folder">14-17</container>
        </did>
        <accessrestrict id="5a63fa0917343ef8eb141521fcb9e24e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3ce9ce08c457fba44042e2deea5066f7" level="file">
        <did>
          <unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="4fca55d2c9c5d7251ed55b856204716d" label="Mixed Materials (A0000000075936)" type="box">94</container>
          <container id="60ae8310214cbc22b7b513146989a397" parent="4fca55d2c9c5d7251ed55b856204716d" type="folder">18</container>
        </did>
        <accessrestrict id="43bc17de19e0d00f4e7031362b3b3efc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="d475b54c5095880adce7b8263966fe2d" level="file">
        <did>
          <unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="02d7a8f691ed3a9c540a335d274a058c" label="Mixed Materials (A0000000075937)" type="box">95</container>
          <container id="8fdd4b36d7330daba3689707d7702ab4" parent="02d7a8f691ed3a9c540a335d274a058c" type="folder">1-8</container>
        </did>
        <accessrestrict id="d727ecc0d3636f553591f418559bc721">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="a6efb00d5c63c6a2ccedf6563ae43110" level="file">
        <did>
          <unittitle>TML - Drugs for Epilepsy - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 May</unitdate>
          <container id="3ff8d0439f03d2c997a7e00a46f2248c" label="Mixed Materials (A0000000075937)" type="box">95</container>
          <container id="400689f8e0e789f54001a5d75d872b87" parent="3ff8d0439f03d2c997a7e00a46f2248c" type="folder">9-14</container>
        </did>
        <accessrestrict id="ae7bd45c44b6a19a25f101af3b5a211a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="5a5ba60bec4d0b97fddcd00799fd7626" level="file">
        <did>
          <unittitle>TML - Drugs for Lipid Disorders - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 August</unitdate>
          <container id="50a1df858a970162b14d433838a37f04" label="Mixed Materials (A0000000075937)" type="box">95</container>
          <container id="953891ac2aec1d43d7055c1b4794ec85" parent="50a1df858a970162b14d433838a37f04" type="folder">15-18</container>
        </did>
        <accessrestrict id="334e64660b4fc298f4d1c26e9a76a343">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3c1aea5febbafdf8b5e437a8e97b9218" level="file">
        <did>
          <unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="33b56a744e37949b4836384bed4e67da" label="Mixed Materials (A0000000075937)" type="box">95</container>
          <container id="519d27f43b07a5d7b959530bceff70a1" parent="33b56a744e37949b4836384bed4e67da" type="folder">19</container>
        </did>
        <accessrestrict id="7cdf942787e0cbed8326189a2020f299">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="ddf6b73987ce0637989f66584610c6ea" level="file">
        <did>
          <unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="7318860108b1defa176cbe83da632518" label="Mixed Materials (A0000000075938)" type="box">96</container>
          <container id="7fd15b4d24789f96a7202d64ac912377" parent="7318860108b1defa176cbe83da632518" type="folder">1</container>
        </did>
        <accessrestrict id="2b960cecbba771988110df8a9cd33742">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="0ca468433bcdc6006e7fb9b0ef21814e" level="file">
        <did>
          <unittitle>TML, 45-93 - Which SSRI</unittitle>
          <unitdate type="inclusive">2003 November 24</unitdate>
          <container id="0dece1711f46b928ac455c980fa6cf79" label="Mixed Materials (A0000000075938)" type="box">96</container>
          <container id="816b7d13b22c65d38cd8f6b1cd8f9493" parent="0dece1711f46b928ac455c980fa6cf79" type="folder">2-5</container>
        </did>
        <accessrestrict id="72e10bfbf01df945876de61f8480a08b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="1e5a72f232d4e116685aff32e9ed9f87" level="file">
        <did>
          <unittitle>TML - Drugs for Allergic Disorders - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 November</unitdate>
          <container id="9f683c9438421e7b90020a8584782263" label="Mixed Materials (A0000000075938)" type="box">96</container>
          <container id="fdbb37ca19ab9ed962f6d79f4d341c93" parent="9f683c9438421e7b90020a8584782263" type="folder">6-9</container>
        </did>
        <accessrestrict id="ce922dcf8bde445758a34a54106e0ec6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="7621ca9e85272fb03e367f6102650bf9" level="file">
        <did>
          <unittitle>TML - Drugs for Pneumonia - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 September</unitdate>
          <container id="3af552d8f0ebe6619748e620379973db" label="Mixed Materials (A0000000075938)" type="box">96</container>
          <container id="b61bb622873be7f450cc21a1247c6132" parent="3af552d8f0ebe6619748e620379973db" type="folder">10-17</container>
        </did>
        <accessrestrict id="429d1928e15342d8a9639e6b6a92e6d4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="68e729c691bb49c8be35f332fbb1e32b" level="file">
        <did>
          <unittitle>TML - Antimicrobial Prophylaxis for Surgery - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="fbd0fe6c1cc4d78fa8a2bda46a6adf49" label="Mixed Materials (A0000000075939)" type="box">97</container>
          <container id="f63b98a51cf1b42e55453e7200c642fe" parent="fbd0fe6c1cc4d78fa8a2bda46a6adf49" type="folder">1-10</container>
        </did>
        <accessrestrict id="084a4278da0f4581918db07f8eb825b4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="07f19737b5f6d3009e9e85a8b0528533" level="file">
        <did>
          <unittitle>TML - Drugs for Cardiac Arrhythmias - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="11811fa6f0a0c8cbf2410195a18f1483" label="Mixed Materials (A0000000075939)" type="box">97</container>
          <container id="188ad7629101cf3b475d8af498bd955a" parent="11811fa6f0a0c8cbf2410195a18f1483" type="folder">11-18</container>
        </did>
        <accessrestrict id="8f26a61c71898392ee05f246c39c61b0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="c099bb967206188345dcdbf9c2975e6d" level="file">
        <did>
          <unittitle>TML - Advice for Travelers - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="b8bd687d0cb51aa14a30f6044279c672" label="Mixed Materials (A0000000075940)" type="box">98</container>
          <container id="279b0d26abea5bc479fd7846343fd711" parent="b8bd687d0cb51aa14a30f6044279c672" type="folder">1-9</container>
        </did>
        <accessrestrict id="e0b7814bc924716eb27275e9522cf9ae">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="237497500e700200226282634e319af9" level="file">
        <did>
          <unittitle>TML - Drugs for Migraine - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="252bf8b356af4c2ea10efd67452f421a" label="Mixed Materials (A0000000075940)" type="box">98</container>
          <container id="de17ec6b08287e2ccb3e79d32ba356ff" parent="252bf8b356af4c2ea10efd67452f421a" type="folder">10-15</container>
        </did>
        <accessrestrict id="00d75b64dab2398628516bc88ce53406">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="423b8c383be805c9a485a8fecfe9ddb1" level="file">
        <did>
          <unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 December</unitdate>
          <container id="d131c2219a47cfb6cba2c23853751751" label="Mixed Materials (A0000000075940)" type="box">98</container>
          <container id="c470bd15baf7524f2eed097ee11910f9" parent="d131c2219a47cfb6cba2c23853751751" type="folder">16</container>
        </did>
        <accessrestrict id="98f8b37e529ccb193a51c645e7d19af9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="26700edc7d4dff9bb83e29c005e8dedd" level="file">
        <did>
          <unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 December</unitdate>
          <container id="a88de6bc7cd47f80c4e2819fbb76fa62" label="Mixed Materials (A0000000075941)" type="box">99</container>
          <container id="4b756fb0dca0dd955cd2b002a446feda" parent="a88de6bc7cd47f80c4e2819fbb76fa62" type="folder">1-5</container>
        </did>
        <accessrestrict id="ff906c4305f7b289ec47141f34c41d10">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="bef1ef630d26c3d4f70cc63b2da9dbfa" level="file">
        <did>
          <unittitle>TML - Drugs for Sexually transmitted infections - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 October</unitdate>
          <container id="63c3c85e7ba2532ff249ee5eb1b2a661" label="Mixed Materials (A0000000075941)" type="box">99</container>
          <container id="7369b932170e600dcc4130b8b0f3a354" parent="63c3c85e7ba2532ff249ee5eb1b2a661" type="folder">6-12</container>
        </did>
        <accessrestrict id="6db6900a0738aa418a1db1239ba995f3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="ef8b77a4a9168df66dbaa1d35328f051" level="file">
        <did>
          <unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 June</unitdate>
          <container id="cdd76915eb7aa26ab4385bd1dbf52018" label="Mixed Materials (A0000000075941)" type="box">99</container>
          <container id="d2d5e7d13306865230f5aa6b4a6cf6ef" parent="cdd76915eb7aa26ab4385bd1dbf52018" type="folder">13-18</container>
        </did>
        <accessrestrict id="d4257f7e3e2891eb7db697e7bd0a7fc7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="4122c98e47eb1d53ed958233e91ca5d6" level="file">
        <did>
          <unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 June</unitdate>
          <container id="d733845963fbe8ac9238ee0dab46cd03" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="0aa249cfc448f3309bc513be2bd28ad6" parent="d733845963fbe8ac9238ee0dab46cd03" type="folder">1-3</container>
        </did>
        <accessrestrict id="4ac25a41ad51ce40a2b44624b0c6f458">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="1db0c21858cc9e616d5906c203e6860d" level="file">
        <did>
          <unittitle>TML, 46-22 - Abarelix (Plenaxis) for advanced prostrate cancer</unittitle>
          <unitdate type="inclusive">2004 March 15</unitdate>
          <container id="145c717ab820fb4429aff2c5b2260941" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="56340a6facbc55b7b02c87fb3a0a5d90" parent="145c717ab820fb4429aff2c5b2260941" type="folder">4-5</container>
        </did>
        <accessrestrict id="d7dfc37db7d6c404c6134b6250ab6400">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="7f8aea6a2a9125acc397a2b721ccebdb" level="file">
        <did>
          <unittitle>TML, 46-9 - Daptomycin (Cubicin) for skin and soft tissue infections</unittitle>
          <unitdate type="inclusive">2004 February 2</unitdate>
          <container id="6db5c73c349d899411d08ecdb7195b3e" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="349bd9611711e0b9a8c6572ac205a71c" parent="6db5c73c349d899411d08ecdb7195b3e" type="folder">6-8</container>
        </did>
        <accessrestrict id="8b64bb10092754b7b8a4c90c8deb7337">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="08fbdaa8a0871e1576f4bafb794f57f9" level="file">
        <did>
          <unittitle>TML, 46-10 - Emergency Contraception OTC</unittitle>
          <unitdate type="inclusive">2004 February 2</unitdate>
          <container id="3f0d87059b9a77e9589ec3989142f426" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="82bb37b499c8dbd135b0f0e3ddc579e4" parent="3f0d87059b9a77e9589ec3989142f426" type="folder">9-10</container>
        </did>
        <accessrestrict id="00f05ef1f3a72bb3da4ce317cb793c27">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="9ea3892837eec8429d01fe1dc14e6b41" level="file">
        <did>
          <unittitle>TML, 46-5 - Lasik and its alternatives - an update</unittitle>
          <unitdate type="inclusive">2004 January 19</unitdate>
          <container id="c20c27da44fd7dccc80cb13331da09ff" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="588ba67403348bb26a6bb05be9df10dc" parent="c20c27da44fd7dccc80cb13331da09ff" type="folder">11-14</container>
        </did>
        <accessrestrict id="7815c3c9e1b402b4a02ed5022e168609">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="f1703fc66140060139d86d70ac0c3846" level="file">
        <did>
          <unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle>
          <unitdate type="inclusive">2004 February 16</unitdate>
          <container id="65e80864bbe64186b1906d6cc016850c" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="fd01a4b544798abecaa412b24d583703" parent="65e80864bbe64186b1906d6cc016850c" type="folder">15-18</container>
        </did>
        <accessrestrict id="dc0cf1e8ca62aefc4f65bdca678ea19e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="e8f33c13c32daa15598a2e144e9f900f" level="file">
        <did>
          <unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle>
          <unitdate type="inclusive">2004 February 16</unitdate>
          <container id="1be9fcd3336178ba92446a396230f02f" label="Mixed Materials (A0000000075943)" type="box">101</container>
          <container id="6c995e5a35c26655e93259ffcf655dc3" parent="1be9fcd3336178ba92446a396230f02f" type="folder">1</container>
        </did>
        <accessrestrict id="81a1621d7a2a2452c30a530869fc9bea">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="f1258ee39d7e2cce0fa124be57ed0634" level="file">
        <did>
          <unittitle>TML - Choice of Antibacterial Drugs - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 March</unitdate>
          <container id="99c9f9b7f11a6a1aee12aec59cb79583" label="Mixed Materials (A0000000075943)" type="box">101</container>
          <container id="9e8dc552697995801dccf4fa21cc1091" parent="99c9f9b7f11a6a1aee12aec59cb79583" type="folder">2-8</container>
        </did>
        <accessrestrict id="d14f31516858f5ff1d6ab38316a1acdf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="dcf6c003359f1d37afb6b89504a47763" level="file">
        <did>
          <unittitle>TML - Drugs for Peptic Ulcers - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 February</unitdate>
          <container id="1b7de318ae9d56d91dbeb31cae350b9a" label="Mixed Materials (A0000000075943)" type="box">101</container>
          <container id="3e62ae35339611dc86efc1fe8c3ff7d1" parent="1b7de318ae9d56d91dbeb31cae350b9a" type="folder">9-17</container>
        </did>
        <accessrestrict id="ee022307e7bb1d19942f259293477255">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="0ba4f3a6cf74e6af72c13dc1e491dbd6" level="file">
        <did>
          <unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 January</unitdate>
          <container id="9a2ed2a3805226daf219f29d486f8d9a" label="Mixed Materials (A0000000075943)" type="box">101</container>
          <container id="b4954f6b9cdf16ff50a423a0bb980263" parent="9a2ed2a3805226daf219f29d486f8d9a" type="folder">18-19</container>
        </did>
        <accessrestrict id="cae76792326d54b966f74999980f0522">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="499346d5020cece037a74d774986c858" level="file">
        <did>
          <unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 January</unitdate>
          <container id="6d941020ebd971d4e6cbeb9cd661bab1" label="Mixed Materials (A0000000075944)" type="box">102</container>
          <container id="e495a7b9f86d14edbd842e9ca877e943" parent="6d941020ebd971d4e6cbeb9cd661bab1" type="folder">1-4</container>
        </did>
        <accessrestrict id="78b76f282a6087796d952eea7ca3851b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="e2ff3268992aa759f09a842e60822ffb" level="file">
        <did>
          <unittitle>TML - Drugs for Pain - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 July</unitdate>
          <container id="ea30ff49a2f2a67bf8ed714330e949db" label="Mixed Materials (A0000000075944)" type="box">102</container>
          <container id="f16ef9595c167c188bd5d67b4492d462" parent="ea30ff49a2f2a67bf8ed714330e949db" type="folder">5-14</container>
        </did>
        <accessrestrict id="04e11af6b467a1e7c10d7574675c44fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
    </dsc>
  </archdesc>
</ead>
